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Summary 
Roughly thirty percent of coronary artery bypass graft (CABG) patients develop atrial 
fibrillation (AF) in the five days following surgery, increasing the risk of stroke, 
prolonging hospital stay three to four days, and increasing the overall cost of the 
procedure. According to some studies, over $1 billion is spent annually on this problem 
in the US alone. Current pharmacologic and nonpharmacologic means of AF prevention 
are suboptimal, and their side effects, expense, and inconvenience limit their widespread 
application. An accurate method for identifying patients at high risk for postoperative AF 
would allow these methods to be focused on the patients on which its utility would be 
highest. Several identification approaches have been proposed for this purpose, but 
results have been unimpressive, with many studies investigating a relatively small variety 
of measurements and/or variables. These studies used simple univariate and/or greedily 
feature selection multivariate techniques that could have missed possible predictive 
optima among variables. 
The main objective of this research was to develop a Bayesian Network (BN) and 
possibly other classifiers which could model/predict/assign risk of the occurrence of atrial 
fibrillation in coronary artery bypass graft patients through the incorporation of different 
types of patient data. Clinical data and electrocardiogram (ECG) derived features, both 
traditional and novel, are selected and combined using an evolutionary computing 
algorithm. A secondary objective was to develop an integrated framework for more 
advanced methods of feature selection and fusion for medical classification/prediction. 
To validate this novel methodology, we compare these advanced methods, specifically 
genetic algorithms and Bayesian networks, to current methods of data investigation. 
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We determined that the naïve Bayesian network classifier used with features selected by 
a genetic algorithm is a better classifier to use, given our cohort. The naïve BN allows for 
reasonable prediction despite being presented with patients with missing data points as 
might occur in the hospital. This classifier achieves a sensitivity of 0.63 and a specificity 
of 0.73 with an area under the receiver operating characteristic curve of 0.74. 
Furthermore, this system is based on probabilities that are well understood and easily 
incorporated into a clinical environment. These probabilities can be altered based on the 
cardiologists’ prior knowledge through Bayesian statistics, allowing for online sensitivity 
analysis by doctors, to perceive the best treatment options. Additionally, we stress that 
with larger datasets a traditional Bayesian network built using the presented genetic 
algorithm would be preferable to the naïve BN. 
Contributions of this research include: 
- An accurate, physician-friendly, postoperative AF risk stratification system that 
performs even under missing data conditions, while outperforming the “state of 
the art” system, 
- A thorough analysis of previously examined and novel pre- and postoperative 
clinical and ECG features for postoperative AF risk stratification, 
- A new methodology for genetic algorithm-built traditional Bayesian network 
classifiers allowing dynamic structure through novel chromosome, operator, and 
fitness definitions, and 
- An integrated methodology for inclusion of doctor’s expert knowledge into a 
probabilistic diagnosis support system. 
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Chapter 1  
Introduction 
Imagine yourself preparing to buy a used car. You arrive at the dealership 
and look the car over, thinking of repair costs. The possibility of each car being a 
“lemon” looms at the forefront of your mind. You take the car to be inspected by 
an independent mechanic; it costs you a little money, and you have an educated 
opinion from someone who knows more about the system. 
Now imagine that the inspection costs hundreds or even thousands of 
dollars, and there is the possibility of the inspection actually damaging the car in 
the process. At this point, you question the utility of the inspection and would most 
likely forgo it completely, hoping for the best. This is similar to situations that 
doctors face every day in hospitals around the nation when speculating on the 
occurrence of atrial fibrillation following coronary artery bypass graft, only the 
situation is more important than your personal transportation.  
1.1 Motivation 
Currently, roughly thirty percent of coronary artery bypass graft (CABG) patients 
develop atrial fibrillation (AF) in the five days following surgery, increasing the risk of 
stroke, prolonging hospital stay three to four days, and increasing the overall cost of the 
procedure[1, 2]. According to some studies, over $1 billion is spent annually on this 
problem in the US alone [1]. Current pharmacologic and nonpharmacologic means of AF 
prevention are suboptimal, and their side effects, expense, and inconvenience limit their 
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widespread use [3]. An accurate method for identifying patients at high risk for 
postoperative AF would allow these methods to be focused on the patients where its 
utility would be highest. 
Several identification approaches have been proposed for this purpose, but results have 
been unimpressive [1-22]. Most clinical studies investigate a relatively small amount of 
measurements and/or variables after a significant amount of time and money have been 
invested. Then, simple univariate and multivariate techniques are used that can miss 
possible correlations between variables that may hold the answer to the problem. By 
simply collecting more data types and using more intelligent feature selection and 
classification techniques, we could shed more light on the problem being investigated.  
This work illustrates the problem with the traditional approach and proposes a novel 
method for the creation of better classifiers based on the data that are already collected in 
many hospitals across the country. We present and test this method in this work and 
evaluate a methodology of electrocardiogram/electrogram (ECG) feature extraction to 
contribute to the risk stratification of AF following coronary bypass graft.  
1.2 Objectives 
The main objective of this research is to develop Bayesian networks (BN) and possibly 
other classifiers which could model/predict/assign risk of the occurrence of AF in CABG 
patients through the incorporation of different types of patient data. Clinical data and 
ECG derived features, both traditional and novel, are selected and combined using an 
evolutionary computing algorithm. We investigate profit or loss due to the inclusion of 
the following data types: 
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• Clinical Data:  Risk factors and other medical indicators currently recorded in the 
hospital after CABG and 
• ECG Features:  Time, frequency, and wavelet domain features derived from the 
collected ECG signals showing AF prediction potential. 
A secondary objective was to develop an integrated framework for more advanced 
methods of feature selection and fusion for medical classification/prediction. To validate 
this novel methodology, we compare current methods of data investigation to more 
advanced methodologies, specifically genetic programming and BNs. 
1.3 Methods 
Clinical data and ECG have been collected in two separate studies. The first, performed 
at the Hospital of the University of Pennsylvania, collected clinical data and ECG 
recordings following CABG and monitored which of these patients developed AF. The 
second study was performed at the Atlanta Veterans Affairs Medical Center, where  
presurgical ECGs were collected along with other clinical variables. Both studies are 
approved by each institution’s respective Institutional Review Boards (IRB). ECG 
features include separation of the ECG into its individual waveforms with further analysis 
of these components, including wavelet, spectral, and time domain features. Using these 
two sets of data, characteristics of the ECG, as well as the clinical variables, are 
investigated singly and in combination to find their relationship to the onset of AF 
following CABG. Multivariate classifiers are created by selecting features with a genetic 
algorithm (GA) and by combining the variables using logistic regression or a BN. These 
classifiers are then validated and their results analyzed and compared.  










Figure 1.1 Block diagram of AF risk stratification system including the patient, the 
decision support system, and the cardiologist. 
In order to more effectively prevent AF in CABG patients, high-risk patients must be 
identified and treated prophylactically through pharmacological or pacing means [3]. The 
overall system level approach to the control of postoperative AF consists of the patient, 
the decision system, and the physician that, based on the outcome of the decision system, 
prescribes the treatment. The contributions of this research focus on the decision system 
in this progression. The patient identification and treatment feedback control loop lends 
itself well to the application of intelligent control, possibly using automatic drug 
administration or electrical stimulation, though its implementation is beyond the scope of 
this research, due to the uncertainty behind the exact characteristics of these treatments. 
Contribution of this research to the decision system specifically includes: 
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- An accurate, physician-friendly, postoperative AF risk stratification system that 
performs even under missing data conditions, while outperforming the “state of 
the art” system, 
- A thorough analysis of previously examined and novel pre- and postoperative 
clinical and ECG features for postoperative AF risk stratification, 
- A new methodology for GA-built traditional BN classifiers allowing dynamic 
structure through novel chromosome, operator, and fitness definitions, and 
- An integrated methodology for inclusion of doctor’s expert knowledge into a 
probabilistic diagnosis support system. 
Important medical problems have been “poked at” with limited feature selection/fusion 
methods for much too long, especially while there are advanced methods of data mining 
and decision-making to be applied. The BN is an excellent tool for making decisions 
based on collected information, and is even able to handle missing data points [23]. By 
combining more types of data and expert knowledge into a BN, better accuracy and 
healthier patients are the likely result. 
1.5 Thesis Organization 
This chapter serves as an introduction to the problem and its complexity. Additionally, 
the objectives of the research are outlined, as well as the exclusion of some topics. A 
basic overview of the methods is presented, and finally, the contributions made to the 
field of medical decision-making and ECG analysis are discussed. 
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Chapter 2 serves as more detailed background of AF following coronary bypass graft and 
previous work in the field. Tools used in this work for risk stratification are further 
described in detail.  
Chapter 3 presents a typical methodology for the classification/prediction of AF 
following CABG using univariate classifiers on both the postoperative University of 
Pennsylvania dataset and the preoperativeVeterans Affairs dataset.  
Chapter 4 presents an advanced method of feature selection with two traditional 
multivariate classification systems contrasting with the approach of the previous 
chapter’s univariate classifier. This includes the usage of logistic regression and k-nearest 
neighbor classifiers. 
Chapter 5 introduces the usage of BNs and a novel approach for their construction using 
genetic algorithms to find better classifiers than the previous methods. Several other 
methods for network structure discovery are also tested and compared using the pre- and 
postoperative AF risk stratification data. We then select the best classifier and compare 
and contrast the previous methods with the current state of the art. Finally, we explore the 
use of a physician’s prior knowledge to influence the probabilities of the network 
offering an online sensitivity analysis of the predictive system. 
Chapter 6 concludes this work by summarizing the classifiers developed and their 
benefits and drawbacks. We then offer suggestions for further work in this area.  
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Chapter 2  
Background 
When addressing a problem of this depth and breadth, spanning fields as diverse as 
cardiac electrophysiology and machine learning, the combination of tools from differing 
domains requires an understanding of the benefits and drawbacks associated with each. 
This chapter will discuss AF and its causes and how this relates to features taken from the 
ECG. Additionally, we will discuss the different approaches that have been taken toward 
risk stratification of AF using the ECG measures, as well as the traditional clinical 
characteristics. We will also address methods for combining a variety of variables into a 
predictive framework, beneficial for use in a clinical setting. 
2.1 Electrocardiogram 
From a bio-mechanical perspective, the human heart is a four-chamber pump, accepting 
deoxygenated blood from the body and oxygenated blood from the lungs. The blood 
arrives in the left and right atria, is moved into the respective ventricles, and is forced out 
to the lungs and body again. The timing for these events is instigated in the sino-atrial 
node, a self-excitatory group of cardiac cells that depolarizes spontaneously at a rate of 
sixty to seventy beats-per-minute (BPM). This wave front of depolarization moves 
through the atrial cardiac tissue in specially adapted tissue channels and reaches the atrio-
ventricular node that then excites the ventricles. This excitation causes the cells to 
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time (s)  
Figure 2.1 Basic ECG signal from a patient in normal sinus rhythm. The waveform 
components and their labels are shown. 
The electrical activity in the heart can be recorded, resulting in the electrocardiogram 
(ECG) (Figure 2.1). This electrical signal is usually monitored with an electrode on the 
surface of the chest, which records the voltage at that point in relation to time. Surface 
electrodes, or leads, are placed on a patient in several different arrangements in order to 
record the electric information from several vantage points. The standard Einthoven 
arrangement is a set of three electrodes, one under the left and right clavicle as well as 
one below the left pectoral muscle as represented in Figure 2.2. These three electrodes are 
then designated as positive and negative in different combinations to create bipolar 
electrode pairs, measuring the potential across the chest. This allows recording of the 
heart’s potential in the frontal plane (plane separating front from back). A second set of 
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chest leads also shown in Figure 2.2, designated V1 through V6, record electrical activity 
in the transverse or horizontal plane—depth-wise through the chest. Alternatively, during 
surgery, electrodes can be attached to the wall of the heart to monitor electrical activity in 
the muscle directly [25]. 
 
Figure 2.2 Standard ECG electrode placement. 
The aforementioned electrodes each have a particular benefit for observing the heart in 
different stages in the contraction cycle. For instance, modified lead II records the R-
wave well, due to its orientation to the depolarization direction of the heart muscle fibers 
during that stage. Lead V1 is an excellent lead for observing the P wave. Therefore, it is 
important to select the correct electrode to observe the needed characteristic [25].  
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As the heart contraction cycle progresses, each part of the cycle has a characteristic 
waveform that appears in the chest ECG signal [25]. Figure 2.3 shows each of the 
portions, along with their contribution to the signal, and the sum of all parts. When there 
is an abnormality in the heart’s conduction system, the ECG’s shape changes, making it a 
useful tool for identifying the problem [25]. 
 
 
Figure 2.3. Cardiac excitatory structure and its associated ECG signal shape [25]. 
Unfortunately, the detection of an abnormality is more complicated than glancing at 
Figure 2.3 and determining if the patient’s signal matches. Every person’s heart structure 
is slightly different, with deviation in the muscle structure and orientation. Additionally, 
tissue densities and compositions differ, causing electrical conduction to change. The 
heart is also continuously adapting and remodeling in response to environmental stress. 
These factors alter the ECG recorded on the surface of the body [26]. Moreover, the 
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autonomic nervous system, through the vagus nerve, alters the pace and filling of the 
chambers, resulting in changes in cardiac output [27]. 
To complicate this, employing different machines, using different electrodes, on days 
with differing humidity, with patients breathing at different rates and depths will alter the 
measurement. There are many factors that change the signal slightly. Therefore, when 
comparing ECG waveforms between patients or among different recordings of the same 
patient, identifying markers of disease is extremely challenging [26, 28, 29]. All of these 
factors make the automation of this task difficult, given that a standard “template” is not 
known or does not exist. 
2.2 Atrial Fibrillation 
Atrial Fibrillation (AF) is the most commonly sustained cardiac arrhythmia, affecting 
over 2.2 million people [30] and roughly 5% of patients over the age of 65. It is 
characterized by erratic electrical activity of the atria as seen in Figure 2.4, causing erratic 
heart rate and fibrillatory P wave activity. This activity persists due to electrical wavelets, 
which in the presence of refractory tissue, reactivate previously depolarized heart muscle 
cells [31]. 





Figure 2.4 Normal sinus rhythm and AF ECG 
Resulting in irregular heart pacing, AF is associated with, and can lead to congestive 
heart failure, cardiomyopathy [2], and mortality [32]. AF is also an independent risk 
factor for developing blood clots and strokes [33], increasing its risk five-fold according 
to the American Heart Association. AF’s onset is highly correlated with age, sex, and the 
presence of coronary artery disease [34]. 
AF can be arrested in the short term through the use of medication or electrical 
cardioversion. Long-term solutions include medication, atrial pacemakers, and surgery 
such as the Maze procedure and radiofrequency ablation [31]. 
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2.3 Coronary Artery Bypass Graft 
Coronary artery bypass graft (CABG) is a procedure that allows the bypass of blood from 
the aorta around a blockage located on the surface of the heart. This blockage is the result 
of coronary artery disease that causes 37% of all deaths, nearly 500,000 Americans every 
year. The bypass conduit is usually the femoral vein, located in a patient’s upper thigh, or 
a mammary artery from the patient’s chest [35]. 
Roughly 30% of patients that undergo CABG surgery develop AF within the five days 
that follow [13], as seen in Figure 2.5. The risk of AF is highest in this period, and falls 
afterward. Postoperative AF is indistinguishable from other types of AF on the ECG and 
develops in both those patients who have and have not had this dysrhythmia previously. 
Though this is thought to be caused by the dramatic stress that is put on the body during 
surgery such as fluid loss, hormonal changes, inflammatory response, and possible 
ischemia, the actual mechanism is still unknown. This stress may trigger an individual’s 
pre-existing substrate or the substrate, may have been created during the surgery, and/or 
while in recovery. The trigger mechanism itself may also be formed during the recovery, 
which then excites cells to start the ectopic beats [15]. 























   
 
 
Figure 2.5 Day of onset of post-surgical AF [17]. 
It is thought that age contributes most significantly to the onset of postoperative AF by 
causing changes to the atrial myocardium, increased amounts of interstitial collagen, 
decreased myocytes, amyloid changes, dilation, fatty infiltration, and increased 
lipofuscin, which are all likely substrate components that would increase the occurrence 
of sustained AF. At age 75, roughly 10% of the original sinus node pacing cells still exist 
and 87% of postoperative AF patients have shown histological abnormalities, including 
myolysis and increased lipofuscin [36]. 



























Figure 2.6 Age related to occurrence of post-surgical AF [5]. 
Once a patient develops AF, the treatment principles, in order of priority, are to restore 
sinus rhythm, control the ventricular rate if sinus rhythm is not restored, and administer 
antithrombotics. Reinitialization of sinus rhythm is important to prevent 
thromboembolisms and minimize the amount of atrial tissue remodeling that may 
promote continued AF, increase the chance of spontaneous conversion to sinus rhythm, 
and decrease the recurrence rate following termination. The downside of treating rhythm 
before rate is the significant side-effects and prodysrhythmic effects of antidysrhythmic 
medications. Despite this, there seems to be no significant difference in the long term 
mortality between rate and rhythm control [37], though there might be a reduction in the 
length of hospital stay when rhythm control is the initial treatment [38]. 
Several methods of prophylaxis of postoperative AF have been suggested. Pharmacologic 
methods include the use of β-blockers, sotalol, and amiodarone, while surgical 
recommendations include biatrial pacing. These methods’ utilities are still not fully 
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quantified, but are generally accepted to be helpful in both reduction of occurrence and 
length of hospital stay when used appropriately [10, 39].  
Many authors agree that a post-surgical AF risk stratification/prediction method would 
contribute greatly to the field [1-7, 13, 15, 17, 19, 22, 39-42]. 
2.4 AF Risk Stratification Research 
Postoperative AF risk stratification has a basic trade-off that has been balanced 
throughout the research done to date: the balance between foresight and detection 
difficulty. Many investigators think that post-surgical AF is a multifactor problem that 
requires a prior tendency, that is then triggered by the stress imposed on the heart and its 
tissues by the surgery and healing [5]. If this is true, then risk could be assigned before 
the surgery, by identifying markers of this prior tendency, and prophylactic measures 
could be taken against AF’s onset. This is best done before surgery while medications 
can be altered or preparations can be made to make alterations in the recovery plan itself. 
Alternatively, by only trying to identify the patient’s predisposition to develop AF, there 
is the risk of not finding the marker because it is a combination of a multitude of factors 
or simply a long train of events, which, without data, cannot be identified. Therefore, 
research has been conducted trying to identify more short-term markers that may be 
evident following the surgery, which are amplified due to both the predisposition and the 
insult due to the surgery. 
In presurgical AF risk stratification, variables investigated include the patient’s 
demographics, history, ECG, and any other information that would be gathered following 
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thoracic surgery. Post-surgical risk-stratification would include all of the presurgical 
variables previously mentioned as well as more variable indication changes that may 
have occurred in the heart due to the surgery, such as a certain morphology or frequency 














Figure 2.7 Clinical and ECG Feature Space Representations 
2.4.1 Clinical Features 
Typically, clinical data collected for these types of studies falls into four main groups: 
• Demographic – age, race, sex, family history, etc. 
• Preoperative – history of AF, beat blocker usage, etc. 
• Operative – duration of cross clamp, temperature, etc. 
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• Postoperative – beat blocker withdrawal, hypokalemia, etc. 
The actual data collected, as expected, vary by the study’s purpose, the facility where it 
was conducted, and the facility’s policies. 
Clinical features are an excellent place to begin an investigation as they analyze 
information that is clearly linked to other issues within the hospital; otherwise, the data 
would never have been collected in the first place. Additionally, the infrastructure has 
already been established for its collection, and the data can be used for the investigation. 
Chang et al. found age greater than 60 to be the best overall predictor of AF occurrence 
(p < 0.01) when they studied 120 patients. Those patients older than 60 had a 3.7-fold 
greater likelihood of developing the dysrhythmia. They also found gender to be another 
independent predictor, with males 3 times as likely to develop AF than women (p = 0.03) 
[9].  
One study that focused entirely on clinical data was done by Mathew et al [17]. They 
studied 4,657 patients, of which, 1503 went into AF, to develop an AF risk index for 
postoperative patients. Demographic, preoperative, operative, and postoperative features 
were taken and combined into a weighted multivariable predictor. Simple t-, chi-squared, 
and rank-sum tests were used to select input variables and weights. They found important 
factors to be advanced age, history of AF or chronic obstructive pulmonary disease, valve 
surgery, and postoperative withdrawal of beta blockers (BB) or angiotensin-converting 
enzyme (ACE) inhibitor. Factors that reduced risk were BB administration, ACE 
inhibitors, potassium supplementation, and nonsteroidal anti-inflammatory drugs. Using 
their risk indicator, they achieved an area under the curve (AUC) of its receiver operating 
- 19 - 
characteristic (ROC) curve of 0.77 [17]. This risk factor was based on a cumulative point 
system, where the predictive factors were given a weighted score, and if a patient’s 
additive score was beyond a threshold, he or she was at risk.  
Following this study, Barnes et al. [7] performed a retrospective study on the use of 
amiodarone prophalaxis (AMP) using Mathew’s risk stratification methodology. They 
classified 509 patients into either high or low risk and determined, from hospital records, 
which patients had received AMP. Overall, the AMP patients had less AF and shorter 
durations. It was not statistically significant that AMP reduced the occurrence of AF in 
high-risk patients, though [7]. 
Aranki et al. [5] reported that 189 of 570 patients developed AF following CABG. The 
major risk factors included age, male gender, history of hypertension, need for an intra 
aortic balloon pump (IABP), postoperative pneumonia, need for prolonged ventilation 
(>24 hours), and return to the intensive care unit. Simple t- and chi-squared tests were 
used to select input variables with a p-value < 0.1 which were then entered into a logistic 
regression model [5]. 
Auer and Lamm et al. [6, 43] performed a similar study in 2005 where 99 of 253 patients 
developed AF following CABG. They found advanced age, having valvular heart disease 
surgery, occurrence of other post surgical complications, elevated white blood cell count, 
and lack of administration of preoperative BB as risk factors. They stress that male 
gender was not an independent risk factor for AF, differing from the Aranki study. 
Funk [13] reported that the most likely risk factors for postoperative AF were advanced 
age (65 years or greater), history of intermittent AF, atrial pacing, sex, race, and not 
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having hyperlipidemia. Risk factors for AF after hospital discharge up to 21 days 
following, included AF while hospitalized, valve surgery, and pulmonary hypertension. 
Of the 302 patients followed, 127 (42%) had AF; 41 had it after discharge, and for 10 it 
was their first episode. 
Hakala and Hedman [3] created a logistic regression model retrospectively using age, left 
ventricle ejection fraction, body surface area, digoxin administration, need for a IABP 
and inotropic medication. With 3676 patients, the predictive results led to only a 0.69 
AUC of the ROC. 
Osranek et al. [18] report that an elevated echocardiographically determined left atrial 
volume (LAV), a marker for chronic high atrial filling pressure, is a risk factor for 
postoperative AF. Patients with left atrial volume > 32 ml had an almost five-fold 
increased risk of postoperative AF, independent of age and clinical risk factors. The area 
under the receiver-operator characteristic curve was 0.729 for LAV and 0.768 for the 
combination of LAV and age. 
As a common thread through many studies, age continues to be a major contributing risk 
factor; possibly due to the physiological changes of that tissue we discussed earlier. The 
incidence of AF following cardiac surgery has been shown to increase 50% for every 
decade [44]. Members of the male sex seem to be generally more susceptible to 
postoperative AF [5, 22]. This is thought to be due to the differences in ion channel 
expression and autonomic tone. A previous history of AF is also indicative of risk, 
possibly due to the pre-existing substrate being already formed in the atrial tissue [15]. 
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When β-blockers are abruptly halted before surgery, catecholamine levels increase, which 
has been a proposed risk factor for postoperative AF as well [3, 15].  
There are many other risk factors that have been identified in study populations, but no 
predictor using these clinical risk factors have developed satisfactorily in a clinical setting 
[3]. So, further investigation has been performed to gain further understanding about the 
heart’s state before and after surgery by observing patient’s ECG. 
Table 2.1 Summary of postoperative AF prediction studies. 
Investigator Performance Sample Size Clinical Data Use ECG Data Use
Amar AUC = 0.69 1553 Yes Yes 
Chandy Not Validated 300 Yes Yes 
Chang Not Validated 120 Yes No 
Fukunami SN = 91% SP = 76% 92 No Yes 
Hakala AUC = 0.69 3676 Yes No 
Hogue Not Validated 31 No Yes 
Klein SN = 69% SP = 79% 45 No Yes 
Mathew AUC = 0.77 4675 Yes No 
Osranek AUC = 0.77 205 Yes No 
Stafford SN = 66%  SP = 70% 20 No Yes 
Vassilikos SN = 91%  SP = 65% 50 Yes Yes 
 
2.4.2 ECG Features 
The ECG can give more information about the immediate state of the heart, possibly 
showing any abnormal conduction patterns or variations. For this reason, the ECG has 
been investigated in a broad range of approaches [20]. The shape or widths of different 
morphological features have posed as a possible predictor, as has the variability of the 
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patient’s heart rate. Frequency measures of both the heart rate and the components of the 
signal itself have also been experimented on. As mentioned before, here are various ECG 
leads as well as different ways of collecting and preprocessing the data that all of these 
approaches might be applied to.  
It may seem like an impossible task to find the predictor amongst the noise, but 
fortunately, a significant amount of work has been done in this and related areas. In the 
following paragraphs, a summary of the features employed in these studies will be 
presented. 
2.4.2.1 Morphology 
Since atrial contractions are associated with the electrographic P wave, P waves’ 
morphology is typically the focus in research when using ECG to determine indicators 
for AF. Many measures have been applied to the P wave including durations, deviations, 
dispersions, and slopes [8, 9, 11, 12, 16, 19, 21, 45-54]. 
The difficulty with P wave measures is their lack of standardization. Each research team 
makes slightly different decisions on where to mark the onset and offset and when a 
particular P wave is not considered acceptable, and thereby discarded from analysis. This 
makes comparison of different methods very difficult. 
2.4.2.1.1 P wave duration 
The P wave duration is the measure of the width of the P wave in milliseconds (ms). This 
can be done on any lead and varies greatly between researches as to how the onset and 
offset points are defined. For instance, some researchers say that 10% rise point defines 
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the onset, while others advocate the first sign of deflection from the baseline, and still 
others don’t specify any particular method. Several studies found that a greater P wave 
duration is an indicator of abnormal atrial conduction, possibly showing substrate for AF. 
It seems to be a good indicator for the atrial conduction velocity [8]. The lengthening of 
the P wave and its associated electrical conduction through the heart can be thought of as 
water sounds in a clogged pipe; the longer the water sounds last, the longer it can be 
assumed the water is traveling due to the clog. If the water sounds are very short in 
overall time, there is probably not a clog, allowing smooth, quick flow with no chance of 
sedimentation fallout or the water finding its way through weak joints in the pipe. This 
could be analogous to action potential propagation through the electrical conduction 
pathways of the heart. 
Buxton and Josephson [46] observed 99 patients undergoing bypass graft, in which 29 
developed AF. They calculated the standard P wave duration on standard lead II as well 
as the simultaneous, three standard leads’ P wave duration. The P wave duration on the 
single modified II lead had little predictive value, while the duration on the three 
simultaneous standard leads was significant (p < 0.001). They used the standard 
definition for intra-atrial conduction defect (IACD) being a P wave duration greater than 
110 ms as defined by the New York Heart Association (NYHA). Passman et al. [19] 
studied the P wave durations of the standard leads I and II, as well as the V1 lead in 152 
patients finding them significantly predictive for AF (p = 0.02, p = 0.04, and p < 0.01, 
respectively). 
Amar et al. [4] used a database of 1,553 CABG patients to develop a risk stratification 
metric including four risk factors: age, history of AF, P wave duration (>110 ms), and 
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low cardiac output. Each factor was assigned a point score developed through multiple 
logistic-regression: age (1 point per year), history of AF (12 points), P wave duration (3 
points), and low cardiac output (10 points). The aggregate score was then transformed to 
a probability score using logistic regression and then thresholded into three risk classes. 
This score puts very little weight on ECG factors: three of roughly 125 possible points. 
The overall area under the ROC curve was 0.69, resulting in a fair overall classifier. 
In addition to the duration on a single P wave, the signal’s P waves can be averaged over 
many cycles to obtain the signal-averaged P wave. This requires the precise marking of 
many P wave onsets and offsets, lining them up, and doing an average. Some methods 
also use a template matching technique which also discards any “abnormal” 
morphologies. The only problem with this approach is how to determine abnormal. 
Chang et al. [9] calculated the signal-averaged P wave duration on the standard lead II 
from a 12-lead system in 120 patients and found a P wave duration (>100 ms in lead II) 
to be an independent predictor of AF (p = 0.04). Steinberg et al. [21] performed a 
prospective study observing the relationship between the signal averaged P wave duration 
and the occurrence of AF with 130 patients, of which 33 developed AF. They used P 
wave template matching and cross correlation measures to select appropriate P waves for 
inclusion. They found the P wave duration significantly longer in the AF patients (p < 
0.001) with a threshold of 140 ms giving a sensitivity of 77% and a specificity of 55%. 
Klein et al. [16] developed a P wave triggered signal averaging method for P wave 
duration measurement using leads X, Y, and Z. The orthogonal leads were combined into 
a vector magnitude and roughly 350 beats per patient were averaged after template 
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matching. There were 45 patients included in the study and 16 developed AF. The two 
groups were highly separable using this P wave duration (p < 0.005). Given a threshold 
of 155 ms, classification yielded a sensitivity of 69% and a specificity of 79%.  
Fukunami et al. performed a study using the same leads to determine whether a patient is 
at risk of paroxysmal AF. They compared 42 AF patients’ signal-averaged P waves to 50 
controls and found the P wave durations to be significantly longer in the AF patients (p < 
0.001). They also found the root-mean-squared amplitude value of the descending P wave 
to be a significant predictor (p < 0.0001). By combining these two measures, a predictive 
classifier was determined, which yielded a sensitivity of 91% and a specificity of 76% 
[47].  
Stafford et al. [50] performed a reproducibility analysis for signal averaged P waves 
taken four weeks apart. They analyzed 20 paroxysmal AF patients and 10 controls, 
recording the X, Y, and Z orthogonal leads. The P wave duration was the most 
reproducible of the measures, while P wave frequency components and spatial velocity 
were not consistent. Stafford suggests that some measures taken under signal averaging 
to predict AF are unreliable and questions their further utility if reproducibility concerns 
are not addressed. 
Additionally, the variance of the P wave duration has been identified as a possible 
indicator of abnormalities in AF patients. Andrikopoulos et al. [45] found that the P wave 
variance combined with several other variables made a good predictor for 60 idiopathic 
paroxysmal AF patients and 50 controls.  
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2.4.2.1.2 Isoelectric interval 
The isoelectric interval (IEI), shown in Figure 2.8, is determined by measuring the total 
onset to offset time across all channels of the ECG recording and subtracting from that, 
the maximum P wave duration seen on a single channel. This is difficult to do since it 
requires precise measurements of onsets and offsets on many channels, and slight 
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Figure 2.8 The Isoelectric Interval (IEI) is calculated as the difference of the maximum 
intra-channel P wave duration and the maximum single channel P wave duration. 
Buxton and Josephson [46] tested this by subtracting the P wave duration on the standard 
II lead from the overall duration from the three standard simultaneous limb leads. Patients 
with AF had an IEI of 12.4 ms while the controls had 5.9 ms (p < 0.001). They propose 
that this measure could be useful in identifying asynchronous activation of atrial 
conduction tissue, thereby stretching the total P wave time on the entire set of ECG leads. 
Stafford et al. [51] performed a similar study and found IEI to not be significant alone, 
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but in a predictor combined with P duration, yielded a sensitivity of 66% and a specificity 







wave Duration  
Figure 2.9 The P wave dispersion is measured as the difference of the maximum and 
minimum P wave durations. 
2.4.2.1.3 P wave dispersion 
P wave dispersion, shown in Figure 2.9, is measured as the difference of the longest and 
shortest P wave durations within a given period of time on a single lead. This is often 
done on the standard lead II, though other leads have been investigated. This is thought to 
be an indicator of the excitability of the atrial tissue surrounding the atrial conduction 
path [8]. If we think of the pipe analogy, this can be seen as the pipe’s wall being cracked 
and releasing water into the surrounding space, while it should be traveling straight 
through the pipe. 
Chandy et al. [8] collected both pre- and postoperative surface ECG signals from 300 
patients undergoing CABG, and observed AF in 81. Their main hypothesis was that age-
related structural and conduction changes of the atria, as well as surgical disruption, lead 
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to postoperative AF. Signs of these factors are hypothetically seen in the ECG. The usual 
demographic, medical condition, medication, surgical, and postoperative condition data 
were collected. P wave features were also calculated including P wave dispersion. Their 
analysis found a relationship between postoperative AF and age (p < 0.0001), body 
surface area (p < 0.0001), and an increase in postoperative P wave dispersion (p < 0.01). 
They used a multivariate logistic regression model to combine these predictors but did 
not report its performance metrics.  
It is thought that changes in P wave dispersion could be caused by fluid overload, thereby 
stretching the atrium, and altering its excitability/conductivity. Studies have been 
conducted that show the pressure and fluid levels in the left atrium, as well as 
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Figure 2.10 The P terminal force is calculated as the product of the width and depth under 
the baseline of the negative deflection of the P wave on the V1 lead. 
2.4.2.1.4 P terminal force 
The P terminal force, shown in Figure 2.10, is a measure of the V1 lead’s negative 
deflection under the baseline following the P wave peak and the length of the P wave. 
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This is measured as the distance under the baseline, multiplied by the length of time it is 
below the baseline. Therefore, it is a combined measure of time and amplitude. Stafford 
et al. [51] investigated this measure with several other measures in a 189-patient study 
and found this variable to not have statistical significance. Hopkins and Barrett [48] 
found this measure to be a somewhat useful diagnostic means to determine a patient’s left 




Figure 2.11 The PR interval is measured as the time interval from the beginning of the P 
wave to the beginning of the QRS complex. 
2.4.2.1.5 PR interval 
The PR interval, shown in Figure 2.11, is the length of time between the onset of the P 
wave and the beginning of the QRS complex. This can be interpreted as the time required 
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to excite the ventricle following the atrial activation, possibly giving insights into this 
activation pathway. 
Chandy et al. [8] performed a study analyzing the pre- and postoperative ECG for several 
P wave features. The PR interval, as well as PR segment depression, had a very high P 
value, thereby having no significant relationship to the occurrence of AF. Passman [19] 
also found the PR interval to be a somewhat useful predictor of AF when above 180 ms 
(p < 0.05, age adjusted). This measure, along with age > 65 and increased P duration 
greater than 110 ms, yielded a somewhat useful predictor. 
2.4.2.1.6 Premature atrial contractions 
 
Figure 2.12 Premature Atrial Contraction 
Premature atrial contractions (PACs) are the result of an activation of the atrium earlier 
than the typical cardiac cycle that propagates to make the ventricle contract early. The 
beat following the PAC is typically the traditional distance from this abnormal beat as 
seen in Figure 2.12. This shows a kind of resetting of the system. These PACs typically 
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have a differing morphology from the normal sinus beat, whose shape is determined by 
the location on the atrium it originated and spread to. 
Kolb et al. [55] studied the apparent cause of onset of spontaneous AF in 33 patients and 
found that over 93% were caused by PACs. This is seen as a possible trigger of the 
predisposing substrate. It can be assumed, then, that a patient with greater numbers of 
isolated PACs could be at higher risk of developing AF since a probably trigger of its 
onset is present. 
Although many of these studies of P wave characteristics had good data sets and 
thorough methods, the analysis of the P wave lacked some technological aspects. For 
instance, many P wave features were taken off of a paper ECG trace and measured with a 
magnifying glass, calipers, and/or metric ruler. Though definitions were clearly set 
individually for these measures, definitions varied greatly between studies.  
2.4.2.2 Heart Rate Variability 
Many investigators have also used the heart rate variability (HRV) as an indicator of 
sympathetic nervous system’s activity and its relation to the refractory period of the atrial 
cells. The HRV is calculated by annotating the R waves or the QRS complex onset and 
creating a tachogram showing the times between each of these contractions. Therefore, a 
person beginning physical exercise would have heart rate values increasing through time. 
Many values can be observed from this trace including traditional statistical measures 
such as mean, standard deviation, and minimum. 
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Hogue et al. [14] have investigated the relationship between RR dynamics and AF 
prediction following CABG. They had 31 patients, of which 18 went into AF. They then 
used three 20-minute pre-onset chunks of data from each patient while in normal sinus 
rhythm to calculate features. The features were mean RR duration and its standard 
deviation, the percentage of successive RR intervals that deviated by > 50% from the 
previous RR interval, and the root-mean-square of successive RR intervals. Power 
features were computed in the following bands: total (0-0.5 Hz), VLF (0.0033-0.04 Hz), 
LF (0.04-0.15 Hz), and HF (0.15-0.4 Hz). Approximate Entropy, a nonlinear measure of 
variability, was calculated on a 2 Hz sampled HRV. The relationships between these 
features were analyzed with a basic multinomial logistic regression analysis. This study 
found that only low Approximate Entropy and heart rate were independently associated 
with AF. These two variables are correlated, so the conclusion of these variables being 
associated with AF is not surprising. A slightly higher or lower heart rate than the control 
group (5 BPM) was also found to be a good indicator of risk. However, this measure 
tends to vary widely within a single patient, and unless compared against a single 
patient’s baseline rate, offers little information. No overall predictive accuracies or 
assessments were made. The small group of patients on which the study was based also 
leads us to have validation concerns. 
Maier et al. [56] performed a study of 200 patients using data provided for the Computers 
in Cardiology 2001 challenge. They extracted HRV measures from several time windows 
ranging from 2 to 30 minutes before onset of AF. The HRV feature set included the 
means and standard deviations of the RR intervals (including ectopic beats) as well as 
between only normal beats and the relative number of successive normal beat pairs which 
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differ by 50 ms. The standard deviation of the RR intervals (including ectopics) was an 
interesting predictor as were the percentage of consecutive normal-to-normal beats which 
differed by more than 50 ms. This seemed to be more of an indicator of the prescience of 
ectopic beats than of the type of analysis. Though a well done study, the sample size was 
too small for any statistically significant results. 
Vikman et al. [57] took a different approach by investigating the frequency content in the 
HRV signal. They investigated the significance of the HRV’s low frequency (0.04 to 0.15 
Hz), high frequency (0.15 to 0.4 Hz) and their relative relationship. They found that both 
of these frequency range magnitude decrease and the relationship between them stay 
relatively constant before AF onset. Additionally, they investigated an approximate 
entropy measure and a short-term detrended fluctuation analyses of the RR interval, 
measures of the repetitive and fractal natures of the signal. They found as AF onset 
approaches, there is increased repetition in the signal through the entropy measure and 
changes in the fratal characteristics of the signal. 
2.4.2.3 Frequency Domain 
Frequency domain analysis can be applied to the ECG data in many ways, both to the 
signal itself and the HRV data as Hogue did [14]. It has been observed that the 
fibrillatory frequency of a patient’s arrhythmia ramps up following the onset and 
decreases prior to termination. Bollmann et al. [58, 59] also found a positive correlation 
between the fibrillatory frequency and AF duration, meaning a low frequency fibrillation 
tended to terminate in a shorter period of time. This could indicate a relationship between 
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the size and/or refractory period of the re-entrant atrial conduction pathway to the 
sustainability as well as initialization of AF.  
Stafford et al. [52] observed the frequency content of the whole P wave and compared 
this with an analysis of its terminal portion. This was prompted by the discovery of the 
relationship between ventricular late potential activity and ventricular fibrillation and its 
possible extension to AF. They found that increased high frequency content in the third 
quarter of the P wave indicates a higher risk of AF. 
2.4.2.4 Wavelet Domain 
Wavelets are a useful tool to observe the time and frequency domain of the signal 
simultaneously. This is done by convolving the signal with a scaled version of a mother 
wavelet to arrive at the wavelet coefficients for that scale. These coefficients generally 
show greater amplitudes as the shape of the signal in the matching time frame correlates 
with the scaled wavelet. In this way we can see the given wavelet’s frequency in that 
window in time. Because the ECG is such a nonstationary signal with small waves that 
resemble wavelets, wavelet analysis seems an obvious choice. 
Vassilikos et al. [54] decomposed the high resolution ECG P wave using the Morlet 
wavelet on 50 patients after undergoing CABG, 17 of which went into AF. Prediction 
features such as hypertension, low ejection fraction, age, and power in the wavelet 
coefficients from several frequency bands were collected. Typical uni- and multivariate 
analyses were used for statistical significance. Overall, the regression yielded a 
sensitivity of 91% and a specificity of 65%. Again, this study uses a small sample size 
with few data types. Though this study begins to include clinical and ECG features in a 
- 35 - 
multivariable context, the max, min, and average P wave durations and Morlet wavelet 
decompositions do not show the short-term temporal information. More ECG features 
should be investigated in conjunction with the clinical features with attention to their 
location in time. 
Maier et al. [56] also used the Daubechies wavelet to analyze the different possible scales 
of fluctuations of the HRV series. They used 10 different scales finding several to have 
interesting classification properties on the training set which did not hold on the testing 
set. Though the study was well planned resulting in interesting findings, the amount of 
data was low and any far reaching statements of utility of these measures would be overly 
bold.  
2.4.3 ECG Feature Summary 
As this research suggests, limited combinations of clinical characteristics and few ECG 
features have been investigated, and those that are, tend to be simple wave duration 
calculations. AF precursors could be hidden in the clutter between more prominent 
morphological features. Wavelet decompositions and novel feature calculations coupled 
with advanced search strategies like data-mining could result in new innovations. A more 
thorough look at the information contained in the ECG is certainly warranted. 
2.5 Evolutionary Computing 
Evolutionary computing [60] uses the principles of a) survival of the fittest, b) 
reproduction, and c) mutation to achieve a predetermined goal in computer algorithms. Its 
applications can be the matching of a curve, the design of the perfect antenna, or anything 
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in between as long as the problem can be encoded and a fitness function can be defined 
for its assessment. The solutions are found through many generations of evolving 
individuals which become more fit through Darwinian selection. A nice property of these 
evaluations is that they can often be done in parallel, allowing an entire generation to be 
calculated at once when employing enough processors. Genetic algorithms are a type of 
evolutionary computing used to address a number of complex engineering problems. 
2.5.1 Genetic Algorithms 
Genetic algorithms (GA) [61, 62] are a tool for problem solving in which an algorithm 
evolves an encoded chromosome through Darwinian evolution. The GA searches the 
space of possible solutions for the one that achieves its goals most satisfactorily. The 
basic sequence of a GA is seen in Figure 2.13. An initial population of individuals, 
encoded as chromosomes, is created through either prior knowledge or randomly. The 
individual’s characteristics are encoded in the chromosome through many single quanta 
of information called nucleotides, just as they do in DNA. These individuals’ fitness are 
assessed and a selection process follows where the more fit individuals breed and mutate 
to form new individuals in the next generation which are then once again tested, and the 
cycle continues. Once a fitness threshold or the maximum number of iterations has been 
reached, the evolution is halted and one is left with the best overall individual, assuming 
the use of elitist selection.  








Figure 2.13 Genetic Algorithm (GA) Flow Chart 
An important aspect of a GA is that the chromosome is of predetermined length that 
encodes the problem, usually in binary or continuous representations. For instance, this 
can be a vector of base-ten numbers or a string of bits. Very often, the chromosome 
encoded corresponds to a high dimensional problem where many combinations of a set 
are tested for the optimum set [63]. The alternative, genetic programming, allows for an 
ever changing chromosome length allowing greater control of the encoding through 
generations but with the drawback of added complexity.  
There are three main operators which are performed while altering an individual’s 
chromosome: selection, mutation, and crossover. 
Elitism allows the selection of the overall best individual for inclusion in future 
generations. It essentially keeps the best gene pool in a population and does not allow the 
loss of the global maximum fitness earner until it has been beaten by another individual. 
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Mutation is the slight change in some part of the individual’s chromosome ranging from a 
single nucleotide alteration to several nucleotides. This is done completely at random just 
as it might in biological mutations. 
The crossover operator emulates chromosome creation following sexual reproduction in 
which a new individual’s chromosome is a combination of both the original parents’ 
chromosome. In the computational domain, this is achieved through an actual swapping 
of a section of chromosome creating two children with portions of each parents’ 
chromosome and all nucleotides are preserved in the population. 
2.6 Bayesian Networks 
A Bayesian network (BN) is a relatively new tool that uses probabilistic correlations 
among multiple variables to make predictions or assessments of class membership based 
on past data [23]. The use of probabilities derived from past data is similar to how a 
doctor currently makes decisions [64]; A doctor assesses the past occurrences of these 
symptoms and test results, to determine a likely diagnosis for a current case. When a BN 
is used for risk stratification, classification results and probabilistic context can be output 
together, allowing the doctor to observe why the network made a suggestion, instead of 
the “black box” method where the doctor does not understand the inner-workings and 
therefore will not trust it in a clinical setting [64]. 
To understand the benefits of BNs, we first need a quick review of basic statistics. A 
conditional probability is the likelihood of some conclusion, C, given some 
evidence/observation, E, where a dependence relationship exists between C and E. This 
probability is denoted as ( | )P C E where 
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Bayes’ theorem is the method of finding the converse probability of the conditional, 
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This conditional relationship allows an investigator to gain probability information about 
either C or E with the known outcome of the other. Now consider a complex problem 
with n binary variables, where the relationships among them are not clear for predicting a 
single class output variable (e.g., node 1 in Figure 2.14). If all variables were related 
using a single joint distribution, the equivalent of all nodes being first-level parents, the 
number of possible combinations of variables would be equal to 2n-1, given each node 
has two possible outcomes. For each combination, a sufficient number of samples must 
occur to obtain a realistic likelihood estimate. This results in the need for a very large 
amount of data [23, 65]. If dependence relationships between these variables could be 
determined resulting in independent variables being removed, fewer nodes would be 
adjacent to the node of interest. This parent-node removal leads to a significant reduction 
in the number of variable combinations, thereby reducing the amount of needed data. 
Furthermore, variables that are directly conditional, not to the node of interest but to the 
parents of the node of interest (as nodes 4 and 5 are with respect to node 1 in Figure 
2.14), can be related, which allows for a more robust system when dealing with missing 
data points. This property of requiring less information based on pre-existing 
understanding of the system’s variable dependencies is a major benefit of BNs [65]. 
Some further theoretical underpinnings of the Bayesian approach for classification have 
been addressed in [66] and [67]. 
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Figure 2.14 Basic BN Structure and Terminology. 
To use a BN as a classifier, first, one must assume that data correlation is equivalent to 
statistical dependence. Though this is not true from a pure mathematical standpoint, for 
purposes of medical diagnosis when few dependencies can be determined with a high 
degree of certainty, correlation between the two variables is assumed to give similar 
information. We also must assume that the data gathered accurately portrays the system, 
and with small datasets, this can be a difficult idea to accept or cross validate. 
In our work, we have investigated two types of BNs. The first type of network is the 
naïve BN, which makes an independence assumption, thereby reducing probability 
computation data requirements. The second type of network is the traditional network. 
The first traditional BNs were created with expert knowledge and usually dealt with 
fairly well understood principles and variable relationships. Currently, many complex 
problems exist where a researcher may have ample data for the variables of interest, but 
does not know the relationships between these variables in order to create the network. 
As the number of parents grows, the amount of data required to derive a conditional 
probability table of the BN grows exponentially. Therefore, the number of possible 
parents is limited by the size and composition of the data set available. Besides the data 
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requirement, the network must be built in a computationally viable way, while still 
producing accurate conditional variable dependencies [23, 65, 68]. 
Two methods of BN discovery are presented below, the first being a greedy hill-climb 
search and the second method based on evolutionary computing using a GA.  
2.6.1 Naïve Bayesian Classifier 
Given an evidence set E = {E1,E2, …, En}, the joint probability, ( , )P C E , can be expanded 




1 2 1 3 1 2
1 2 1 3 1 2 4 1 2 3
( , ,..., )
( ) ( ,..., | )
( ) ( | ) ( ,... | , )
( ) ( | ) ( | , ) ( ,... | , , )






P C E E
P C P E E C
P C P E C P E E C E
P C P E C P E C E P E E C E E
P C P E C P E C E P E C E E P E E C E E E
= ⋅
= ⋅ ⋅
= ⋅ ⋅ ⋅
= ⋅ ⋅ ⋅ ⋅
 (3) 
This expansion requires the use of significant amounts of data to determine the many 
probabilities. In order to reduce the number of required data samples, an assumption of 
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The use of this independence assumption is at the basis of the “naïve” Bayesian classifier. 
A network is created with only one node representing the class of interest and all other 
nodes as its first-level parents. The joint probability of the node of interest is then 
computed as in equation (4). 
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While the independence assumption may seem to simplify the situation and would 
therefore lead to less accurate classification, this has not been true in many applications. 
For instance, several datasets are classified in [69] using the naïve Bayesian classifier, 
decision tree induction, instance-based learning, and rule induction. These methods are 
compared showing the naïve classifier as the overall best method. 
2.6.2 K2 Algorithm 
Researchers have proposed various techniques for BN structure discovery without the 
above independence assumption, the most notable being Cooper and Herskovits, who 
developed the K2 algorithm, a greedy-hill climb algorithm [65]. This method starts with a 
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• i, j, and k are the indexes of the child node, of the parents of the child node, and of the 
possible values of the child node, respectively, 
• q is the number of different instantiations of parent nodes, 
• ri is the number of values that the child node can assume, 
• s is the number of times that the child node has the value of the kth index value of the 
node, 
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• a is the number of times that the parents and the child correlate positively in discrete 
cases, and 
• Γ (•) is the Gamma function which satisfies Γ (x+1)= xΓ (x) and Γ (1)=1. 
This selection criterion is basically a measure of how well the given graph correlates to 
the data. This method requires a complete dataset without any missing data points and a 
hierarchical causal ordering of nodes. This means that the nodes are listed so that any 
node preceding a given node can be its parent, while those following it cannot [23, 65, 
68]. 
As a greedy-hill climb algorithm, the K2 algorithm suffers from a major limitation: it can 
terminate the search after encountering the first local maximum without finding the 
overall global maximum. Several methods for random restarts, such as simulated 
annealing and best-first search, have been proposed to eliminate this problem. 
Nonetheless, these methods are more computationally expensive, but in many cases, can 
still improve the network’s accuracy when dealing with large data sets [23]. 
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2.6.3 Genetic Algorithms for Network Structure Discovery 
 
Figure 2.15. Flow diagram for the genetic algorithm based evolution of a BN. 
A genetic algorithm (GA) is another tool that can be used to discover the BN structure 
[68]. The general GA-evolved BN algorithm framework is shown in Figure 2.15. The 
algorithm can be designed to begin with an initial BN structure population and then 
assesses fitness of these structures. Iteratively, random crossovers and mutations of 
networks within a population are tested, and the most fit of the population are kept for 
future generations. As generations pass, the population evolves, leaving the fitter 
structures while those performing poorly are discarded. This method is quite useful, due 
to the inherent randomness that alleviates the local maximum problem as seen in the K2 
algorithm. An improvement is also gained since the structure of the resulting network is 
dynamic without regard to individual node-to-node fitness measures that have not been 
proven to be optimum or accurate [68]. These method characteristics allow intelligent 
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model construction without requiring an exhaustive search of all possible structure 
combinations of nodes. 
2.7 Bayesian Networks in Medicine 
Considering the many benefits of BNs and how they match in many cases with medical 
decision making, BNs have been under-used in a clinical setting. For instance, BNs 
combine data much as a physician does: combining past experience from other patients 
and combining different pieces of information based on relative probabilities. Medical 
decision making is also plagued by a lack of information or missing data points, 
something that BNs excel at dealing with. A BN’s probability tables are very easily 
updated as well, ever increasing and improving the data set with which diagnoses are 
made.  
There has been a recent thrust in using BNs to identify malignant versus benign tumors. 
Many of these networks have been constructed through expert knowledge but some have 
been learned from data. Kahn et al. used BNs to help in the diagnosis of breast cancer 
using a number of radiological features and several demographic features [70]. Though 
having a relatively large AUC of the ROC, there appeared to be no testing and training 
set and a huge number of features were used with very few patients, possibly indicating 
over-fitting. Following this, Wang et al. investigated the relationship of several types of 
variables to the development of breast cancer. They incorporated the breast cancer 
detection image features as well as non-image features into a BN. They also investigated 
using several feature sub-networks and combining the outcomes of each one versus the 
inclusion of all features in a single network. This proved a single network with more 
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features is more informative than less features or several combined sub-networks of 
fewer features. The final network, which took data from mammographies and other 
clinical data, yielded a better prediction accuracy than is the national average when done 
manually [64]. This shows the potential of Bayesian risk-stratification. This problem was 
fairly straightforward, though with dependencies that were practical and sometimes 
obvious. Also, the network was very small with a single layer of variables of the 
predicted value, making the complexity very low. 
It is important to determine why a given classifier or system is good for given situations. 
Eisenstein et al. addressed this when they compared a BN, a Neural network, and logistic 
regression when used for patient myocardial infarction (MI) risk stratification. He 
compared the three learning systems with varying training sets and variable numbers 
with/without missing data points to determine which is better for a given situation. He 
found that with a BN, more variables included generally makes for better classification 
accuracy, plus the benefit of ease of understanding the outcomes of the BN. BNs, 
although not having the highest accuracy overall in all permutations of the experiment, 
were the most robust, given variation in missing data, small sample size, and number of 
input variables [71]. 
Other areas besides the diagnostic relationships have been modeled with BNs as well. 
Brogini et al. constructed a BN from 23,000 patients to access hospitalization satisfaction 
relationships. He used the Cooper-Herskovits K2 method, meaning he had complete 
information and an ordered set of nodes [72]. This resulted in a fairly complex network 
structure, though most of the relationships were previously understood. The paper did not 
- 47 - 
report on the accuracy or predictive value of the graph and offered little on the use of 
BNs except its ability to find interesting relationships among variables. 
An interesting use of BNs in eastern medicine was presented by Pang et al. where they 
extracted textural and chromatic features from digital images of patients’ tongues in order 
to predict disease using Chinese tongue diagnoses. These features were taken of healthy 
patients as well as patients with 13 different diseases. The variables were used to create a 
BN using a free PowerPredictor network program. The network was trained and tested 
using a k-fold validation resulting in over 75% sensitivity, which was significantly better 
than the nearest neighbor classifier to which it was compared [73]. This was an 
interesting study, and obviously shows some benefit from the use of quantitative features 
and BNs for diagnosis. However, there is ambiguity concerning the medical quality of the 
experiment’s set-up as well as the lack of understanding of how the BN was built. Also, 
the analysis of 455 patients to discriminate fourteen different classes did not seem like 
enough data to populate the needed joint probability tables for the traditional full BNs 
that were built. 
There have been other applications than those mentioned here [74], but this gives several 
examples of what has been done in the field where the experiments have been done with 
questionable statistical rigor and validation. 
- 48 - 
2.8 Bayesian Statistics 
 





1 Beta(1, 1) 


















Figure 2.16. Sample beta distributions given several different α and β values. 
In order to use the doctor’s knowledge of the situation in a quantitative decision support 
system, the physician’s opinions must be incorporated in a well defined, structured 
manner. Bayesian statistics is a structured method for the combination of objective data 
(experimentally collected) and other previously known information to predict future 
outcomes [23]. The inclusion of expert opinion with objective data is one of its uses. The 
objective data probabilities are easy to calculate, but the quantification of an expert 
opinion is a little more difficult. This must be made into a distribution with which it is 
easy to perform calculations. For example, if the data are binary, a binomial distribution 
is used for representation of the data’s probabilities. When the data are modeled as 
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binomial, a beta distribution is both theoretically and intuitively rationalized for the 
quantification of the expert knowledge contribution [75]. 
The beta distribution has two input parameters, α and β, which both scale and shift the 
distribution. The uniform distribution is created when α=β=1 as shown in Figure 2.16. 
When α=β>1, the mass is concentrated around α/(α+β). In this way, α and β can be 
thought of as the number of successes and failures, respectively. The more certain the 
expert is on a given distribution, the tighter the peak should be around that probability, 
and correspondingly, the higher the α and β values are relating to more statistical 
evidence of the probability estimate. By using these two parameters, an expert can make 
a multitude of different distribution shapes, which can then be combined with Bayes’ 
theorem to determine a balanced prediction probability. 
For example, we perform an experiment to deduce the probability of an unbiased coin 
landing on tails when flipped. In our experiment, we can only flip the coin four times and 
it lands on heads all four times (H=4) and none on tails (T=0). The traditional Frequentist 
approach to statistics might say the probability of getting tails with this coin is 0/4 = 0%. 
The previous estimate might seem odd to the observer because we know the probability 
of tails and heads should be around 50%. This is considered our prior information and it 
can be derived through intuition, expert knowledge, or previous experiments. Usually, the 
prior probability is given with some statistical distribution showing the certainty of the 
prior knowledge. Here, since we are modeling a binary outcome, we use a Beta(α,β) 
distribution to model the probability of tails where α=2 and β=2. Figure 2.17 shows the 
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Beta(2,2) distribution with a maximum probability at 50%, just like our instincts tell us 
about an unbiased coin. 
 








1.6 Beta(alpha, beta) where alpha=2 and beta=2
 
Figure 2.17 The beta(2,2) distribution. 
Using the prior knowledge and the four coin flips we did earlier, a Bayesian would find a 
distribution of the probability of tails with a maximum at one-third. Although it is still not 
quite correct, a balance between observed data and expert knowledge often yields better 
results than data alone, especially when little data are available due to cost or difficulty of 
collection.  
This example parallels how physicians’ data would be incorporated into a single node in 
a BN, altering a single probability which is directly responsible for estimating the 
patient’s risk of developing AF. It would of course be a little more complex than an 
unbiased coin toss, but the math is still the same. We need to use Bayesian statistics to 
help us use all pertinent information to solve the problem. 
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Table 2.2 Bayesian terminology and definitions 
Name Notation Equivalent Description 
Model ( | )f x θ   Data Distribution 
Prior ( )π θ   Expert Knowledge Distribution 
Joint ( , )h x θ  ( | ) ( )f x θ π θ⋅  Combined Model and Prior Distribution 
Marginal ( )m x  ( | ) ( )f x dθ π θ θ
Θ
⋅∫  Data Independent of Prior for Normalization 
Posterior ( | )xπ θ  
( | ) ( )








Bayes’ Theorem: Distribution of θ  Given 
Data 
Some further nomenclature should be explained for a better understanding of Bayesian 
statistics. There are several main pieces of information needed and arrived at when 
solving a Bayesian problem. We will explain these components in an example using a 
sequence of Bernoulli trial data y1,…,yn, where each value is zero or one. This data set 
can be modeled using the binomial distribution, Binomial(n,θ) where n is the number of 
trials and θ is the proportion of successes in the entire population or, equivalently, the 
probability of success in each trial.  
 ( | ) ( | ) ( | , ) (1 )x n x
n
f x p x Binomial x n
x
θ θ θ θ θ −⎛ ⎞= = = −⎜ ⎟
⎝ ⎠
 
This distribution of the data is considered the model where x is the number of successes 
during the n trials such as the four heads or zero tails in the previous example.  
Since the probability of success in each trial, or θ, is an unknown system wide parameter 
and can never be found exactly, we wish to estimate its value. In order to do this using 
Bayesian statistics, we also need some sort of previous knowledge of the variable to be 
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estimated. Our prior information distribution is notated as π(θ) where the distribution is a 
function of θ.  
The joint probability, h(x,θ), is the probability of the value x and θ occurring at the same 
time, such as x=4 successes with an overall system probability of θ=0.5. The joint 
probability distribution is found by taking the product of the likelihood and the prior, 
( , ) ( | ) ( )h x f xθ θ π θ= ⋅ . 
Finally, the posterior, π(θ|x) is the probability of θ given the value x has occurred. This is 
found by dividing the joint by the marginal, 
( , ) ( | ) ( )( | )
( , ) ( | ) ( )
h x f xx
h x d f x d
θ θ π θπ θ





This equation is the Bayes’ theorem equivalent for use with probability distributions. 
For instance, let’s take our medical prediction problem of patients developing a heart 
arrhythmia following surgery. We have a population of 81 patients, N=81, where 28 of 
them develop an arrhythmia, x=28. A Frequentist might say the overall probability of 
developing an arrhythmia after surgery is 28/81=0.346, but we have more information 
that can be included in the estimate. We have hypothetically found an expert doctor who 
says that she believes the probability is more like 0.5 and gives a Beta distribution of 
Beta(θ|α=30,β=30) as her certainty of this figure. This is our prior. We already have the 
model of the data as a Binomial(x|n,θ) distribution. We find the posterior to be 
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Binomial(x | n=81, ) ( | 40, 41)( |x=28)=
Binomial(x | n=81, ) ( | 40, 41)
( | , )
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Beta
Beta
θ θ α βπ θ
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The simplification of a Binomial and Beta distribution to a Beta posterior is a standard 
Bayesian conjugate pair and a proof will not be presented here. 
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Figure 2.18 Combining of the model and prior distributions into the posterior probability. 
As seen in the Figure 2.18, the prior and the model both contribute to the posterior 
(dashed) making an overall, more accurate probability distribution of θ.  
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2.9 Summary 
In this chapter, we have discussed the conduction pathways of the heart and how, during 
AF, these pathways are deviated. Since the ECG is an aggregate exterior summation of 
the electrical activity of the heart, it can reveal characteristics of these pathways. For this 
reason, the ECG signals, as well as many clinical factors, have been studied in order to 
determine those patients who might be predisposed to AF occurrence following CABG. 
Many of the studies have resulted in interesting, but inconclusive results, showing a clear 
need for thorough study of the various ECG and clinical predictors available. In order to 
combine these features we discussed the use of a BN learned from the data itself using a 
number of structure learning techniques. 
The next chapter will discuss in detail the calculation and span of the various features 
being implemented as well as their univariate predictive outcomes in relation to the 
problem. 
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Chapter 3  
Univariate AF Prediction 
In this chapter, we explore the traditional approach to discovering relationships for 
diagnostic medicine using a univariate predictor and present the basic methods employed 
in these analyses. We will also use these statistical methods to investigate the relationship 
of many pre- and post-surgical characteristics to the onset of AF. The univariate predictor 
is the most desirable predictor due to its use of a single characteristic as well as its 
simplicity of use and discovery. The drawback of a univariate predictor is that many 
problems are too complex for this type of analysis. Dealing with these situations will be 
addressed in later chapters. 
3.1 Clinical Context 
When searching for a connection between a disease and some possible cause or 
characteristic, these relationships can be investigated individually very simply using 
univariate statistics. The physician may record the disease state of the patient (either 
positive or negative) and the data of the possible predictor. If the possible predictor seems 
to indicate the outcome of diagnosis, this could lead to better prediction accuracy. 
However, this can be difficult to do objectively in many cases. For instance, how does 
one determine what quantifies statistical significance? What type of test does one use for 
a given type of data?  
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In any case, the diagnostic tool needs to be simple enough and have good enough 
performance to be used in a real-world clinical setting. If it is not simple, it might be 
prone to user error causing more confusion than benefit. If it requires too much expertise, 
then a hospital might resist the expense of hiring a person trained to use it. If it requires 
too much time to run, physicians might not use it. The different methods for measuring 
the performance of a system are an important consideration as well.  
The performance of a diagnostic system can be quantified in terms of how well it actually 
performs the diagnosis. This can be calculated by observing the actual disease state and 
the diagnostic system’s predictions on a given patient set [76]. The outcomes of this 
diagnostic test yield four patient classes (assuming there are two outcomes):  
• True Positive (TP) – the test accurately identified the patient as having the disease 
• False Positive (FP)– the test mistakenly identified the patient as having the 
disease 
• True Negative (TN)– the test accurately identified the patient as not having the 
disease 
• False Negative (FN) – the test mistakenly identified the patient as not having the 
disease 
Table 3.1 Confusion Matrix 
Actual Disease State 
 
Negative Positive 
Negative TN FN 
Predicted Disease State
Positive FP TP 
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These four outcomes can then be placed in a matrix, termed the confusion matrix, 
showing the number of outcomes in each of these bins. From these values, several 
important performance metrics can be derived which place importance on the differing 
qualities of a diagnostic system. Sensitivity (TP/(TP+FN)) is the measure of how well the 
system identifies those patients that have the disease while specificity (TN/(FP+TN)) is 
the measure of the systems ability to identify those without the disease. These are 
measured from the populations who, in reality, actually have (TP+FN) or do not have 
(FP+TN) the disease. Alternatively, positive predicted value (TP/(TP+FP)) tells how well 
the system’s positive prediction actually coincides with a positive outcome and negative 
predictive value (TN/(TN+FN)) tells how well the system’s negative prediction actually 
coincides with a negative outcome. These are measured from the populations derived as 
either positive (TP+FP) or negative (TN+FN) by the predictor itself. 
Depending on the type of steps that might be taken following diagnosis, differing levels 
of these performance metrics are desirable. For instance, in the case of a very safe and 
beneficial drug being administered with very few harmful affects resulting from 
administration to those without the disease, a high sensitivity is very important in order to 
cover the entire diseased population. But, if the drug is very dangerous, a high specificity 
would be desirable in order to protect the patients without the disease from its harmful 
side effects. There are many other influencing factors associated with this decision: 
• Financial costs, both direct and indirect, of treating and not treating the 
disease 
• Side effects and benefits of the treatment 
• Discomfort of the patient  
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• Severity of disease 
• Death associated with the treatment and disease 
All of these performance metrics and the associated consequences should be weighed 
appropriately when designing a decision support system (DSS). In the risk stratification 
of postoperative AF, both the failure to treat the disease and the administration of 
unnecessary pharmacological prophylactics has undesirable consequences [20]. 
3.2 Methods 
In medicine, there continues to be, and always will be, the need to compare new 
treatments and determine which is “better.” In order to prove statistical significance of 
improvement of one treatment over another, we usually form a hypothesis (null 
hypothesis, Ho) stating that there is no difference between the two treatments. Based on 
the data collected from both treatments and using an appropriate test, we calculate the 
probability of having collecting our data while Ho is true. This probability is termed the 
p-value. So, if the p-value is very small, the null hypothesis can be rejected. The two 
most widely used tests are the student t-test and the chi-squared test [76]. After finding 
the statistical significance of a characteristic, one should assess the characteristic’s utility 
for diagnosis. This can be done using a receiver operating characteristic (ROC) curve 
[77]. 
3.2.1 t-test 
The student t-test is a simple calculation telling if two different sample groups’ means are 
possibly the same assuming the data are normally distributed [76]. For instance, when 
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comparing the age of the patient to the occurrence of post-op AF, two groups are 
observed: those who do develop AF and those who do not. Each of these separate groups 
has a range of age values from which the groups sample mean and variance can be 
calculated. The null hypothesis, Ho, can be considered to be that the distribution means 
are not sufficiently far apart to say they are different. The p-value is defined as the 
probability of observing the given data while the null hypothesis is true. So, if the p-value 
is very small, Ho can be rejected.  
Unfortunately, for older patients, Ho is rejected for our example statistical test. The p-
value of this test is well below 0.01 meaning it is very unlikely that both AF and normal 
patients have similar age distributions. 
The t-test is used pervasively through medical literature to compare two groups and has 
identified many relationships that have been significant.  
3.2.2 Chi-squared test 
The chi-squared test is very similar to the t-test in that it, given data, supports or denies a 
given hypothesis. The chi-squared test deals in categorical data instead of a continuous 
data, though. An example of categorical information would be which vessel was occluded 
that needed to be bypassed during CABG. Each of the vessels can be thought of as a 
category without any clear order or hierarchy. The chi-squared test calculates the 
likelihood that the individual bypassed vessel had some influence on the occurrence of 
AF with a given p-value.  
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An important note is that for small samples, the chi-squared test is not statistically valid 
and the Fischer’s Exact Test should be used [76]. 
3.2.3 Receiver Operating Characteristic 
The receiver operating characteristic (ROC) curve is a product of 1950’s research into the 
transmission and receiving of radio signals in a noisy environment [77]. It is basically a 
way of comparing the actual signal to what is reconstructed at the receiver to show how 
well the communication system functions. There is a parallel for this in medicine when 
patients have a given disease and a test is being developed in order to identify those 
patients. The test diagnoses should match as closely as possible to the actual patient’s 
disease state. 
The ROC curve is calculated by placing, in ascending order, the labeled feature values of 
the characteristic in question and determining, at each sample, what the sensitivity and 
specificity would be if the classification threshold was placed there. The sensitivity is 
then plotted against one minus the specificity making a plot that starts in the bottom left 
corner of the plot (sensitivity=1, specificity=0) and moves to the upper right 
(sensitivity=0, specificity=1). If the plotted sensitivity/specificity relationship is a straight 
line from corner to corner, the classification measure is equivalent to random guessing. A 
plot that traces up the left axis and then follows the sensitivity-equals-one asymptote has 
perfect classification accuracy. The quality of the classifier can be calculated by 
computing the area under this curve (AUC). The AUC can be thought of as a probability 
that the feature value of a randomly selected diseased sample is larger than the feature 
value of a randomly selected non-diseased sample (assuming a higher feature value 
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generally correlates with the disease) [78]. The closer the AUC is to one, the better the 
classifier [77]. In quality of a classifier based on the AUC has been broken down into 
several subjective quality measure where,  
• 0.50 - 0.60 is Poor, 
• 0.60 - 0.75 is Fair, 
• 0.75 - 0.90 is Good, 
• 0.90 - 0.97 is Very Good, and  
• 0.97 - 1.00 is Excellent. 
 
Figure 3.1 Receiver Operative Characteristic Curve. The solid line represents a classifier 
which would be equivalent to random guessing with an AUC of 0.5. The dotted line 
represents a better classifier while the dashed line is the best with the greatest AUC. 
In this way, a univariate classifier can be evaluated based on the overall population 
distribution and classification threshold possibilities instead of at a single sensitivity and 
specificity value. 
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The ROC curve can also help to find the optimum classification boundary in a feature 
value to achieve the appropriate balance of sensitivity and specificity. In our application, 
the sensitivity and specificity are equally important (discussed further in chapter four), so 
we set the feature value classification boundary at the point on the ROC where the 
product of the sensitivity and specificity is at its peak. This can be visualized on the 
sensitivity/specificity product plot which shows the value of this product for all points on 
the ROC. Figure 3.2 shows a sample of this where the optimum classification threshold is 
difficult to decide just by looking at the ROC curve. By looking at the maximum of the 
sensitivity/specificity product plot, the optimum threshold is easily found and seems to 
offer good separation between the two classes represented by circles and pluses.  







































Figure 3.2 Sample ROC curve and sensitivity/specificity product plot from the output of a 
logistic regression classifier. 
It should be noted that for instances when several patients have the same feature value, 
these patients’ labels are spread vertically down the plot under the actual product value. 
This allows one to view the actual labels as well as the number of patients that fall on that 
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point. Examples of this phenomenon can be seen at both the far right and left of the 
sample plot above. 
3.3 Preoperative 
Table 3.2 Summary of the preoperative data showing both the total number of patient 
samples and features used in future analyses. 
Data Type Number of Patient Samples Number of Features
Clinical Dataset 545 79 
ECG Dataset 244 4608 
Combined Clinical and ECG Dataset 545 4687 
In this work, we focused on both the pre- and postoperative period for AF risk 
stratification. For the former, we used a dataset collected from the Atlanta Veterans 
Affairs (VA) Medical Center associated with Emory University. This dataset contains 
many demographic and clinical variables related to the surgery. Data were obtained for 
all patients who underwent cardiothoracic surgery between January 2000 and March 
2005 under a protocol approved by the Emory University IRB. The diagnosis of post-op 
AF (157 of 545 subjects) was based on review of notes and ECGs. Most subjects were 
male (99.2%), consistent with the general VA population.  
3.3.1 Clinical Dataset 
Seventy-nine variables were collected including patient demographics, current medical 
conditions, pre- and post-op medications, echocardiogram results, ECG results, coronary 
angiogram, and pre-op laboratory results including the use of pre-op peroxisome 
proliferator activator receptor (PPAR) agonists, a patient’s NYHA functional class, the 
European Society of Cardiology’s SCORE risk measure, and the physician’s estimate of 
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operation mortality. The total set of variables consisted of those collected by the VA 
Continuous Improvement in Cardiac Surgery Program (CICSP) with the addition of 
fields for the classes of medications prescribed at the time of surgery. A list of CICSP 
variables and their definitions are available at [79]. Missing data constituted roughly 20% 
of the total data fields. 
3.3.2 ECG Feature Dataset 
In addition, this dataset has standard 12-lead ECG recordings, for each patient, taken 
prior to surgery that are 2.5 seconds in length. This translates to roughly 2 or 3 complete 
cardiac cycles to be observed. The signal is sampled at 250 Hz and, in the clinical setting, 
was used to evaluate the patient’s heart rhythm and rate in the days leading up to the 
surgery. The number of total recordings varies among patients: some having 10-20 while 
others have one. This is related to the physician’s need for monitoring the patient, 
possibly due to pending complications or dysrhythmias. 
Since these data were not originally recorded for signal processing or research purposes, 
many of the recordings have abnormal amplitude levels, some not large enough to span 
several dicretization levels. It is assumed that these particular recordings were useless to 
the physician for the clinical evaluation and were therefore left out of our analyses. 
3.3.2.1 Pre-processing 
The preprocessing of these signals included a high-pass Butterworth filter with cut-off 
frequency of 1 Hz to remove the DC voltage and any very low frequency baseline drift. 
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The signals were further Butterworth low-pass filtered at a cut-off frequency of 35 Hz to 
remove high frequency noise. 
In order to properly extract information from the signals, important reference points in 
the signals such as the atrial and ventricle contractions must be observed and handled. 
For this reason, manual annotation was done on a single beat in each record of the offset 
of a T wave, the onset and offset of the P wave, and the onset of the QRS complex. These 
are referred to as fiducial points and are often done on several different leads. These 
markings indicate the important reference points of the cardiac cycle and allow for 
standardized comparison between patients for a given measure. 
It is important to annotate the important fiducial points on several of the leads to give a 
complete representation of the cardiac cycle at different vantage points. For instance, the 
onset and offset of the P wave varies from lead to lead. For this reason, we have marked 
the P wave onset and offset of the standard II lead which has been compared in several 
studies. In addition to this channel, and overall marking was done for the I, II, and III 
leads together. This gives an overall impression of the entire P wave morphology from 
several electrode orientations. Lastly, the V1 lead was also marked for the onset, offset, 
and the mid-point deflection. These points allow for computation of features such as the 
P wave terminal force or spatial velocity. Figure 3.3 shows the different channels and 
where individual fiducial points were placed. 
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Figure 3.3 Annotations for leads II, V1, and combined I, II. and II leads. 
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It is important to note that the ideal ECG waveform is in no way what the physician 
encounters in the hospital. The inter-patient variation in waveform morphology causes 
great difficulty in the comparison of signals. Furthermore, the morphology of a patient’s 
ECG waveform also changes through time. These inter-patient and intra-patient 
variations make fiducial point annotation difficult and frustrating [26, 28]. 
3.3.2.2 Feature Extraction 
Following fiducial point placement, several morphological features were computed from 
the signals and the individual leads. For instance, the P wave duration was calculated on 
the V1 lead, the II lead, and the composite I, II, and III leads. It should be noted that not 
all patients’ leads had identifiable fiducial points preventing all features from being 
calculated causing missing data points in the dataset. The morphological features that 
were calculated include the following: 
The P terminal force, calculated on the V1 lead was a difficult feature to calculate due to 
its dependence on existence and voltage values of two fiducial points. For this reason, a 
nested set of conditional rules were used for the several permutations that arise, and the 
calculation of the terminal force from their locations and distances was performed. The 
ideal case is shown at the top of Figure 3.4 and the terminal force is defined as the time 
between the midpoint deflection and the P wave offset multiplied by the depth of the 
negative voltage curve as measured from the offset voltage [50]. The same calculation is 
applied to the case of the mid-point voltage being less than the offset voltage. It becomes 
more difficult as the offset voltage is higher than the mid-point voltage. Here, the height 
is measured as the average of the two voltages and the width is the time difference 
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between them. These differences in feature calculations are needed due to the inter-
patient inconsistencies of shape and markings of the midpoint, due to its location on a 
slope. Additionally, alterations of the baseline that often occur between P onset and offset 
need to be handled in a defined and controlled way for comparison between patients. 












If exists Ponset, Pmidpoint, and Poffset
P terminal force = W1 * H1
Else if exists Pmidpoint and Poffset
If ECG(Pmidpoint) < ECG(Poffset)
P terminal force = W2 * H2
Else if ECG(Pmidpoint) >= ECG(Poffset)
P terminal force = W3 * H3
End
End  
Figure 3.4 P terminal force calculation 
The P wave duration, calculated on the V1 lead, also becomes complicated due to its 
dependence on three fiducial points. If one of the points is absent, a rule must be made to 
calculate the overall duration. We decided that the distance between whatever points 
were present would be labeled the P wave duration. For instance, if there was no positive 
deflection (meaning there was no classic P wave onset), the distance from the midpoint to 
the offset would be termed the duration. Alternatively, if there was no negative 
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deflection, the distance from the onset to the mid point would be measured. In this 
manner, the P wave duration was measured with the data that could be marked and 
properly identified. The P wave durations were much easier to calculate on the II and 
composite I, II, III leads by just subtracting each lead’s onset from the offset time point 
[20]. 
The PR time interval was measured between the composite I, II, III lead’s QRS complex 
onset and the P wave offset [20]. 
The isoelectric interval (IEI) was measured as the P wave duration of the composite I, II, 
III lead minus the P wave duration of the II lead [20]. 
Table 3.3 Feature Set F 
Feature Calculation 
Energy 2ix∑  
Nonlinear Energy (Teager Energy) 22 1i i ix x x− −− ⋅ +∑  
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Peak Power max( )PSD  
Peak Frequency (max( ))index PSD  
Mean Frequency ( ( ))index mean PSD  
Median Frequency ( ( ))index median PSD  
Spectral Entropy log( )PSD PSD⋅∑  
Shannon Entropy ( ) log( ( ))hist x hist x− ⋅∑  
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In addition to the above traditional morphological features, several time, frequency, and 
information domain features were calculated on the ECG. The ECG segment from the T 
wave offset to the Q wave onset encompasses the main region of interest in the cardiac 
cycle for AF, the atrial contraction period. These segments were extracted and the feature 
set, F, listed in Table 3.3, was computed. The rationale for choosing these features is 
based on insights and background in biological signal processing. 
The energy of the signal can show the signal’s tendency to stay either above or below the 
baseline, closely related to the signal’s integral. The nonlinear energy, known as Teager’s 
energy in [80], includes amplitude and instantaneous frequency information, along with 
the energy component.  
Frequency domain based features can reveal other important characteristics of the signal 
[81]. The peak frequency and peak power identify at what frequency the signal oscillates 
with the most power and the magnitude of this power peak, respectively. The mean and 
median frequency features reveal the frequency value in the power spectrum where the 
mean and median frequencies appear, respectively. Spectral entropy is a measure of the 
regularity of the power spectrum of the signal [80]. This feature can give an indication of 
the overall frequency distribution, while the above frequency characteristics do not. 
Shannon entropy is a measure of the randomness of the amplitude values of the signal 
[82]; the higher the entropy, the more disordered and closer the signal is to random 
Brownian motion. Both Katz fractal dimension and the Hurst parameter are 
measurements of the long-range dependence of the signal. These measurements can 
identify if a signal is becoming non-stationary, increasing in complexity, or changing its 
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space filling properties. Most importantly, they show the signal’s self-similarity. This 
property can be very useful when looking for repetitions that may not be obvious to a 
human observer. The feature curve length tends to correlate with the two previous 
features closely, also showing the space-filling property without as much sensitivity to 
the self-similarity measure [80]. 
Table 3.4 Wavelet and Scales used for ECG decomposition 
Wavelet Name Scales Calculated 
Daubechies Two 5, 10, 15, 20, 25, and 30 
Daubechies Three 5, 10, 15, 20, 25, and 30 
Symlets Four 5, 10, 15, 20, 25, and 30 
Symlets Six 5, 10, 15, 20, 25, and 30 
Coiflets One 5, 10, 15, 20, 25, and 30 
Coiflets Four 5, 10, 15, 20, 25, and 30 
Biorthogonal 2.2 5, 10, 15, 20, 25, and 30 
Biorthogonal 4.4 5, 10, 15, 20, 25, and 30 
Biorthogonal 5.5 5, 9, 13, 17, 21, and 25 
Biorthogonal 6.8 5, 10, 15, 20, 25, and 30 
Reverse Biorthogonal 2.2 5, 9, 13, 17, 21, and 25 
Reverse Biorthogonal 4.4 5, 10, 15, 20, 25, and 30 
Reverse Biorthogonal 5.5 5, 10, 15, 20, 25, and 30 
Reverse Biorthogonal 6.8 5, 9, 13, 17, 21, and 25 
Gaussian One 2, 4, 6, 8, 10, and 12 
Gaussian Two 4, 7, 10, 13, 16, and 19 
Gaussian Three 4, 7, 10, 13, 16, and 19 
Gaussian Four 4, 7, 10, 13, 16, and 19 
Mexican Hat 3, 5, 7, 9, 11, and 13 
Following these feature computations of the actual ECG segments, wavelet 
decompositions of the ECGs were performed, the T offset to Q onset segments were re-
extracted, and the features of feature set F were computed. The wavelets and their 
associated scales are listed in Table 3.4. These wavelets were selected based on their 
ability to decompose the ECG signal allowing for visually interesting dynamics around 
the P wave, the wave associated with the atrial contraction and AF. Additionally, 
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wavelets that had more lobes caused spreading of the QRS complex into the adjacent P 
wave at higher scales were not selected. The symlet four wavelet decomposition of an 
ECG sample at scales 1 through 40 can be seen in Figure 3.5. The P wave magnitude rise 
and fall can be seen as the scale increases. 
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Figure 3.5 Symlet Four Wavelet Decomposition of the ECG showing the P wave 
changing at several scales. 
In order to identify and discuss these complicated features, a naming convention has been 
instituted that allows for easier communication. There are several sections of the feature 
identifier which are separated by underscores which each have different possible values 
and meanings. For the preoperative data set, the first section identifies that the TQ 
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segment is being investigated. Next the lead is indicated as V1, I, II, or III. If a wavelet 
decomposition was employed, the next two sections contain the abbreviation of the 
wavelet employed followed by the scale that was used. The last section is the feature that 
was performed on the resulting signals listed above. For instance, the mean frequency of 
the symlet four wavelet decomposition (scale twenty) of the TQ segment on modified 
lead II would be abbreviated as TQ_II_sym4_sc20_Mean_Freq. This makes encoding in 
the algorithms and discussing the resulting features much less cumbersome.  
3.4 Postoperative 
Table 3.5 Summary of the postoperative data showing both the total number of patient 
samples and features used in future analyses. 
Data Type Number of Patient Samples Number of Features
Clinical Dataset 80 60 
ECG Dataset 46 111,672 
Combined Clinical and ECG Dataset 80 111,732 
Following the preoperative analysis, post surgical variables were investigated. During a 
postoperative atrial pacing study done several years ago, data were collected from eighty 
patients that were not paced. Patients were older than eighteen, in normal sinus rhythm 
before surgery, and on no anti-arrhythmic medications [83, 84]. Of these patients, twenty-
seven develop AF in the following four days. Clinical data as well as ECG data were 
collected from these patients. A significant characteristic of this dataset is that some 
patients are missing information; for instance, the physician may have not tested the 
patient’s cholesterol levels. 
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3.4.1 Clinical Dataset 
The collected clinical data include the patients’ demographic, preoperative, operative, 
and postoperative data. Some fields contain binary information, such as History of AF or 
Beta Blocker Administered, other fields contain continuous data, such as Age or Heart 
Rate, and others contained categorical data such as the number of bypassed vessels. 
Appendix A lists these data variables in their entirety. 
3.4.2 ECG Feature Dataset 
ECG data were also collected from patients in the form of Holter monitor tapes. Of the 
eighty-one patients, we have 49 with post surgical ECG recordings consisting of an intra-
atrial lead and a chest lead. Most have two 48-hour tapes with between 72 and 90-hours 
of recorded signals. These recordings were sampled at 128 Hz with 16-bit A-to-D 
conversion. In some patients, the leads have been disconnected accidentally or for 
medical reasons. This results in only having one or no recordings at some time points for 
patients. 
3.4.2.1 Pre-processing 
Preprocessing consists of preparing the signal for feature extraction. This includes 
removing artifacts, filtering noise, and snipping data segments. Each ECG was filtered 
using both a high- and low-pass fifth-order Butterworth filter with a cutoff of one and 
thirty-five Hz, respectively. This removes the baseline drift DC voltage that sometimes 
builds on ECG electrodes (Figure 3.6) [85] as well as any high frequency noise not 
containing useful cardiac data. 




Figure 3.6 Raw Unfiltered ECG and filtered ECG 
In this second dataset, we only have data directly following the surgery. We have 
extracted up to four, five-minute ECG segments at roughly twelve hour increments 
following surgery: zero, twelve, twenty-four, and thirty-six hours as shown in Figure 3.7. 
The locations were selected due the cardiologists’ desire to identify patients early 
following surgery in order to administer the prophylactic when it might have the most 
benefit. At each of the time points, we selected a five-minute segment, trying to avoid 
muscle and other artifacts. This sometimes involved moving an hour away from the point 
of interest. These small ECG clips taken at large intervals were done to reduce the time 
needed for manual correction of annotations on each clip. 
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Figure 3.7. Five -minute clips of ECG are taken from both the chest and atrial leads at 
intervals of twelve hours following surgery. 
Unlike many collected biosignals, ECGs contain “strong” reference points in the signal, 
from which much information can be determined. The R waves’ large amplitude on the 
chest lead allows for identification of the ventricle contraction times, while the atrial 
contraction can be determined from the intra-atrial lead. Each of the five-minute 
segments was annotated for both ventricle contraction on the chest lead and atrial 
contraction on the atrial lead. With these collected time points and the signals’ segments 
that they are associated with, many different computations can be performed. 
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Figure 3.8. ECG segments extracted from the chest and atrial leads according to the P and 
R points. 
With the R and P wave locations, we extracted and stored consecutive R-R, P-P, R-P, and 
P-R segments of the signal. This was done on both the chest and atrial lead, yielding eight 
different segment groups, as seen in Figure 3.8, from a single five-minute clip with each 
group containing all the possible peak-to-peak segments. 
The durations of each of these ECG segments were also calculated as shown in Figure 
3.9. The locations in time of the R positions were used to determine the heart rate (R-to-R 
durations). Many studies have been done investigating heart rate variability (HRV) and 
its association with arrhythmia occurrence, citing the importance of the sympathetic 
nervous system on cardiac rate control [14]. 
Each of the segments and their associated durations can then be analyzed for a correlation 
with AF by first decomposing the signal using a feature set consisting of several 
approaches. 
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Figure 3.9. ECG segment durations observed from ECG segments. 
3.4.2.2 Feature Extraction 
The ECG segments were then used to calculate the feature set, F, comprising the eleven 
feature measures listed in Table 3.3. Following feature extraction on the individual ECG 
segments (R-R, R-P, P-P, and P-R), we run the statistics set, S, on each of the features 
calculated on each of the segments, yielding some characteristics of the data obtained 
from feature calculation. The statistics set, S, consists of the maximum, minimum, 
median, mean, standard deviation, skewness, and kurtosis.  
The location in time of P and R positions were also used to determine the heart rate (R-
to-R durations) and other time durations of importance (P-P, R-P, P-R) as referred to 
previously. Again, the statistics set, S, is then applied to all these duration measures. The 
durations and the locations in time are also analyzed for frequency domain information 
by performing a Lomb-Scargle periodogram [86]. This is needed in order to find the 
frequency spectrum of the non-uniformly spaced duration samples. The frequency bands 
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investigated were very low frequency (VLF) consisting of 0.0033 to 0.04 Hz, low 
frequency (LF) consisting of 0.04 to 0.15 Hz, and high frequency consisting of 0.15 to 
0.4 Hz. The power in each of these bands was calculated and ratios between the bands 
(VLF/LF, VLF/HF, LF/HF) as well as the total power (VLF/TP, LF/TP, HF/TP) were 
calculated as features. 
Signal averaging techniques were performed on the P wave of the signal to derive two 
average P waves. This was done by triggering on both the atrial contraction on the atrial 
lead and the ventricular contraction on the chest lead. These two P waves were subjected 
to the feature set F as well as the morphological P wave features discussed previously. 
The number of ectopic beats, abnormal extra or skipped beats, was counted for each of 
the clips as well. These were further identified individually as premature atrial 
contractions (PAC) or premature ventricular contractions (PVC). These types can be 
identified by their timing with previous and following contractions. A PAC will generally 
follow the previous too closely while the next beat occurs after the usual time delay. An 
PVC also usually follows the previous beat too closely but the next beat has a large delay. 
After identifying these beats, the ratios of their occurrence were calculated as features. 
Following these feature computations of the ECG segments, wavelet decompositions of 
the ECG clips were taken, the R-R, R-P, P-P, and P-R segments were re-extracted, and 
the feature set F and statistic set S were computed as previously discussed. The wavelets 
and their associated scales are listed in Table 3.4. 
Given the inherent variability in ECG signals among patients, each of these features 
offers information that can be used to distinguish between patient classes. We believe 
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that, collectively, these features can help distinguish the two classes [87-90]. The 
extraction of feature values from the ECG signals reduces the dimensionality of the 
problem to a computationally tractable level. In this process, signal information is 
encoded so that it can be used for classification or prediction [91]. 
In order to identify and discuss these complicated features, a naming convention has been 
instituted that allows for easier communication. There are several sections of the feature 
identifier which are separated by underscores which each have different possible values 
and meanings. For the preoperative features, the first section is the clip identifier which 
starts with a “c” and follows with a number between one and four corresponding to the 
clips taken zero, twelve, 24, and 36 hours after surgery. The second section identifies 
which segment the feature is being calculated on, being either PP, PR, RP, or RR. Next 
identifies the feature as being taken from the chest or atrial lead. If a wavelet transform 
was employed, the next two identifiers will be an abbreviation of the wavelet used 
followed by the scale of the wavelet identified as “sc” and the number of the scale 
following. Next is the feature of feature set F that was computed and lastly comes the 
statistic that was computed. For instance, the curve length of the daubechies three 
wavelet decomposition (scale 15) of the PR segment of the Atrial lead’s first clip TQ 
segment is abbreviated to c1_PR_Atrial_db3_sc15_Curve_length_skewness. This makes 
encoding in the algorithms and discussing the resulting features much less cumbersome. 
3.5 Results 
For both the pre- and postoperative features calculated above, univariate t-tests and Chi-
squared tests were used to determine their classification potential for postoperative AF 
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onset. Appendix B shows the characteristics of those pre- and postoperative variables 
which had a p-value < 0.05 except for the postoperative continuous variable, for which 
only those with a p-value < 0.01 was listed due to their large amount. Table 3.6 and Table 
3.7 show the univariate pre- and postoperative characteristics that have a p-value < 0.01 
and 0.003, respectively. Binary and categorical variables are listed as the percentage of 
AF or non-AF patients in that category having the given value. Continuous variables have 
the mean plus or minus the standard deviation of the feature for AF or non-AF patients. 
For each variable, either the ratio of the patients having that characteristic in the category 
or the number of patients in that category is shown in these tables.  
As is seen from their absence in Table 3.6, traditional ECG measures did not perform 
well on the preoperative cohort. The morphological P wave characteristics performed 
poorly as seen in Table 3.8 with the best being the P terminal force which had a p value 
of 0.169.  
The features computed on the ECG itself, without wavelet decomposition, did not fare 
much better as seen in Table 3.9, with similarly low values, none having a p-value below 
0.05. Two features, median frequency of the T-to-Q segment on the V1 lead and the 
Shannon entropy of the T-to-Q segment on the I lead performed the best among these 
with p-values of 0.077 and 0.063, respectively. 
Table 3.6 Preoperative features with a p-value < 0.01 
Preoperative Binary Feature  Non-AF  AF   Total   p value 
Preoperative AF   1.6% (6/386)  19.7% (31/157)  6.8% (37/543)  0.000 
Cardiomegaly    13.7% (53/388)  29.3% (46/157)  18.2% (99/545)  0.000 
Prior heart surgery   1.8% (7/388)  5.7% (9/157)  2.9% (16/545)  0.014 
Current digoxin use   3.4% (13/388)  9.6% (15/157)  5.1% (28/545)  0.003 
African-American   16.2% (63/388)  5.7% (9/157)  13.2% (72/545)  0.001 
 
Preoperative 
Categorical Feature Category Non-AF  AF   Total   p value 
Left Atrial Size    384   157   541   0.000 
     0 58.9% (226/384)  38.2% (60/157)  52.9% (286/541) 
     1 6.8% (26/384)  7.6% (12/157)  7.0% (38/541) 
     2 23.4% (90/384)  29.9% (47/157)  25.3% (137/541) 
     3 3.9% (15/384)  12.7% (20/157)  6.5% (35/541) 
     4 1.6% (6/384)  2.5% (4/157)  1.8% (10/541) 
     5 3.9% (15/384)  7.6% (12/157)  5.0% (27/541) 
     6 1.0% (4/384)  0.6% (1/157)  0.9% (5/541) 
     7 0.5% (2/384)  0.6% (1/157)  0.6% (3/541) 
Ejection Fraction    387  157   544   0.010 
     0 53.0% (205/387) 35.0% (55/157)  47.8% (260/544) 
     1 0.5% (2/387)  0.0% (0/157)  0.4% (2/544) 
     2 1.6% (6/387)  2.5% (4/157)  1.8% (10/544) 
     3 3.4% (13/387)  3.8% (6/157)  3.5% (19/544) 
     4 7.5% (29/387)  8.3% (13/157)  7.7% (42/544) 
     5 8.0% (31/387)  14.6% (23/157)  9.9% (54/544) 
     6 19.6% (76/387)  22.9% (36/157)  20.6% (112/544) 
     7 5.9% (23/387)  12.1% (19/157)  7.7% (42/544) 
     8 0.5% (2/387)  0.6% (1/157)  0.6% (3/544) 
Mitral Regurgitation   332   141   473   0.002 
     1 83.1% (276/332) 68.8% (97/141)  78.9% (373/473) 
     2 11.7% (39/332)  17.7% (25/141)  13.5% (64/473) 
     3 2.1% (7/332)  6.4% (9/141)  3.4% (16/473) 
     4 3.0% (10/332)  7.1% (10/141)  4.2% (20/473) 
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Table 3.6 Continued 
 
Mammary Artery Anastamoses  388   157   545   0.003 
     0 12.1% (47/388)  22.3% (35/157)  15.0% (82/545) 
     1 87.4% (339/388) 75.2% (118/157) 83.9% (457/545) 
     2 0.3% (1/388)  1.9% (3/157)  0.7% (4/545) 
     3 0.3% (1/388)  0.6% (1/157)  0.4% (2/545) 
 
Preoperative Continuous Feature  Non-AF  AF   Total   p value 
Age      61.49+/-9.1(388) 64.98+/-8.9(157) 62.50+/-9.1(545) 0.000 
Height (In)     69.70+/-2.7(388) 70.43+/-2.4(157) 69.91+/-2.6(545) 0.003 
Ischemic Time (min)    61.19+/-36.5(388) 71.45+/-38.4(157) 64.14+/-37.3(545) 0.004 
Cardiopulmonary bypass time (min)  98.90+/-49.7(388) 112.39+/-48.7(157) 102.78+/-49.7(545) 0.004 
TQ_II_sym4_sc20_Mean_Freq   9.79+/-4.0(104)  11.67+/-4.8(54)  10.43+/-4.3(158) 0.009 
TQ_II_coif1_sc15_Median_Freq   8.86+/-1.6(104)  10.06+/-3.3(54)  9.27+/-2.4(158)  0.003 
TQ_V1_coif1_sc20_Peak_Freq   7.35+/-2.4(102)  6.13+/-2.9(55)  6.92+/-2.7(157)  0.006 
TQ_II_bior4.4_sc5_Mean_Freq   31.97+/-5.3(104) 34.49+/-6.1(54)  32.83+/-5.7(158) 0.008 
TQ_II_bior5.5_sc21_Mean_Freq  10.24+/-3.5(104) 11.91+/-4.3(54)  10.81+/-3.9(158) 0.010 
TQ_II_rbio5.5_sc5_Mean_Freq   29.29+/-6.0(104) 31.92+/-6.1(54)  30.19+/-6.1(158) 0.010 
TQ_II_gaus3_sc13_Peak_Freq   6.64+/-1.4(104)  5.87+/-1.9(54)  6.38+/-1.6(158)  0.004 
Table 3.7 Postoperative features with a p-value < 0.003 
Postoperative Continuous Feature   Non-AF  AF   Total   p value 
Age       63.47+/-10.6(53) 72.59+/-6.9(27)  66.55+/-10.5(80) 0.000 
c3_PP_Chest_Energy_skewness   1.93+/-1.3(26)  3.91+/-2.5(14)  2.62+/-2.0(40)  0.002 
c3_PP_Chest_Energy_kurtosis    10.09+/-7.4(26)  32.10+/-31.9(14) 17.80+/-22.1(40) 0.002 
c3_PP_Atrial_db2_sc5_Energy_skewness  0.43+/-0.4(29)  1.54+/-1.8(15)  0.81+/-1.2(44)  0.003 
c1_PR_Atrial_db3_sc15_Curve_length_skewness 0.48+/-0.9(25)  -0.90+/-1.6(14)  -0.01+/-1.3(39)  0.001 
c1_PR_Atrial_db3_sc20_Nonlinear_Energy_skewness 0.75+/-1.0(25)  -0.42+/-1.2(14)  0.33+/-1.2(39)  0.003 
c1_PR_Atrial_db3_sc20_Curve_length_skewness 0.42+/-0.8(25)  -0.78+/-1.5(14)  -0.01+/-1.2(39)  0.002 
c1_PR_Atrial_sym4_sc15_Curve_length_skewness 0.53+/-0.9(25)  -0.90+/-1.8(14)  0.02+/-1.5(39)  0.002 
c2_PR_Atrial_sym4_sc20_Peak_Freq_skewness 0.76+/-3.7(27)  -4.30+/-5.5(14)  -0.97+/-5.0(41)  0.001 
c3_PP_Atrial_sym6_sc5_Energy_skewness  0.43+/-0.3(29)  1.49+/-1.8(15)  0.79+/-1.2(44)  0.003 
- 84 - 
Table 3.7 Continued 
c2_RP_Atrial_sym6_sc10_Mean_Freq_kurtosis  4.18+/-2.2(27)  11.55+/-10.7(14) 6.70+/-7.3(41)  0.001 
c2_RP_Atrial_sym6_sc10_Median_Freq_kurtosis 4.07+/-3.1(27)  12.49+/-12.4(14) 6.95+/-8.5(41)  0.002 
c1_PR_Atrial_sym6_sc20_Nonlinear_Energy_skewness 0.79+/-1.1(25)  -0.36+/-1.1(14)  0.38+/-1.2(39)  0.003 
c2_PR_Chest_sym6_sc20_Median_Freq_min  4.80+/-1.0(27)  6.69+/-2.7(14)  5.45+/-2.0(41)  0.002 
c3_PP_Atrial_coif1_sc5_Peak_Freq_std   5.34+/-2.0(29)  7.13+/-1.4(15)  5.95+/-2.0(44)  0.003 
c2_RP_Atrial_coif1_sc10_Shannon_Entropy_kurtosis 5.21+/-4.8(27)  20.10+/-23.6(14) 10.30+/-15.7(41) 0.003 
c1_PR_Atrial_coif1_sc15_Curve_length_skewness 0.38+/-0.7(25)  -0.97+/-1.8(14)  -0.10+/-1.4(39)  0.002 
c4_PP_Atrial_coif1_sc25_Peak_Freq_mean  2.33+/-1.1(24)  1.21+/-1.0(14)  1.92+/-1.1(38)  0.002 
c4_PR_Chest_coif1_sc25_Shannon_Entropy_skewness -0.60+/-0.5(22)  -2.61+/-2.8(13)  -1.35+/-2.0(35)  0.002 
c3_PP_Atrial_coif4_sc5_Energy_skewness  0.42+/-0.4(29)  1.48+/-1.7(15)  0.78+/-1.2(44)  0.003 
c3_PP_Atrial_coif4_sc5_Nonlinear_Energy_skewness 0.48+/-0.4(29)  1.66+/-2.0(15)  0.88+/-1.3(44)  0.003 
c2_RP_Atrial_coif4_sc10_Median_Freq_kurtosis 3.67+/-2.8(27)  8.94+/-6.6(14)  5.47+/-5.0(41)  0.001 
c1_PR_Atrial_coif4_sc20_Nonlinear_Energy_skewness 0.79+/-1.0(25)  -0.33+/-1.1(14)  0.39+/-1.2(39)  0.003 
c3_PP_Atrial_bior2.2_sc10_Mean_Freq_skewness 0.33+/-0.9(29)  1.66+/-1.7(15)  0.79+/-1.4(44)  0.001 
c3_PP_Atrial_bior2.2_sc10_Peak_Freq_min  3.97+/-2.4(29)  1.80+/-1.6(15)  3.23+/-2.4(44)  0.003 
c3_RP_Atrial_bior2.2_sc10_Mean_Freq_skewness 0.16+/-0.6(26)  1.69+/-1.8(14)  0.70+/-1.3(40)  0.000 
c3_PP_Atrial_bior2.2_sc15_Katz_FD_skewness  0.60+/-0.4(29)  1.63+/-1.5(15)  0.95+/-1.1(44)  0.002 
c3_PP_Atrial_bior2.2_sc15_Nonlinear_Energy_kurtosis 3.63+/-1.4(29)  12.34+/-14.7(15) 6.60+/-9.4(44)  0.003 
c3_RP_Atrial_bior2.2_sc15_Katz_FD_skewness 0.68+/-0.5(26)  2.12+/-2.2(14)  1.18+/-1.5(40)  0.002 
c3_PR_Atrial_bior2.2_sc15_Katz_FD_skewness 0.68+/-0.4(26)  1.87+/-1.7(14)  1.10+/-1.2(40)  0.002 
c4_PP_Atrial_bior2.2_sc20_Peak_Freq_min  1.83+/-1.3(24)  0.50+/-0.8(14)  1.34+/-1.3(38)  0.002 
c3_RP_Atrial_bior2.2_sc25_Katz_FD_skewness 0.66+/-0.6(26)  1.57+/-1.3(14)  0.98+/-1.0(40)  0.003 
c3_RP_Atrial_bior2.2_sc25_Katz_FD_kurtosis  4.02+/-1.7(26)  9.98+/-9.2(14)  6.11+/-6.2(40)  0.002 
c1_PP_Atrial_bior4.4_sc5_Peak_Freq_kurtosis  6.60+/-4.5(28)  12.82+/-7.3(15)  8.77+/-6.3(43)  0.001 
c1_PR_Atrial_bior4.4_sc15_Curve_length_skewness 0.46+/-0.8(25)  -0.88+/-1.8(14)  -0.02+/-1.4(39)  0.002 
c1_PR_Chest_bior4.4_sc15_Peak_Freq_std  0.57+/-0.3(25)  1.25+/-1.0(14)  0.81+/-0.7(39)  0.003 
c1_PR_Atrial_bior4.4_sc20_Curve_length_skewness 0.41+/-0.8(25)  -0.81+/-1.6(14)  -0.03+/-1.3(39)  0.002 
c1_PR_Atrial_bior4.4_sc25_Peak_Freq_kurtosis 20.94+/-34.0(23 ) 152.42+/-175.3(13) 68.42+/-124.0(3 6) 0.001 
c2_RP_Atrial_bior4.4_sc25_Shannon_Entropy_kurtosis 4.79+/-4.4(27)  14.74+/-15.1(14) 8.19+/-10.5(41)  0.003 
c3_PP_Atrial_bior5.5_sc5_Energy_skewness  0.43+/-0.4(29)  1.46+/-1.7(15)  0.78+/-1.1(44)  0.003 
c4_PP_Atrial_bior5.5_sc5_Mean_Freq_max  22.30+/-3.7(24)  26.40+/-3.8(14)  23.81+/-4.2(38)  0.002 
c1_PR_Atrial_bior5.5_sc17_Curve_length_skewness 0.52+/-1.0(25)  -0.88+/-1.7(14)  0.01+/-1.4(39)  0.002 
c1_PR_Atrial_bior5.5_sc25_Peak_Freq_kurtosis 22.90+/-36.8(23) 149.74+/-158.7(12) 66.39+/-113.0(35) 0.001 
c1_PR_Atrial_bior6.8_sc20_Curve_length_skewness 0.45+/-0.9(25)  -0.75+/-1.5(14)  0.02+/-1.3(39)  0.003 
c1_PR_Atrial_rbio2.2_sc13_Curve_length_skewness 0.49+/-0.9(25)  -0.87+/-1.5(14)  0.00+/-1.3(39)  0.001 
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c4_PP_Atrial_rbio2.2_sc17_Peak_Freq_mean  2.40+/-1.1(24)  1.20+/-0.9(14)  1.96+/-1.1(38)  0.001 
c4_PP_Atrial_rbio2.2_sc21_Peak_Freq_mean  2.08+/-1.0(24)  1.06+/-0.8(14)  1.70+/-1.1(38)  0.003 
c1_PR_Atrial_rbio4.4_sc15_Curve_length_skewness 0.64+/-1.2(25)  -0.84+/-1.7(14)  0.11+/-1.5(39)  0.003 
c2_RP_Atrial_rbio5.5_sc10_Peak_Freq_skewness 0.36+/-1.7(27)  3.12+/-3.7(14)  1.30+/-2.8(41)  0.002 
c3_RP_Atrial_rbio5.5_sc10_Shannon_Entropy_std 0.04+/-0.0(26)  0.07+/-0.0(14)  0.05+/-0.0(40)  0.002 
c2_PR_Chest_rbio5.5_sc20_Median_Freq_min  4.92+/-1.1(27)  6.93+/-2.8(14)  5.61+/-2.0(41)  0.002 
c1_PP_Atrial_rbio5.5_sc25_Peak_Freq_max  4.86+/-0.8(28)  3.83+/-1.1(15)  4.50+/-1.1(43)  0.002 
c1_RP_Atrial_rbio5.5_sc25_Peak_Freq_max  5.08+/-1.1(25)  3.50+/-1.3(14)  4.51+/-1.4(39)  0.000 
c1_PR_Atrial_rbio5.5_sc25_Peak_Freq_kurtosis 36.54+/-58.7(24) 172.79+/-176.5(11) 79.36+/-124.9(35) 0.002 
c3_PP_Atrial_rbio6.8_sc5_Energy_skewness  0.40+/-0.4(29)  1.42+/-1.6(15)  0.75+/-1.1(44)  0.002 
c3_PP_Atrial_rbio6.8_sc5_Nonlinear_Energy_skewness 0.45+/-0.4(29)  1.60+/-1.9(15)  0.84+/-1.2(44)  0.002 
c2_RP_Atrial_rbio6.8_sc9_Mean_Freq_kurtosis  4.38+/-2.6(27)  9.74+/-7.9(14)  6.21+/-5.6(41)  0.002 
c2_RP_Atrial_rbio6.8_sc9_Median_Freq_kurtosis 3.96+/-3.1(27)  10.70+/-9.0(14)  6.26+/-6.5(41)  0.001 
c3_PP_Atrial_rbio6.8_sc9_Mean_Freq_min  7.20+/-0.8(29)  6.32+/-0.9(15)  6.90+/-0.9(44)  0.002 
c1_PR_Atrial_rbio6.8_sc17_Curve_length_skewness 0.53+/-1.0(25)  -0.80+/-1.6(14)  0.05+/-1.4(39)  0.003 
c2_PR_Atrial_rbio6.8_sc17_Peak_Freq_kurtosis 10.91+/-14.4(25) 51.14+/-53.6(14) 25.35+/-38.7(39) 0.001 
c2_PR_Chest_gaus1_sc2_Mean_Freq_min  4.47+/-2.0(27)  8.72+/-4.7(14)  5.92+/-3.7(41)  0.000 
c3_PP_Atrial_gaus1_sc2_Energy_skewness  0.34+/-0.6(29)  1.58+/-1.7(15)  0.76+/-1.3(44)  0.001 
c3_PP_Atrial_gaus1_sc2_Energy_kurtosis  3.80+/-2.1(29)  15.92+/-19.8(15) 7.93+/-12.8(44)  0.002 
c3_PR_Atrial_gaus1_sc2_Median_Freq_skewness 0.15+/-0.8(26)  2.55+/-3.4(14)  0.99+/-2.3(40)  0.001 
c4_PR_Chest_gaus1_sc6_Peak_Freq_mean  5.12+/-3.1(22)  1.71+/-2.4(13)  3.85+/-3.3(35)  0.002 
c3_PR_Chest_gaus1_sc8_Katz_FD_skewness  0.65+/-1.1(26)  2.17+/-1.8(14)  1.18+/-1.5(40)  0.002 
c3_PR_Chest_gaus1_sc10_Energy_skewness  0.67+/-1.0(26)  2.36+/-2.2(14)  1.26+/-1.7(40)  0.002 
c3_PR_Chest_gaus1_sc12_Energy_skewness  0.76+/-0.9(26)  2.58+/-2.4(14)  1.40+/-1.8(40)  0.001 
c2_PR_Chest_gaus2_sc10_Median_Freq_min  4.28+/-1.1(27)  6.30+/-2.8(14)  4.97+/-2.1(41)  0.002 
c4_PP_Atrial_gaus2_sc10_Peak_Freq_mean  2.44+/-1.1(24)  1.30+/-0.9(14)  2.02+/-1.2(38)  0.002 
c2_PR_Atrial_gaus3_sc7_Mean_Freq_mean  7.69+/-1.6(27)  6.18+/-1.0(14)  7.17+/-1.6(41)  0.003 
c2_PR_Atrial_gaus3_sc7_Peak_Freq_mean  6.90+/-1.3(27)  5.21+/-1.0(14)  6.32+/-1.5(41)  0.000 
c1_PR_Atrial_gaus3_sc10_Nonlinear_Energy_skewness0.73+/-1.0(25)  -0.39+/-1.1(14)  0.33+/-1.2(39)  0.003 
c1_RP_Atrial_gaus3_sc13_Mean_Freq_min  3.29+/-1.1(25)  4.61+/-1.3(14)  3.77+/-1.3(39)  0.002 
c1_RP_Atrial_gaus3_sc13_Median_Freq_min  4.25+/-1.8(25)  6.66+/-2.5(14)  5.11+/-2.3(39)  0.001 
c3_PR_Chest_gaus3_sc13_Katz_FD_skewness 0.51+/-1.0(26)  2.35+/-2.4(14)  1.15+/-1.8(40)  0.001 
c1_PP_Atrial_gaus3_sc19_Peak_Freq_skewness -0.30+/-2.6(26)  -4.95+/-6.6(15)  -2.00+/-4.9(41)  0.003 
c2_PR_Chest_gaus4_sc13_Median_Freq_min  4.30+/-0.6(27)  5.83+/-2.3(14)  4.82+/-1.6(41)  0.002 
c2_RP_Atrial_gaus4_sc19_Shannon_Entropy_skewness0.02+/-1.7(27)  -2.55+/-3.5(14)  -0.85+/-2.7(41)  0.003 
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c2_RP_Atrial_mexh_sc3_Median_Freq_kurtosis  3.26+/-1.5(27)  6.24+/-3.9(14)  4.28+/-2.9(41)  0.001 
c4_PP_Atrial_mexh_sc3_Peak_Freq_min  1.79+/-1.3(24)  0.43+/-0.7(14)  1.29+/-1.3(38)  0.001 
c2_PR_Chest_mexh_sc7_Median_Freq_min  4.31+/-1.1(27)  6.34+/-3.0(14)  5.00+/-2.1(41)  0.003 
c4_PP_Atrial_mexh_sc7_Peak_Freq_mean  2.46+/-1.1(24)  1.32+/-0.9(14)  2.04+/-1.2(38)  0.002 
Table 3.8 Preoperative morphological P wave features and their univariate results.  
P wave Features   Non-AF  AF   Total   p value  
VAraw_Pdur_V1   24.57+/-6.6(98)  24.69+/-7.4(50)  24.61+/-6.9(148) 0.922 
VAraw_Ptermfor   137.57+/-138.5(92) 105.17+/-91.8(42) 127.42+/-126.3(134) 0.169 
VAraw_Pdur_II    29.38+/-5.4(101) 29.97+/-7.0(53)  29.58+/-6.0(154) 0.558 
VAraw_Pdur_std   30.88+/-6.1(101) 31.06+/-5.7(54)  30.94+/-6.0(155) 0.857 
VAraw_PRsegint   11.92+/-7.4(101) 11.79+/-6.2(54)  11.88+/-7.0(155) 0.909 
VAraw_IEI    1.62+/-4.5(100)  0.99+/-4.8(53)  1.40+/-4.6(153)  0.420 
VAraw_TP_PQlevel   -0.02+/-0.1(104) -0.03+/-0.1(54)  -0.02+/-0.1(158) 0.425 
 
Table 3.9 Preoperative features derived from the raw (no wavelet decomposition) ECG signal 
Preoperative ECG Features  Non-AF   AF    Total    p value 
TQ_V1_Energy    71.46+/-94.8(102)  87.32+/-121.4(55)  77.02+/-104.8(157)  0.367 
TQ_V1_Spectral_entropy  -21876.36+/-34808.7(102) -27716.55+/-35289.1(55) -23922.29+/-34976.4(157) 0.320 
TQ_V1_Katz_FD   1.06+/-0.1(102)   1.06+/-0.1(55)   1.06+/-0.1(157)   0.608 
TQ_V1_Nonlinear_Energy  31.20+/-34.7(102)  29.04+/-29.9(55)  30.45+/-33.0(157)  0.696 
TQ_V1_Mean_Freq   5.96+/-3.4(102)   5.15+/-3.9(55)   5.68+/-3.6(157)   0.176 
TQ_V1_Median_Freq   4.77+/-3.1(102)   3.83+/-3.3(55)   4.44+/-3.2(157)   0.077 
TQ_V1_Peak_Freq   1.73+/-3.2(102)   1.26+/-2.6(55)   1.57+/-3.0(157)   0.347 
TQ_V1_Peak_Pow_Amp  2398.58+/-7257.8(102)  2877.04+/-6035.2(55)  2566.20+/-6838.4(157)  0.677 
TQ_V1_Shannon_Entropy  0.23+/-0.1(102)   0.24+/-0.1(55)   0.23+/-0.1(157)   0.623 
TQ_V1_Curve_length   56.74+/-52.4(102)  51.67+/-41.8(55)  54.96+/-48.9(157)  0.536 
TQ_I_Energy    90.84+/-160.4(86)  84.87+/-175.4(46)  88.76+/-165.1(132)  0.844 
TQ_I_Spectral_entropy -  26209.94+/-49227.1(86) -22912.60+/-47719.5(46) -25060.86+/-48549.9(132) 0.712 
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TQ_I_Katz_FD    1.08+/-0.1(86)   1.07+/-0.1(46)   1.08+/-0.1(132)   0.661 
TQ_I_Nonlinear_Energy  35.97+/-44.9(86)  37.64+/-86.4(46)  36.55+/-62.2(132)  0.884 
TQ_I_Mean_Freq   6.04+/-2.9(86)   6.70+/-3.1(46)   6.27+/-3.0(132)   0.230 
TQ_I_Median_Freq   4.56+/-2.6(86)   4.94+/-2.6(46)   4.69+/-2.6(132)   0.424 
TQ_I_Peak_Freq   1.69+/-2.7(86)   1.86+/-2.7(46)   1.75+/-2.6(132)   0.738 
TQ_I_Peak_Pow_Amp   1972.06+/-4787.6(86)  1210.88+/-2391.6(46)  1706.80+/-4119.5(132)  0.314 
TQ_I_Shannon_Entropy  0.24+/-0.1(86)   0.27+/-0.1(46)   0.25+/-0.1(132)   0.063 
TQ_I_Curve_length   60.80+/-51.8(86)  61.95+/-74.8(46)  61.20+/-60.6(132)  0.918 
TQ_II_Energy    169.43+/-212.4(104)  156.41+/-198.8(54)  164.98+/-207.3(158)  0.709 
TQ_II_Spectral_entropy   -61736.78+/-85461.5(104) -64680.81+/-83390.8(54) -62742.97+/-84504.9(158) 0.836 
TQ_II_Katz_FD    1.10+/-0.1(104)   1.09+/-0.1(54)   1.10+/-0.1(158)   0.397 
TQ_II_Nonlinear_Energy  50.59+/-37.9(104)  48.95+/-51.7(54)  50.03+/-43.0(158)  0.821 
TQ_II_Mean_Freq   5.44+/-2.6(104)   5.42+/-2.9(54)   5.43+/-2.7(158)   0.966 
TQ_II_Median_Freq   4.50+/-2.4(104)   4.37+/-2.2(54)   4.46+/-2.3(158)   0.738 
TQ_II_Peak_Freq   2.37+/-2.7(104)   1.96+/-2.4(54)   2.23+/-2.6(158)   0.333 
TQ_II_Peak_Pow_Amp   3659.65+/-8262.0(104)  3259.78+/-4972.8(54)  3522.99+/-7291.5(158)  0.745 
TQ_II_Shannon_Entropy  0.26+/-0.1(104)   0.27+/-0.1(54)   0.26+/-0.1(158)   0.665 
TQ_II_Curve_length   79.79+/-47.6(104)  72.70+/-53.4(54)  77.36+/-49.6(158)  0.396 
TQ_III_Energy    131.56+/-218.7(86)  98.85+/-127.7(46)  120.17+/-192.0(132)  0.353 
TQ_III_Spectral_entropy  -36906.08+/-69832.9(86) -33597.21+/-52865.6(46) -35752.99+/-64239.9(132) 0.779 
TQ_III_Katz_FD   1.09+/-0.1(86)   1.08+/-0.1(46)   1.09+/-0.1(132)   0.907 
TQ_III_Nonlinear_Energy  43.00+/-54.3(86)  48.54+/-75.9(46)  44.93+/-62.4(132)  0.629 
TQ_III_Mean_Freq   5.95+/-3.3(86)   5.44+/-3.3(46)   5.77+/-3.3(132)   0.405 
TQ_III_Median_Freq   4.23+/-2.4(86)   3.97+/-2.4(46)   4.14+/-2.4(132)   0.556 
TQ_III_Peak_Freq   1.72+/-2.4(86)   1.37+/-2.2(46)   1.60+/-2.4(132)   0.414 
TQ_III_Peak_Pow_Amp  2677.41+/-9513.2(86)  2059.31+/-3700.7(46)  2462.01+/-7969.5(132)  0.673 
TQ_III_Shannon_Entropy  0.27+/-0.1(86)   0.27+/-0.1(46)   0.27+/-0.1(132)   0.863 
TQ_III_Curve_length   69.30+/-56.8(86)  73.21+/-66.5(46)  70.66+/-60.1(132)  0.72 
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3.6 Discussion 
From these univariate observations it is now important to validate how well each of the 
predictors might perform. In order to access this, we build the ROC curve from the 
individual variable and estimate the AUC. It is important to note that this uses the same 
training and testing set for the evaluation of the significance of a given feature just as is 
done in many clinical studies to date [6, 8, 9, 13, 14, 19, 46]. Even though this is not the 
best methodology for a predictor, this offers an opportunity for comparison to other 
methods and can show how an individual variable might perform with a homogeneous 
dataset. 
We calculated the AUC for each of the pre- and postoperative continuous variables listed 
in Table 3.6 and Table 3.7, which are shown, along with their p-values, in Table 3.10. 
The postoperative values tend to be higher, though this could be due to a smaller sample 
size, therefore, more testing should be done to verify this hypothesis. Though they are 
interesting, all have an AUC having poor or fair stratification ability. 
Table 3.10 AUC of the ROC for features found significant in Table 3.6 and Table 3.7 
Preoperative Continuous Feature    p value  AUC of ROC 
Age        0.000  0.611 
Height (In)       0.003  0.584 
Ischemic Time (min)      0.004  0.594 
Cardiopulmonary bypass time (min)    0.004  0.589 
TQ_II_sym4_sc20_Mean_Freq     0.009  0.631 
TQ_II_coif1_sc15_Median_Freq     0.003  0.625 
TQ_V1_coif1_sc20_Peak_Freq     0.006  0.632 
TQ_II_bior4.4_sc5_Mean_Freq     0.008  0.613 
TQ_II_bior5.5_sc21_Mean_Freq    0.010  0.617 
TQ_II_rbio5.5_sc5_Mean_Freq     0.010  0.619 
TQ_II_gaus3_sc13_Peak_Freq     0.004  0.616 
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Postoperative Continuous Feature    p value  AUC of ROC 
Age        0.000  0.757 
c3_PP_Chest_Energy_skewness    0.002  0.734 
c3_PP_Chest_Energy_kurtosis     0.002  0.720 
c3_PP_Atrial_db2_sc5_Energy_skewness   0.003  0.768 
c1_PR_Atrial_db3_sc15_Curve_length_skewness  0.001  0.791 
c1_PR_Atrial_db3_sc20_Nonlinear_Energy_skewness  0.003  0.791 
c1_PR_Atrial_db3_sc20_Curve_length_skewness  0.002  0.780 
c1_PR_Atrial_sym4_sc15_Curve_length_skewness  0.002  0.789 
c2_PR_Atrial_sym4_sc20_Peak_Freq_skewness  0.001  0.778 
c3_PP_Atrial_sym6_sc5_Energy_skewness   0.003  0.754 
c2_RP_Atrial_sym6_sc10_Mean_Freq_kurtosis   0.001  0.757 
c2_RP_Atrial_sym6_sc10_Median_Freq_kurtosis  0.002  0.796 
c1_PR_Atrial_sym6_sc20_Nonlinear_Energy_skewness  0.003  0.791 
c2_PR_Chest_sym6_sc20_Median_Freq_min   0.002  0.706 
c3_PP_Atrial_coif1_sc5_Peak_Freq_std    0.003  0.784 
c2_RP_Atrial_coif1_sc10_Shannon_Entropy_kurtosis  0.003  0.704 
c1_PR_Atrial_coif1_sc15_Curve_length_skewness  0.002  0.780 
c4_PP_Atrial_coif1_sc25_Peak_Freq_mean   0.002  0.783 
c4_PR_Chest_coif1_sc25_Shannon_Entropy_skewness  0.002  0.815 
c3_PP_Atrial_coif4_sc5_Energy_skewness   0.003  0.740 
c3_PP_Atrial_coif4_sc5_Nonlinear_Energy_skewness  0.003  0.793 
c2_RP_Atrial_coif4_sc10_Median_Freq_kurtosis  0.001  0.775 
c1_PR_Atrial_coif4_sc20_Nonlinear_Energy_skewness  0.003  0.794 
c3_PP_Atrial_bior2.2_sc10_Mean_Freq_skewness  0.001  0.793 
c3_PP_Atrial_bior2.2_sc10_Peak_Freq_min   0.003  0.794 
c3_RP_Atrial_bior2.2_sc10_Mean_Freq_skewness  0.000  0.816 
c3_PP_Atrial_bior2.2_sc15_Katz_FD_skewness   0.002  0.786 
c3_PP_Atrial_bior2.2_sc15_Nonlinear_Energy_kurtosis  0.003  0.720 
c3_RP_Atrial_bior2.2_sc15_Katz_FD_skewness  0.002  0.725 
c3_PR_Atrial_bior2.2_sc15_Katz_FD_skewness  0.002  0.750 
c4_PP_Atrial_bior2.2_sc20_Peak_Freq_min   0.002  0.786 
c3_RP_Atrial_bior2.2_sc25_Katz_FD_skewness  0.003  0.755 
c3_RP_Atrial_bior2.2_sc25_Katz_FD_kurtosis   0.002  0.709 
c1_PP_Atrial_bior4.4_sc5_Peak_Freq_kurtosis   0.001  0.748 
c1_PR_Atrial_bior4.4_sc15_Curve_length_skewness  0.002  0.800 
c1_PR_Chest_bior4.4_sc15_Peak_Freq_std   0.003  0.766 
c1_PR_Atrial_bior4.4_sc20_Curve_length_skewness  0.002  0.740 
c1_PR_Atrial_bior4.4_sc25_Peak_Freq_kurtosis  0.001  0.722 
c2_RP_Atrial_bior4.4_sc25_Shannon_Entropy_kurtosis  0.003  0.733 
c3_PP_Atrial_bior5.5_sc5_Energy_skewness   0.003  0.729 
c4_PP_Atrial_bior5.5_sc5_Mean_Freq_max   0.002  0.768 
c1_PR_Atrial_bior5.5_sc17_Curve_length_skewness  0.002  0.754 
c1_PR_Atrial_bior5.5_sc25_Peak_Freq_kurtosis  0.001  0.793 
c1_PR_Atrial_bior6.8_sc20_Curve_length_skewness  0.003  0.757 
c1_PR_Atrial_rbio2.2_sc13_Curve_length_skewness  0.001  0.780 
c4_PP_Atrial_rbio2.2_sc17_Peak_Freq_mean   0.001  0.807 
c4_PP_Atrial_rbio2.2_sc21_Peak_Freq_mean   0.003  0.801 
c1_PR_Atrial_rbio4.4_sc15_Curve_length_skewness  0.003  0.780 
c2_RP_Atrial_rbio5.5_sc10_Peak_Freq_skewness  0.002  0.733 
c3_RP_Atrial_rbio5.5_sc10_Shannon_Entropy_std  0.002  0.788 
c2_PR_Chest_rbio5.5_sc20_Median_Freq_min   0.002  0.717 
c1_PP_Atrial_rbio5.5_sc25_Peak_Freq_max   0.002  0.756 
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c1_RP_Atrial_rbio5.5_sc25_Peak_Freq_max   0.000  0.814 
c1_PR_Atrial_rbio5.5_sc25_Peak_Freq_kurtosis  0.002  0.686 
c3_PP_Atrial_rbio6.8_sc5_Energy_skewness   0.002  0.733 
c3_PP_Atrial_rbio6.8_sc5_Nonlinear_Energy_skewness  0.002  0.795 
c2_RP_Atrial_rbio6.8_sc9_Mean_Freq_kurtosis   0.002  0.685 
c2_RP_Atrial_rbio6.8_sc9_Median_Freq_kurtosis  0.001  0.796 
c3_PP_Atrial_rbio6.8_sc9_Mean_Freq_min   0.002  0.749 
c1_PR_Atrial_rbio6.8_sc17_Curve_length_skewness  0.003  0.754 
c2_PR_Atrial_rbio6.8_sc17_Peak_Freq_kurtosis  0.001  0.734 
c2_PR_Chest_gaus1_sc2_Mean_Freq_min   0.000  0.757 
c3_PP_Atrial_gaus1_sc2_Energy_skewness   0.001  0.777 
c3_PP_Atrial_gaus1_sc2_Energy_kurtosis   0.002  0.731 
c3_PR_Atrial_gaus1_sc2_Median_Freq_skewness  0.001  0.731 
c4_PR_Chest_gaus1_sc6_Peak_Freq_mean   0.002  0.818 
c3_PR_Chest_gaus1_sc8_Katz_FD_skewness   0.002  0.772 
c3_PR_Chest_gaus1_sc10_Energy_skewness   0.002  0.755 
c3_PR_Chest_gaus1_sc12_Energy_skewness   0.001  0.734 
c2_PR_Chest_gaus2_sc10_Median_Freq_min   0.002  0.735 
c4_PP_Atrial_gaus2_sc10_Peak_Freq_mean   0.002  0.798 
c2_PR_Atrial_gaus3_sc7_Mean_Freq_mean   0.003  0.788 
c2_PR_Atrial_gaus3_sc7_Peak_Freq_mean   0.000  0.839 
c1_PR_Atrial_gaus3_sc10_Nonlinear_Energy_skewness 0.003  0.789 
c1_RP_Atrial_gaus3_sc13_Mean_Freq_min   0.002  0.786 
c1_RP_Atrial_gaus3_sc13_Median_Freq_min   0.001  0.783 
c3_PR_Chest_gaus3_sc13_Katz_FD_skewness  0.001  0.709 
c1_PP_Atrial_gaus3_sc19_Peak_Freq_skewness  0.003  0.723 
c2_PR_Chest_gaus4_sc13_Median_Freq_min   0.002  0.706 
c2_RP_Atrial_gaus4_sc19_Shannon_Entropy_skewness 0.003  0.780 
c2_RP_Atrial_mexh_sc3_Median_Freq_kurtosis   0.001  0.788 
c4_PP_Atrial_mexh_sc3_Peak_Freq_min   0.001  0.808 
c2_PR_Chest_mexh_sc7_Median_Freq_min   0.003  0.728 
c4_PP_Atrial_mexh_sc7_Peak_Freq_mean   0.002  0.798 
 
Several of the traditional AF predictors show up in the superior group listed in Table 3.10 
such as age and prior AF. Additionally, cardiomegaly, left atrium size, prior heart 
surgery, and ischemic and cardiopulmonary bypass time appear significant. Apart from 
these clinical features, the ECG derived features seem to perform well when calculating 
frequency measures on the II lead. This leads us to believe that the frequency content of 
the wavelet decomposed T-to-Q segment has significant risk stratification properties. The 
top row of Figure 3.10 shows the ECG of a non-AF and an AF patient with the offset of 
the T wave and the onset of the Q wave marked. The middle row of Figure 3.10 shows 
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this same TQ segment following wavelet decomposition with the symlet four wavelet at a 
scale of twenty. Notice the significantly more complex wave shape in the AF patient 
which then results in higher frequency components than the non-AF patient. This is 
illustrated in the bottom row if Figure 3.10, which shows the difference of the mean 
frequency of ~6.8 and ~13.7 Hz for the non-AF and AF patient, respectively. Figure 3.11 
shows the averaged spectrum of the II lead’s T-Q segment symlet four wavelet 
decomposition at scale twenty for all the patients in both AF and non-AF patients. Notice 
the difference of these plots particularly in the 15-40 Hz area of the spectrum which 
appears to show a higher magnitude for AF patients. 
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Non-AF patient - Symlet 4 wavelet 























AF patient - Symlet 4 wavelet 
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Figure 3.10 Non-AF (left column) and AF (right column) patient ECG (top row), the P 
























































































Figure 3.11 Averaged frequency spectrums of the P wave’s symlet 4 wavelet 
decompositions (as seen in Figure 3.10) Non-AF and AF patient's (left) and a close-up of 
the 10-40 Hz region showing an interesting difference between the classes. 
The sensitivity/specificity product plot in Figure 3.12 shows the class labeled patients and 
their associated feature value as well as the maximum value where an optimum 
classification threshold could be placed (further uses and reasoning behind this plot are 
discussed on chapter four). You can see a greater percentage of non-AF patients have a 
low feature value while those higher have a greater risk of AF. The ROC curve for this 
feature is shown in Figure 3.13 having an AUC of 0.6307 which does not correspond to a 
good classifier. 
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Figure 3.12 Sensitivity/specificity product plot of the symlet four (scale 20) wavelet 
decomposition of the TQ segment. This also marks the maximum of this plot which 
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Figure 3.13 ROC of the mean frequency of the symlet four (scale 20) wavelet 
decomposition of the TQ segment. 
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In the postoperative feature set, again, age appears significant along with 2 features 
computed directly from the ECG on the third clips’ PP segment. Additionally, many 
features derived from the wavelet decompositions are significant, particularly  
• the atrial lead’s first clips’ PR segments’ skewness of the curve length and 
• the atrial lead’s third clips’ PP segments’ skewness of the energy/nonlinear 
energy, 







































Figure 3.14 (Left) Histogram for non-AF and AF patients of the curve length of the 
daubechies three wavelet decomposition (scale 15) of the PR segment of the atrial lead’s 
TQ segment. (Right) ROC for this feature. 
We decided to investigate the first of these relationships more thoroughly, in particular 
the curve length of the daubechies three wavelet decomposition (scale 15) of the PR 
segment of the Atrial lead’s TQ segment. The plot of occurrences of each value of this 
curve length is shown in Figure 3.14 for the two classes. It looks as if the right tail of the 
distribution is larger in the non-AF patients overall, causing a large skewness value, 
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while the AF patients have a small or negative skewness value. This can be thought of as 
AF patients have an overall smaller variation in curve length from beat to beat, while the 
non-AF patients’ values tend to move a little higher more frequently. This is confirmed 
by the sensitivity/specificity product plot in Figure 3.15. The ROC curve shows an AUC 
of 0.791 with great potential for a three class separation system (low, medium, and high 
AF risk) by using the two significantly high sensitivity and specificity points which seem 
to hug either of the axes before the curve crosses the interior of the plot. 
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Figure 3.15 The sensitivity/specificity product plot of the curve length of the daubechies 
three wavelet decomposition (scale 15) of the PR segment of the atrial lead’s TQ 
segment. 
Concluding this section, though these univariate classification variables show promise, 
their current classification utility is too low for use in the clinical setting. Though more 
work should be done with better and larger data sets to determine their actual utility and 
robustness, we believe efforts in combining the predictive power of several variables 
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might yield a better classifier. We will investigate this hypothesis in the following 
chapters. 
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Chapter 4  
Multivariate AF Prediction 
In order to improve upon predictive accuracies found in the univariate analysis, in this 
chapter, we test two multivariate predictors on both the pre- and postoperative data to 
observe their classification ability. We perform this on the clinical data, the ECG feature 
data, as well as the combined dataset. When building these multivariate classifiers, we 
have paid particular attention to the fact that the best individual features, which we found 
in the preceding chapter, are not always the best feature set [92-94]. For this reason, we 
use a GA to select the features for these classifiers. By selecting a feature set, we reduce 
the dimensionality of the problem to a more generalized model with lower data collection 
and computation needs. The GA can sample the feature search-space effectively without 
becoming trapped in local maxima as would many greedy search methods. 
4.1 Methods 
Two typical multivariate classification techniques are being employed: the k-nearest 
neighbor algorithm (k-NN) and multivariate logistic regression. Both methods have a 
long usage history in practice and literature [91, 95] and are to be used here as a 
benchmark for further multivariate classifiers that will be presented in the next chapter. 
The features used with each of these classifiers are being selected by a GA in order to 
optimize the coverage of the feature search space and find the best risk stratifier’s 
characteristics while concurrently reducing the dimensionality of the data.  
 














Feature Set  
Figure 4.1 Flow Chart of GA feature selection with a classifier. 
4.1.1 Logistic Regression 
Logistic regression is a standard method for the modeling of binary outcomes and their 
dependence on predictive values, xj,i, where i is the sample number and j is the variable 
number. The link between the binary outcome and the data are defined by a linear 
regression mapped onto the logit function of the probability of the class variable, pi, at the 














βββ L , 
where there are k predictive variables. The {βj} are linear fit coefficients which are 
usually found through maximum likelihood estimation. This model allows for a smooth 
approximation of the predicted binary variable from predictive data. Though used often 
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in medical risk stratification methods, logistic regression has the unfortunate 
characteristic of requiring a complete dataset for training and testing, meaning no missing 
values. 
For our application, the features are selected through evolution of the classifier performed 
by the GA and all samples with missing data points are removed. The regression was 
performed, finding the {βj} coefficients using Matlab’s generalized linear model tools 
and the class probability, pi is found for the entire data set. The entire set is used rather 
than leave-one-out (LOO) validation because when this is used with a GA, unusual 
results are obtained. To be more specific, while the GA searches for the best feature set 
with LOO, retraining of the classifier is done for every test patient, meaning a new set of 
{βj} parameters for every patient. The GA then looks for the feature set that allows the 
aligning of the different sets of {βj} parameters for perfect accuracy. The GA trained with 
LOO performs excellently when validated with LOO but when trained and tested on the 
same set, the results are poor. We have often observed this when combining LOO 
validation when assessing the individual’s fitness in a GA if the coefficients or 
parameters of the classifier change with each individual tested. This is also observed in 
slightly different conditions by other researchers [96]. For this reason, the logistic 
regression’s fitness will be evaluated using the entire dataset for training and testing and 
later validated through LOO. 
The fitness of this classifier structure is evaluated by taking the probabilities and the 
associated class labels, constructing an ROC curve, finding the optimal classification 
threshold as discussed in chapter two, and calculating the sensitivity and specificity using 
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this threshold. Through the generations of the GA, the best feature set for risk 
stratification is found.  
4.1.2 k-Nearest Neighbor 
The k-nearest neighbor algorithm (k-NN) classifies samples based on the idea that its 
class will be that of the majority class among neighboring samples in the predictive 
feature space. The nearest neighbors are typically measured as those with the lowest 
Euclidian distance. The number of neighbors, k, is selected as a small fraction of the total 
dataset, typically odd to avoid the need for tie-breakers. Unfortunately, this classification 
method, like logistic regression, does not tolerate missing data points. 
As in the logistic regression approach, the features were selected by the GA and all 
samples with missing data points were removed. Unlike logistic regression, the k-NN 
does not involve changing of any parameters during training, just the absence of the 
current individual from the feature space. Therefore, LOO validation is performed using 
all the patients but one to populate the feature space. Each test patient was labeled by 
finding the three nearest neighbors (k=3) and using the majority’s label. We then assessed 
the sensitivity and specificity on the test set to find the best overall risk stratifier. 
4.1.3 Genetic Algorithm 
The genetic algorithm for this research was implemented in Matlab® 6.5 using the GA 
optimization toolbox (GAOT) [97]. The prediction of patients being either AF or non-AF 
patients was performed using between two and five features from the data calculated as 
described in chapter three. Therefore, the chromosome encoding the individual was a 
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vector of six integers as seen in Figure 4.2. The first integer, p, is a number from two to 
five specifying how many of the following five possible features will be used. The 
following five integers, f1 through f5, identify the actual feature to be used.  
p f1 f2 f3 f4 f5  
Figure 4.2 Chromosome integers for feature selection 
We initialized the GA with a random population of 200 individuals when an initial set is 
not already specified and allowed the algorithm to run for up to 10,000 generations. 
There were two other termination conditions for the GA that allowed termination before 
this point. The first stopped the GA if the best individual reached the highest possible 
fitness of two input features (the minimum) and perfect sensitivity and specificity. The 
second termination condition was if the GA went for 250 iterations (over 167,000 
individuals (250*(2*(50+50+50)+300+30+20+20+1))) with no improvement. 
Within each generation, a specified number of crossovers and mutations were performed 
on the previous population: 
• 50 arithmetic crossovers, 
• 50 heuristic crossovers, 
• 50 simple crossovers, 
• 300 uniform mutations, 
• 30 swap mutations 
• 20 multiple point, nonuniform mutations, 
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• 20 single point, nonuniform mutations, and 
• 1 boundary mutation. 
The three crossover operators allow for good mixing of chromosomes between fit 
individuals. Uniform mutation is responsible for the roughly half of the new individuals 
allowing good coverage of the search space. Sufficient usage of this operator is important 
since the integers of the chromosome represent an unordered feature set and uniformly 
distributed mutations allow for better coverage of all possible feature combinations. If the 
chromosome integer coded a coefficient in a polynomial, as the value increased, the 
expected equation solution would move in a predetermined direction, therefore, 
mutations that caused small and nonuniform moves of the integer was desirable because 
to the adjacent value being closely related. In this implementation, as the integer 
identifying the feature increases, there is no clear relationship to how the classification 
will improve until it has been tested.  
The 41 nonuniform mutations per generation are included to allow for adjacent features 
which may be in the same family and might be somewhat related. Please refer to [97] for 
further information on this toolbox and its operators. Moreover, we added the swap 
operator to help in rearranging the integers in the chromosome. This is not included as an 
option in the toolbox. This swapping of integers allows the better features to move 
toward the beginning of the chromosome, and as the number of selected variables 
decrease, a more generalized model is found and the fitness increases as we will discuss 
later. The list of operators above allows for excellent mixing through the generations and 
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creates a minimum of 167,000 individuals to be tested through the minimum 250 
generations.  
We used both elitist and normalized geometric distribution selection [97] to keep the best 
individuals as well as a fair mix of more diverse individuals. The fitness function for the 
GA was chosen to be a mix of both the sensitivity and the specificity of the classifier. We 
chose to use the product of these two measures because it sets both cases of high 
sensitivity/low specificity and vice versa to zero as seen in Figure 4.3 [98], something the 
sum does not provide. It puts more emphasis on a classifier being both sensitive and 
specific in imbalanced training sets as is needed in postoperative risk stratification. 
 
Figure 4.3 Fitness surfaces for product (left) and sum (right) of sensitivity and specificity. 
In addition to the product of the sensitivity and the specificity, we also wanted to punish a 
classifier based on its complexity, i.e. the number of variables required. For instance, a 
classifier requiring a doctor to perform five tests is not as desirable as a classifier with 
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only two data inputs. For this reason, the fitness was penalized for every feature needed 
for classification, making the fitness function 
Tfyspecificitysensitivitfitness 99.0⋅⋅=  
where fT is the total number of features.  
4.2 Evaluation 
We ran four different GAs for feature selection with both the k-NN and the logistic 
regression: on the clinical data alone, the ECG data alone, and two initializations of the 
combined data types. The classifiers that used clinical or ECG data alone were initialized 
with a random population of individuals. The classifiers which used both the clinical and 
ECG data together were tested using both the best individuals from the previous clinical 
and ECG data only experiments, as well as by random population initialization. These 
different initializations will allow both the possibility of building on previously 
discovered maxima as well as starting at random. 
Since none of the ECG features overlap between the pre- and post-surgical datasets and 
very few of the clinical features are comparable (different collection or recording 
methods), we did not perform a combined run of pre- and postoperative data.  
4.3 Results 
For each of the classifiers, we list the variables that were found to be of importance as 
well as the fitness of the classifier, the total dataset’s sensitivity/specificity, the number of 
generations required to reach this solution, and the number of patients the classification 
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system used, both non-AF (NAF) and AF. We have also plotted the fitness of the 
classifiers in relation to the generation number of the GA. For the k-NN classifiers, when 
the number of variables is three or less, we have plotted the feature space and where the 
patients fall in this space actually as well as their predicted location. For the logistic 
regression classifiers, we have plotted the ROC curve of the classifier and its associated 
sensitivity/specificity product plot and the associated maximum which defines our 
identified optimum classification threshold. Additionally, we have plotted each patient’s 
value on the regression curve as well as the associated threshold found in the previous 
plot. The summary of all of these results are seen here in Table 4.1 with their specifics in 
the sections following. Since the combined data classifier results that initialized with 
previous best individuals used repeated feature sets from the clinical or ECG data only 
runs, they are not presented in this table.  
Table 4.1 Logistic regression and k-NN classifier results 
   Features Sen/Spec Fitness NAF/AF Generations
Reg. 5 0.64/0.81 0.4932 116/75 202 Clinical 
k-NN 5 0.67/0.80 0.5082 158/97 98 
Reg. 5 0.72/0.86 0.5848 84/46 773 ECG 
k-NN 4 0.63/0.82 0.4975 84/46 65 







k-NN 2 0.63/0.80 0.4908 84/46 24 
Reg. 4 1/1 0.9606 14/6 29 Clinical 
k-NN 3 0.83/0.93 0.7508 14/6 150 
Reg. 2 1/1 0.9801 17/6 214 ECG 
k-NN 4 1/1 0.9606 20/13 160 








k-NN 4 0.92/1 0.8867 22/13 72 
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4.3.1 Preoperative Risk Stratifiers 
4.3.1.1 Clinical Dataset 
4.3.1.1.1 Logistic Regression 
The logistic regression model of the preoperative clinical data took 202 generations to 
find a classifier with a fitness of 0.4932, a sensitivity of 0.64, and a specificity of 0.81 
using the following five variables. 
• Ejection Fraction (3 level categorical: normal, moderate, severe LV function) 
• Preoperative AF occurrence 
• Cardiomegaly 
• Left ventricle end-diastolic pressure – preoperative 
• CABG distal anastomoses (number with vein) 






















Figure 4.4 Preoperative clinical dataset’s logistic regression plot 
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For this feature set, missing data points limited the dataset to 116 non-AF patients and 75 
AF patients. The {βj} regression coefficients for this model were [-0.4630, 0.4449, 
0.6368, 0.5296, 0.2454, 0.3805] and the regression as well as the patient positions on this 
regression are shown in Figure 4.4. All the values seem to have a positive relation to AF 
with preoperative AF occurrence and cardiomegaly being the strongest characteristics. 
Both of these variables as well as ejection fraction and the number of anastamoses 
(though of the mammery artery, not a vein) were found to be univariately significant in 
chapter three. Poor ejection fraction and high diastolic blood pressure are signs of a 
possibly ailing heart and a large number of anastamoses (loops in the circular system 
sometimes formed in response to a need for more blood flow) possibly show previous 
ischemic conditions. Figure 4.5 shows the evolution of the classifier with the fitness of 
the best individual as well as the average fitness of the population. There seems to be 
good mixing showing that the evolving population was not too closely tied to the fittest 
individual yet yielded improvements to these individuals. 
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Figure 4.5 Evolutionary fitness plot and the ROC curve of the preoperative clinical 
dataset's logistic regression 
 
- 110 - 
Figure 4.5 also shows the ROC of this classifier, making it a fair to good risk stratifier 
(AUC = 0.75). The sensitivity/specificity product plot, shown in Figure 4.6, shows the 
threshold value of the logistic regression found to best separate the classes, 0.40361.  
This threshold is set immediately above the maximum of this curve for optimal 
separation given our need for equally high sensitivity and specificity. We set it 
immediately above this value to prevent the patient that defines the maximum from 
having an indeterminate predicted class. This optimum threshold selection method is used 
for all threshold determination in this work. The figure shows that the AF patients tend to 
have values over this threshold while non-AF patients tend to be under this value. 




















Figure 4.6 Product of the sensitivity and specificity of the logistic regression output of the 
preoperative clinical dataset including the maximum point indicating the optimum 
threshold. 
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4.3.1.1.2 k-Nearest Neighbor 
The k-NN classifier of the preoperative clinical data took 98 generations to find a 
classifier with a fitness of 0.5082, a sensitivity of 0.67, and a specificity of 0.80 using the 
following five variables: 
• CABG distal anastomoses (total number) 
• Preoperative AF occurrence 
• Left atrial hypertrophy 
• Low density lipoprotein 
• Emergency Surgical Priority 
For this feature set, missing data points limited the dataset to 158 non-AF patients and 97 
AF patients. Again, anastamoses appear as a predictor as well as the preoperative 
occurrence of AF. Anastamoses, preoperative AF occurrence, as well as left atrial size 
were also seen as independent predictors in chapter three and the first two were also in 
the logistic regression system above. Large left atrial size also tends to be a sign of 
increased load on the heart which could be a possible indicator of increased AF risk. 
Figure 4.7 shows the evolution of the classifier implying good mixing and a steady 
increase in fitness. 
 
















Figure 4.7 Evolutionary fitness plot of the preoperative clinical dataset's k-NN classifier 
4.3.1.2 ECG Feature Dataset 
4.3.1.2.1 Logistic Regression 
The logistic regression model of the preoperative ECG data took 773 generations to find 
a feature set with a fitness of 0.5848, a sensitivity of 0.72, and a specificity of 0.86 using 
the following five variables. 
• TQ_V1_coif1_sc20_Peak_Freq 
• TQ_III_rbio2.2_sc9_Mean_Freq 
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Figure 4.8 Preoperative ECG dataset logistic regression plot 
For this feature set, missing data points limited the dataset to 84 non-AF patients and 46 
AF patients. The {βj} regression coefficients for this model were [-0.6702, -0.6157, 
0.4388, 0.3990, -0.2805, -0.2183] and the regression as well as the patient positions on 
this regression is shown in Figure 4.8. The first, fourth, and fifth features have a negative 
relation to AF occurrence. The first feature, TQ_V1_coif1_sc20_Peak_Freq, was also 
identified as a significant independent univariate predictor in chapter three where it again 
had an inverse relationship to AF occurrence. It is also the most heavily weighted 
variable in the regression model. Figure 4.9 shows the evolution of the classifier implying 
good mixing and a steady increase in fitness. 
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Figure 4.9 Evolutionary fitness plot and the ROC curve of the preoperative ECG dataset's 
logistic regression 
Figure 4.9 shows the ROC of this classifier, making it a fair risk stratifier (AUC = 0.72). 
The sensitivity/specificity product plot, shown in Figure 4.10, shows the threshold value 
of the logistic regression found to best separate the classes, 0.38157. The figure shows 
that the AF patients tend to have values over this threshold while non-AF patients tend to 
be under this value. 
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Figure 4.10 Product of the sensitivity and specificity of the logistic regression output of 
the preoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
4.3.1.2.2 k-Nearest Neighbor 
The k-NN classifier of the preoperative ECG data took 65 generations to find a classifier 






For this feature set, missing data points limited the dataset to 84 non-AF patients and 46 
AF patients. Notice that these features were not independently significant predictors in 
chapter three or found in the previous regression approach, yet are the best ECG data 
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based k-NN feature combination found. Figure 4.11 shows the evolution of the classifier, 
again implying good mixing and a steady increase in fitness. 
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Figure 4.11 Evolutionary fitness plot of the preoperative ECG dataset's k-NN classifier 
4.3.1.3 Clinical and ECG Combined Dataset 
4.3.1.3.1 Logistic Regression 
When initialized with the best individuals of the previous clinical or ECG data 
experiments, the combined dataset results matched one of these previous individuals. The 
best logistic regression individual used the same variables found in the ECG only feature 
set, while the best k-NN individual used the same variables as in the clinical only feature 
set.  
When randomly initialized, new and different solutions were found. The logistic 
regression model of the preoperative combined data took 53 generations to find a 
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classifier with a fitness of 0.6030, a sensitivity of 0.76, and a specificity of 0.83 using the 
following five variables: 
• TQ_III_gaus4_sc10_Mean_Freq 




























Figure 4.12 Preoperative combined clinical and ECG dataset logistic regression plot. 
For this feature set, missing data points limited the dataset to 84 non-AF patients and 46 
AF patients. The {βj} regression coefficients for this model were [-0.76087, 0.5533, 
0.6082, -0.2858, 0.0815, 0.1732] and the regression as well as the patient positions on 
this regression is shown in Figure 4.12. Notice that a single clinical feature is being used 
in conjunction with several ECG features for our final classifier. Figure 4.13 shows the 
evolution of the classifier implying good mixing and a steady increase in fitness. 
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Figure 4.13 Evolutionary fitness plot of the preoperative combined clinical and ECG 
dataset's logistic regression 
Figure 4.13 shows the ROC curve of this classifier making it a good risk stratifier 
(AUC=0.75). The sensitivity/specificity product plot, shown in Figure 4.14, shows the 
threshold value of the logistic regression found to best separate the classes, 0.43616. The 
figure shows that the AF patients tend to have values over this threshold while non-AF 
patients tend to be under this value. 
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Figure 4.14 Product of the sensitivity and specificity of the logistic regression output of 
the preoperative combined clinical and ECG dataset including the maximum point 
indicating the optimum threshold. 
4.3.1.3.2 k-Nearest Neighbor 
The k-NN classifier of the preoperative combined clinical and ECG data took 24 
generations to find a classifier with a fitness of 0.4908, a sensitivity of 0.63, and a 
specificity of 0.80 using the following two variables: 
• TQ_I_coif1_sc20_Peak_Freq 
• TQ_III_rbio2.2_sc9_Median_Freq 
The second of these features is very similar to the TQ_III_rbio2.2_sc9_Mean_Freq used 
in the ECG data regression analysis found previously. For this feature set, missing data 
points limited the dataset to 84 non-AF patients and 46 AF patients. Figure 4.15 shows 
the evolution of the classifier, again implying good mixing and a steady increase in 
fitness. 
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Figure 4.15 Evolutionary fitness plot of the preoperative combined clinical and ECG 
dataset's k-NN classifier 
With there being two predictive variables, we were able to plot these and show both the 
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Figure 4.16 Non-AF and AF patient samples plotted in the optimum feature space found 
by the k-NN. The actual class labels are in the left plot while the right shows the 
predicted class labels. 
Though there seems to be a slight AF clustering in the left and right areas of the plots, the 
overlap between the classes are very large without any apparent separation. We believe 
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that this classifier was found to be the best, not because of actual class separation but by 
chance. 
4.3.2 Postoperative Risk Stratifiers 
4.3.2.1 Clinical Dataset 
4.3.2.1.1 Logistic Regression 
The logistic regression model of the postoperative clinical data took 29 generations to 
find a classifier with a fitness of 0.9606 and a perfect sensitivity and specificity using the 
following four variables: 
• Performed vessel bypasses (number) 
• Age 
• High temperature during surgery (Co) 
• Left main coronary artery disease 


























Figure 4.17 Postoperative clinical dataset logistic regression plot 
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For this feature set, missing data points limited the dataset to 14 non-AF patients and 6 
AF patients. The {βj} regression coefficients for this model were [-16.5715, -10.9853, 
25.6700, -7.7289, -16.1106] and the regression as well as the patient positions on this 
regression is shown in Figure 4.17. The extreme step seen in this regression is a result of 
the large separation between the classes in this regression and the large range of the 
regression sum. Age is certainly a predictor of AF that has been discussed in chapter two 
and was significant in chapter three’s univariate analysis. Additionally, the number of 
vessels bypassed increases the time of the surgery and the stress put on the patients heart, 
which could possibly make it more susceptible to AF. Figure 4.18 shows the evolution of 
the classifier implying good mixing and a steady increase in fitness. 



































Figure 4.18 Evolutionary fitness plot and ROC curve of the postoperative clinical 
dataset's logistic regression 
Figure 4.18 also shows the perfect 1.00 AUC of this classifier making it an excellent risk 
stratifier. The sensitivity/specificity product plot, depicted in Figure 4.19, shows the 
threshold value of the logistic regression found to best separate the classes, 0.16131. The 
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figure shows that the AF patients tend to have values over this threshold while non-AF 
patients tend to be under this value. 

























Figure 4.19 Product of the sensitivity and specificity of the logistic regression output of 
the postoperative clinical dataset including the maximum point indicating the optimum 
threshold. 
4.3.2.1.2 k-Nearest Neighbor 
The k-NN classifier of the postoperative clinical data took 150 generations to find a 
classifier with a fitness of 0.7508, a sensitivity of 0.83, and a specificity of 0.93 using the 
following three variables: 
• Age 
• Left anterior descending coronary artery disease 
• Calcium blocker administration 
For this feature set, missing data points limited the dataset to 14 non-AF patients and 6 
AF patients. Again, age is found to be an important predictor along with another vessel 
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having coronary artery disease as we saw in the previous regression predictor. Figure 
4.20 shows the evolution of the classifier having good mixing and a steady increase in 
fitness. 















Figure 4.20 Evolutionary fitness plot of the postoperative clinical dataset's k-NN 
classifier 
With there being three predictive variables, we were able to plot these in three 
dimensions and show both the actual classes and predicted classes of all the patients in 
Figure 4.21. You can see the continuous age variable being an important predictor and 
both the calcium blocker and coronary artery disease of the left anterior descending 
separating the non-AF patients from the cluster of AF patients that remain. 
 







































Figure 4.21 Non-AF and AF patient samples plotted in the optimum feature space found 
by the k-NN. The actual class labels are in the left plot while the right shows the 
predicted class labels. 
4.3.2.2 ECG Feature Dataset 
4.3.2.2.1 Logistic Regression 
The logistic regression model of the postoperative ECG data took 214 generations to find 
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Figure 4.22 Postoperative ECG dataset logistic regression plot 
For this feature set, missing data points limited the dataset to 17 non-AF patients and 6 
AF patients. The {βj} regression coefficients for this model were [-11.0210, 1.1592, 
22.9708] and the regression as well as the patient positions on this regression is shown in 
Figure 4.22. As the weight of the second variable is much larger than that of the first, this 
is a very significant feature though it did not appear to be independently significant in 
chapter three. Figure 4.23 shows the evolution of the classifier, again with good mixing 
and a steady increase in fitness. 
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Figure 4.23 Evolutionary fitness plot of the postoperative ECG dataset's logistic 
regression 
Figure 4.23 shows the “perfect” ROC curve of this classifier making it an excellent risk 
stratifier (AUC = 1.00). The sensitivity/specificity product plot, shown in Figure 4.24, 
shows the threshold value of the logistic regression found to best separate the classes, 
0.15375. The figure shows that, again, the AF patients tend to have values over this 
threshold while non-AF patients tend to be under this value. 
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Figure 4.24 Product of the sensitivity and specificity of the logistic regression output of 
the postoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
4.3.2.2.2 k-Nearest Neighbor 
The k-NN classifier of the postoperative ECG data took 160 generations to find a 
classifier with a fitness of 0.9606 and a perfect sensitivity and specificity using the 
following four variables: 




For this feature set, missing data points limited the dataset to 20 non-AF patients and 13 
AF patients. Most of the features selected for this classifier as well as for the last are from 
the later two clips, 24 and 36 hours after surgery (C3 and C4). This could be a reflection 
of the patient’s susceptibility to AF as the patient heals. Remember that AF tends to occur 
most on the second or third day following surgery. Figure 4.25 shows the evolution of the 
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classifier with good mixing in the population and a sudden jump in the best individual’s 
fitness after roughly 100 generations. These significant evolutionary leaps are the reason 
we chose to perform 250 iterations with no improvement before halting the GA. 
















Figure 4.25 Evolutionary fitness plot of the postoperative ECG dataset's k-NN classifier 
4.3.2.3 Clinical and ECG Combined Datasets 
Again, when initialized with the best individuals of the previous clinical or ECG data 
only experiments, the combined dataset results matched one of these previous 
individuals. This time the best individual for both classifiers used the same variables 
found in the ECG only feature set that was found previously. When randomly initialized, 
new and different solutions were found.  
 
- 130 - 
4.3.2.3.1 Logistic Regression 
The logistic regression model of the preoperative combined data took 35 generations to 
find a classifier with a fitness of 0.9703 and a perfect sensitivity and specificity 1.00 






























Figure 4.26 Postoperative combined clinical and ECG dataset logistic regression plot 
Again, several c4 clips are found important pointing to the later features’ importance. 
For this feature set, missing data points limited the dataset to 22 non-AF patients and 13 
AF patients. The {βj} regression coefficients for this model were [-10.0613, -23.7183, 
20.0191, -7.9062] and the regression as well as the patient positions on this regression is 
shown in Figure 4.26. Figure 4.27 shows the evolution of the classifier implying good 
mixing and a steady increase in fitness. 
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Figure 4.27 Evolutionary fitness plot of the postoperative combined clinical and ECG 
dataset's logistic regression 
Figure 4.27 shows the perfect ROC curve of this classifier making it a good risk stratifier 
(AUC=1.00). The sensitivity/specificity product plot, shown in Figure 4.28, shows the 
threshold value of the logistic regression found to best separate the classes, 0.48232. The 
figure shows that the AF patients tend to have values over this threshold while non-AF 
patients tend to be under this value. 

























Figure 4.28 Product of the sensitivity and specificity of the logistic regression output of 
the postoperative combined clinical and ECG dataset including the maximum point 
indicating the optimum threshold. 
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4.3.2.3.2 k-Nearest Neighbor 
The k-NN classifier of the preoperative combined clinical and ECG data took 72 
generations to find a classifier with a fitness of 0.8867, a sensitivity of 0.92, and a 





For this feature set, missing data points limited the dataset to 22 non-AF patients and 13 
AF patients. Figure 4.29 shows the evolution of the classifier, again implying good 
mixing and a steady increase in fitness. 















Figure 4.29 Evolutionary fitness plot of the postoperative combined clinical and ECG 
dataset's k-NN classifier 
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4.4 Validation 
Since none of the above multivariate logistic regression classifiers could use leave-one-
out (LOO) validation, we performed LOO validation on these classifiers after the best 
individual was found. This is not needed for the k-NN classifier since it was performed in 
the GA yet its results are presented again. The LOO validation results are shown in Table 
4.2. Again, only the random initialized GA classifier results are listed in this table since 
the best individual initialization results are repeated from the clinical or ECG data cases.  
Table 4.2 Validation Results of logistic regression and k-NN classifier 
   Sen/Spec Fitness 
Reg. 0.64/0.76 0.4617 Clinical 
k-NN 0.67/0.80 0.5082 
Reg. 0.65/0.74 0.4578 ECG 
k-NN 0.63/0.82 0.4975 
Reg. 0.72/0.71 0.4873 
Preoperative 
Combined
k-NN 0.63/0.80 0.4908 
Reg. 1/0.79 0.7548 Clinical 
k-NN 0.83/0.93 0.7508 
Reg. 1/0.95 0.9192 ECG 
k-NN 1/1 0.9606 
Reg. 0.85/0.95 0.7837 
Postoperative
Combined
k-NN 0.92/1 0.8867 
4.4.1 Preoperative Risk Stratifiers 
4.4.1.1 Clinical Dataset – Logistic Regression 
Figure 4.30 shows the ROC curve for the preoperative clinical dataset logistic regression 
classifier with an AUC of 0.71, considered a fair classifier. This is slightly less than the 
0.75 AUC that was reported when trained and tested on the same set. This similar result 
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Figure 4.30 ROC curve of the validation of the preoperative clinical dataset's logistic 
regression 






















Figure 4.31 Product of the sensitivity and specificity of the validation of the logistic 
regression output of the preoperative clinical dataset including the maximum point 
indicating the optimum threshold. 
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Figure 4.31 shows the sensitivity/specificity product plot as well as the new classification 
threshold of 0.37706. This is slightly less than the 0.40361 that was set in the previous 
testing of this classifier but the plots look very similar with similar patient placement 
even though every patient had a different {βj} regression coefficient set. 
4.4.1.2 ECG Feature Dataset – Logistic Regression 
Figure 4.32 shows the ROC curve for the preoperative ECG dataset logistic regression 
classifier with an AUC of 0.6633, considered a fair classifier. This is less than the 0.72 
AUC that was reported when trained and tested on the same set. This slightly larger 














Figure 4.32 ROC curve of the validation of the preoperative ECG dataset's logistic 
regression 
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Figure 4.33 Product of the sensitivity and specificity of the validation of the logistic 
regression output of the preoperative ECG dataset including the maximum point 
indicating the optimum threshold. 
Figure 4.33 shows the sensitivity/specificity product plot as well as the new classification 
threshold of 0.36367. This is slightly less than the 0.38157 that was set in the previous 
testing of this classifier and the non-AF points around the threshold have shifted 
significantly but there is still a fair separation between the classes in spite of this.  
4.4.1.3 Clinical and ECG Combined Dataset – Logistic Regression 
Figure 4.34 shows the ROC curve for the preoperative combined clinical and ECG 
dataset logistic regression classifier with an AUC of 0.6915, considered a fair classifier. 
This is less than the 0.75 AUC that was reported when trained and tested on the same set. 
This slightly larger change could indicate that this is not as informative as the previous 
risk stratification system. 
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Figure 4.34 ROC curve of the validation of the preoperative combined clinical and ECG 
dataset's logistic regression 






















Figure 4.35 Product of the sensitivity and specificity of the validation of the logistic 
regression output of the preoperative combined clinical and ECG dataset including the 
maximum point indicating the optimum threshold. 
Figure 4.35 shows the sensitivity/specificity product plot as well as the new classification 
threshold of 0.40195. This is slightly less than the 0.43616 that was set in the previous 
testing of this classifier and the plots look slightly different with less of a 
sensitivity/specificity product peak, which defined a strong boundary between classes. 
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This could be indicative of over-fitting, but the classification performance is still much 
better than random. 
4.4.2 Postoperative Risk Stratifiers 
4.4.2.1 Clinical Dataset – Logistic Regression 
Figure 4.36 shows the ROC curve for the postoperative clinical dataset logistic regression 
classifier with an AUC of 0.86, considered a good classifier. This is significantly less 
than the perfect 1.00 AUC that was reported when trained and tested on the same set. 
Additionally, Figure 4.36 shows the sensitivity/specificity product plot. This shape has 
changed significantly and the patient position is different from the plot seen previously. 
Though not statistically convincing, this predictor still has promise following further 




































Figure 4.36 ROC curve and the product of the sensitivity and specificity of the validation 
of the logistic regression output of the postoperative clinical dataset including the 
maximum point indicating the optimum threshold. 
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Figure 4.37 ROC curve and the product of the sensitivity and specificity of the validation 
of the logistic regression output of the postoperative ECG dataset including the maximum 
point indicating the optimum threshold 
Figure 4.37 shows the ROC curve for the postoperative ECG dataset logistic regression 
classifier with an AUC of 0.96617, considered a very good classifier. This is similar to 
the perfect 1.00 AUC that was reported when trained and tested on the same set. Figure 
4.37 shows the sensitivity/specificity product plot. Patient position has changed 
somewhat yet good classification is still reached, though this variable set should be tested 
with a larger sample size. 
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4.4.2.3 Clinical and ECG Combined Dataset – Logistic Regression 







































Figure 4.38 ROC curve and the product of the sensitivity and specificity of the validation 
of the logistic regression output of the postoperative combined clinical and ECG dataset 
including the maximum point indicating the optimum threshold. 
Figure 4.38 shows the ROC curve for the postoperative combined clinical and ECG 
dataset logistic regression classifier with an AUC of 0.9546, considered a very good 
classifier. This is similar to the perfect 1.00 AUC that was reported when trained and 
tested on the same set. The patient position in the sensitivity/specificity product plot 
(Figure 4.39) has changed somewhat from the plot seen previously, yet there is still good 
separation though this should be further tested with a larger sample size.  
4.5 Discussion 
We should be careful comparing the results above to determine the best method for 
finding a classifier as the regression method’s GA fitness was trained and tested on the 
same set while the k-NN used LOO. However, we can compare the results using a given 
classifier with a given set of features on this cohort. In fact, the postoperative data were 
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separated better by both classifiers and on both clinical and ECG data. We believe that 
with such a large feature set and such a small dataset, there exists a good probability of 
finding a pair of feature by pure random chance that would yield these results making 
these classifiers strongly overfitted. To test this for certain, a larger sample size is needed. 
Since we do not have this sample set and we desire a preoperative classification system 
(better treatment options for the patient), we will focus on the preoperative classifiers. 
Furthermore, since regression performed equally or better than the k-NN in the 
preoperative data and that physicians are well acquainted with this type of scoring risk 
stratification methods, we chose this to be the benchmark method for comparison in the 
next chapter. Since, the ECG dataset’s logistic regression has some signs of overfitting 
and the combined dataset’s classifer uses less than a quarter of the supplied dataset, we 
select the preoperative clinical logistic regression classifier as the best classifier of this 
chapter. 
Also notice that the final combined clinical and ECG classifiers, when initialized with the 
previous best individuals, always seemed to be the same feature set that was discovered 
in one of the individual clinical or ECG classifier discoveries. This seems to show that 
these individuals overpower the rest of the population’s individuals, possibly preventing 
effective search of the rest of the search space. As for performance of these 
initializations, the fixed and the random initializations return solutions with insignificant 
fitness differences. 
Analysis of the features used in the multivariate classifiers shows that many of the 
features found in the univariate analysis done in chapter three are certainly helpful for 
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multivariate predictors. We also find that these cannot make up all of a classifier. We 
reap significant gains by trying many feature combinations that may resolve class subsets 
which might not be separated by use of only independently significant variables. 
Additionally, we see age, preoperative AF occurrence, number of anastamoses, coronary 
artery disease, and heart chamber size (atrial or left ventricular) appear prominently in the 
risk stratifiers. In the preoperative ECG feature set, we see a strong showing of frequency 
domain features performed on low to mid scale wavelet decompositions. This could be a 
further realization of the frequency differences described in the ECG wavelet 
decomposition discussed in chapter three. In the preoperative ECG feature set, we don’t 
see this frequency domain dominance but there certainly are a significant numbers of c3 
and c4 clips (clips taken at 24 and 36 hours following surgery). These clips occur near to 
when the majority of the patients go into AF, possibly showing a physiological precursor 
to AF onset. Though this would be of significant research interest, the applicability of 
current prophylactic measures would be ineffective this close to AF onset. 
A major limitation of these methods of classification is their need for complete datasets. 
Otherwise, patients with missing data points must be left out of the analysis and we have 
no predictive means. This has greatly reduced this dataset as is seen in Table 4.3. Some 
patient groups are reduced more than 50%, greatly decreasing the value of our classifier 
and contributing to the over fitting problem. 
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Table 4.3 Summary of Sample usage and reduction when patients with missing data 
points were excluded from analysis in logistic regression or k-NN classification. 
  Total Patients(NAF/AF)  Features
Patients Analyzed
NAF/AF 
Reg. 5 116/75 Clinical 388/157 k-NN 5 158/97 
Reg. 5 84/46 ECG 104/54 k-NN 4 84/46 






Combined 388/157 k-NN 2 84/46 
Reg. 4 14/6 Clinical 53/27 k-NN 3 14/6 
Reg. 2 17/6 ECG 29/15 k-NN 4 20/13 







Combined 53/27 k-NN 4 22/13 
It is evident that we need a classifier that can handle the missing data that will be 
encountered in a clinical setting where there might not be time to get results back from a 
test. The patient may need emergency surgery immediately, and a classification system 
that can still perform satisfactorily with missing data points is a high priority. For this 
reason, we will investigate a BN in the next chapter which can handle missing variables 
by relying on the data points which are provided. In this way, as the physician gets data, 
it can be entered in the model for a better risk stratification estimate. Additionally, as the 
system is fed more data, it continues to be further trained and improves future 
predictions. 
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Chapter 5  
 Bayesian network based AF Prediction 
In this chapter, we present several methods for building Bayesian networks from data and 
assess each based on performance of risk stratification of pre- and postoperative AF. One 
should take note of the ability of the BN to incorporate the entire dataset into their 
analysis including cases with missing data points. This greatly reduces the influence of 
overfitting the previous chapters’ classifiers were effected by. Additionally, the BN can 
infer information probabilistically, much as a doctor would when weighing and 
combining previous information, making its usage and acceptance more likely in a 
clinical setting. 
5.1 Methods 
Three different BN classifiers are developed in this chapter, all previously described in 
chapter two: 
• Naïve BNs evolved with a GA, 
• Traditional BNs built with the greedy K2 algorithm, and 
• Traditional BNs evolved with a GA. 
5.1.1 GA Built Naïve Bayesian Classifier 
To ease the computational burden and the exponentially increasing need for data samples 
as the number of nodes increase in a BN structure, a naïve BN assumes conditional 
 
- 145 - 
independence between the adjacent parents in a network. The child node’s joint 
probability is the product of each of the child’s probabilities conditioned on that parent 
only, as explained in chapter two. To determine the actual prediction, we calculate the 
likelihood ratio between the prediction of AF and non-AF, allowing the denominator of 
Bayes’ rule to cancel, dismissing any complications in calculating the predictive 
variable’s joint probability. 
We use the same GA method and chromosome structure as shown in Figure 4.2 to select 
the feature sets of a naïve BN in this chapter. We allow the AF node to have two to five 
predictive parent variables and no secondary parents. 
5.1.2 K2-built Bayesian Network 
By adding nodes greedily, a reasonable traditional Bayesian network can be found 
relatively quickly, though the chance of finding the best network is very slim. To counter 
this disadvantage, when building the network using K2, we allowed the network to have 
five first-level parents and five second-level parent nodes. We also performed a second 
structure construction using three first- and second-level parents. These second-level 
parents allow for prediction of their child in the case of a missing value. We allow this 
network a greater number of predictive variables, in order to compensate for the lack of a 
global optimization routine the other BNs will have the benefit of evolving under. 
Traditionally, this network building method requires a causal list of the variables, 
meaning that causes must precede effects. Since the cause and effect relationship is not 
clear for almost all of these relationships, we have removed this requirement to allow the 
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greedy addition of any node on the list. Additionally, for the evaluation of the network’s 
fitness, the dataset is allowed no missing data points. For this reason, patients with 
missing data points in the variables of interest during a particular networks’ training were 
removed. All patients that had at least one filled data point that the classifier used were 
included in testing. 
5.1.3 GA Built Traditional Bayesian Network 
We chose to allow two to three first-level parents and zero to two second-level parents in 
this network. This puts this network at a slight disadvantage to the naïve network and the 
K2-built network which has a possible five first-level nodes. However, the optimization 
training performed by the GA roughly accounts for this difference as we will see in the 
results. 
5.1.4 Genetic Algorithm 
The chromosome for the GA built traditional BN was constructed in a manner to reflect 
the tree structure of the network. The first integer in the chromosome, p, is the number of 
parents the node of interest has, the occurrence of AF. Following this, there are p vectors 
of integers, which code for each of the branches that the first-level nodes begin. Within 
each of these vectors, the first integer encodes the feature number of this first-level node 
branch. The next integer, p’, encodes the number of second-level parents this first-level 
parent has, while following this are the integers that encode those features. The 
chromosome construction is seen in Figure 5.1. 
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p fp’ ff fp’ ff fp’ ff











Figure 5.1 Encoded chromosome for the BN structure and feature nodes. An example is 
shown of how these value are made into the structure. 
The chromosome always contains the maximum number of possible node combinations, 
while the p and p’ integers limit which of those feature nodes will be used. This allows 
for point-to-point crossovers and mutations to occur in identical places in the graph. The 
unused values in the chromosome add significantly to the size and complexity of the 
chromosome and slightly degrades the utility of the GA crossovers and mutations, due to 
some of the alleles being unused for a given structure. However, as seen in nature, many 
genes of an organism stay inactive through their lifetime and are passed down to future 
generations for later mutations or crossovers to activate [99], so this is seen as 
safeguarding diversity and consistent gene transmission, not a complexity drawback. 
The genetic algorithm parameters, including generations, initializations, crossover and 
mutation rates, etc., are the same as those listed in chapter four. There are far greater 
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numbers of possibilities for the structure in these networks though, due to the larger 
chromosome. However, the global maximum is still approached due to the termination 
condition of stopping only after the GA has run 250 generations with no improvement. 
5.2 Evaluation 
For the creation of probability tables, the number of values a parameter may take, must 
be limited. Therefore, after extraction, feature values are discretized into binary form, 
based on their value being above or below a certain threshold. This threshold was set 
using a receiver operating characteristic (ROC) curve, where a feature value is predictive 
of the variable of interest—in this case, the occurrence of AF. We used the same method 
for finding the optimum threshold, as seen in chapter four: the maximum of the 
sensitivity/specificity product plot. This discretization of the data allows for the 
computation of well-populated conditional probability tables needed to build a BN 
classifier. 
For each of these networks created, both pre- and postoperative data were evaluated for 
clinical and ECG data, as well as their combined data sets, just as was done for the 
logistic regression and k-NN classifiers in the previous chapter, making a total of 
eighteen networks. Since the GA evolved classifiers in chapter four identified only 
previously created solutions, the combined data set classifiers in this chapter were all 
initialized randomly. 
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5.3 Results 
For each BN classifier, we show the network structure that was found to have the best 
fitness, given this dataset and structural limitations. The average population fitness, as 
well as the best individual’s fitness, are also plotted to show the evolutionary process that 
was performed through the GA to find this individual. We additionally plot the 
sensitivity/specificity product for all patient values, which also shows the optimum 
threshold point for separation of the non-AF and AF classes. The ROC plot of the 
classifier is shown along with the AUC, showing the quality of the classifier or its ability 
to order and separate the classes. For each classifier we also list the number of first-level 
parents/features used by that classifier, the sensitivity and specificity, the fitness, the 
number of patients the classification system used, both non-AF (NAF) and (AF), and the 
number of generations required to reach this solution. The summary of all of these results 
are seen here in Table 5.1 with their specifics in the sections following.  
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Table 5.1 For each classifier, the number of first-level parents/features used, the 
sensitivity and specificity, the fitness, the number non-AF(NAF) and AF patients used, 
and the number of GA generations were run before finding this optimum solution. 
   First-level Features Sen/Spec Fitness NAF/AF Generations
Naïve BN 5 0.63/0.73 0.70029 13 
K2 BN 3 prnts 3 0.59/0.31 0.46658







Traditional BN 3 0.61/0.71 0.68139
388/157 
19 
Naïve BN 5 0.70/0.62 0.60962 263 
K2 BN 3- prnts 3 0.65/0.44 0.52609





Traditional BN 3 0.51/0.86 0.73032
162/82 
452 
Naïve BN 5 0.68/0.68 0.69438 382 
K2 BN 3- prnts 3 0.38/0.46 0.52558













Traditional BN 3 0.61/0.58 0.6056 
388/157 
52 
Naïve BN 5 0.89/0.91 0.91976 24 
K2 BN 3- prnts 
K2 BN 5- prnts 






Traditional BN 3 0.85/0.92 0.8955 
53/27 
23 
Naïve BN 4 1/0.90 0.94359 42 
K2 BN 3- prnts 3 0.19/0.83 0.46532





Traditional BN 3 0.94/0.93 0.9496 
30/16 
203 
Naïve BN 3 0.96/0.83 0.93063 297 
K2 BN 3- prnts 
K2 BN 5- prnts 
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5.3.1 Preoperative Risk Stratifiers 
5.3.1.1 Clinical Dataset 
5.3.1.1.1 Naïve Bayesian Network 
The naïve BN of the preoperative clinical data took 13 generations to find a classifier 
with a fitness of 0.70029, a sensitivity of 0.63, and a specificity of 0.73 using the five 
variables in the structure seen in Figure 5.2. We see preoperative AF or atrial flutter as a 
predictor, which we also saw to be statistically significant in chapter three, as well as 
being significant in previous authors’ work in chapter two. In chapter three, we also saw 
that race (specifically black) and having cardiomegaly were statistically significant. 
Chapter four’s multivariate predictors also used preoperative AF, smoking, and 







Figure 5.2 Naïve BN with the best fitness for the preoperative clinical dataset. 
Figure 5.3 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing, showing 
that the evolving population was not too closely tied to the fittest individual. Notice that 
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the best individual was found in the thirteenth generation, but the plot continues to show 
250 generations following this, as this is one of the terminating conditions of the GA.  







































Figure 5.3 Evolutionary fitness plot and ROC curve of the preoperative clinical dataset's 
naive BN. 
Figure 5.3 shows the ROC of this classifier, with an AUC of 0.74, making it a fair to 
good risk stratifier. The sensitivity/specificity product plot, shown in Figure 5.4, shows 
the threshold value of the likelihood of AF occurrence output from the naïve BN found to 
best separate the classes, 0.0046709. This threshold is set immediately above the 
maximum of this curve for optimal separation, given our need for equally high sensitivity 
and specificity as discussed in chapter four. Again, the threshold was set immediately 
above this value to prevent the patient that defines the maximum from having an 
indeterminate predicted class. This optimum threshold selection method is used for all 
threshold determination in this work.  
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While it is difficult to discern the individuals in the plot, one can see that the AF patients 
tend to have values above this threshold while non-AF patients tend to be under this 
value. 




Pre-op Clinical Naive BN
Threshold=0.0046709 
















Figure 5.4 Product of the sensitivity and specificity of the naïve BN output of the 
preoperative clinical dataset, including the maximum point indicating the optimum 
threshold. 
5.3.1.1.2 K2-built Traditional Bayesian Network 
The 3-parent restricted K2-built traditional BN of the preoperative clinical data has a 
fitness of 0.46658, a sensitivity of 0.59, and a specificity of 0.31, using the three first-
level and the five second-level variables in the structure seen in Figure 5.5. Notice that 
smoking appears as a second-level node in this graph, while it was a first-level node in 
the previous BN. Additionally, left atrial size and mitral valve regurgitation appeared in 
chapter three as a statistically significant univariate predictor. Chapter four’s multivariate 
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predictors also used left ventricle diastolic pressure, left atrial hypertrophy, low density 


















Figure 5.5 K2-built 3-parent BN with the best fitness for the preoperative clinical dataset. 















Figure 5.6 ROC curve of the preoperative clinical dataset's K2-built 3-parent BN. 
Figure 5.6 shows the ROC of this classifier, making it a poor risk stratifier (AUC = 0.51). 
The sensitivity/specificity product plot, shown in Figure 5.7, shows the threshold value of 
the likelihood of AF occurrence tat was output from the traditional K2-built BN found to 
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best separate the classes, 0.47608. There does not appear to be a good separation of the 
two classes of data and the sensitivity/specificity product maximum is a fairly low value. 
These observations, combined with the low AUC, make this a poor classifier. 





















Figure 5.7 Product of the sensitivity and specificity of the K2-built 3-parent BN output of 
the preoperative clinical dataset including the maximum point indicating the optimum 
threshold. 
The 5-parent restricted K2-built traditional BN of the preoperative clinical data has a 
fitness of 0.53568, a sensitivity of 0.45, and a specificity of 0.75, using the five first-level 
and the six second-level variables in the structure seen in Figure 5.8. Since this structure 
is built by adding nodes one-by-one in a greedy manner, it has the same nodes seen in the 
previous graph with several added. You can see that two second-level nodes in the 
previous network, mitral valve regurgitation and low density lipoprotein, were shifted to 
first-level nodes. This shows that a strong correlation exists between the second-level 
nodes and the node of interest, which in this work is the occurrence of postoperative AF. 
 
























Figure 5.8 K2-built 5-parent BN with the best fitness for the preoperative clinical dataset. 















Figure 5.9 ROC curve of the preoperative clinical dataset's K2-built 5-parent BN. 
Figure 5.9 shows the ROC of this classifier, with an AUC equal to 0.60, making it a poor 
to fair risk stratifier. The sensitivity/specificity product plot, shown in Figure 5.10, shows 
the threshold value of the likelihood of AF occurrence output from the traditional K2-
built BN found to best separate the classes, 0.53929. There does not appear to be a good 
separation of the two classes of data and the sensitivity/specificity product maximum is a 
fairly low value. This reinforces the fact that this is only a poor to fair classifier. 
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Figure 5.10 Product of the sensitivity and specificity of the K2-built 5-parent BN output 
of the preoperative clinical dataset including the maximum point indicating the optimum 
threshold. 






Figure 5.11 Traditional BN with the best fitness for the preoperative clinical dataset. 
The GA built traditional BN of the preoperative clinical data took 19 generations to find a 
classifier with a fitness of 0.68139, a sensitivity of 0.61, and a specificity of 0.71, using 
the three first-level and one second-level variables in the structure seen in Figure 5.11. 
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We see that the preoperative occurrence of AF, smoking, and ejection fraction are once 
again predictors as found in this chapter, as well as in chapters three and four. The 
number of anastamoses is once again a predictor, as seen previously in chapter four, but 
we find it interesting that this node was included. Second-level nodes only contribute to a 
patient’s risk stratification for AF if the first-level node it is connected to has a missing 
value. In this dataset, preoperative AF had only two missing values of 545 patients. We 
can only assume that predicting these two patients made it better than a competing 
network or that the GA never created an individual which did not have this node. 





































Figure 5.12 Evolutionary fitness plot and ROC curve of the preoperative clinical dataset's 
traditional BN. 
Figure 5.12 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to continue to be good mixing 
after finding the best solution relatively early in the number of generations. 
Figure 5.12 also shows the ROC of this classifier, making it a fair risk stratifier (AUC = 
0.71). The sensitivity/specificity product plot, shown in Figure 5.13, shows the threshold 
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value of the likelihood of AF occurrence output from the GA built traditional BN found 
to best separate the classes, 0.22086. There do appear to be relatively more AF patients 
with probability values above the threshold, yet a great number of non-AF patients have 
these values as well. 























Figure 5.13 Product of the sensitivity and specificity of the traditional BN output of the 
preoperative clinical dataset including the maximum point indicating the optimum 
threshold. 
5.3.1.2 ECG Feature Dataset 
5.3.1.2.1 Naïve Bayesian Network 
The naïve BN of the preoperative ECG data took 263 generations to find a classifier with 
a fitness of 0.60962, a sensitivity of 0.70, and a specificity of 0.62, using the five 
variables in the structure seen in Figure 5.14. The feature 
TQ_II_sym4_sc20_Median_Freq is very similar to TQ_II_sym4_sc20_Mean_Freq that 
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was statistically significant in chapter three, which we investigated further by plotting an 
ROC and a sensitivity/specificity product graph. None of the other features appear to be 
significant in chapters three or four. Additionally, notice the exclusive usage of the II lead 
in this classifier, which is similar to this lead’s domination of statistically significant 
features in chapter three.  
AF
TQ II rbio4.4 sc20 Curve LengthTQ II gaus1 sc10 Spectral Entropy
TQ II sym4 sc20 Median Freq
TQ II bior2.2 sc15 Median Freq
TQ II gaus2 sc19 Spectral Entropy
 
Figure 5.14 Naïve BN with the best fitness for the preoperative ECG dataset. 
Figure 5.15 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing, showing 
that the evolving population was not too closely tied to the fittest individual. 
Additionally, you see more fit individuals being found after more than one hundred 
generations of no improvements. This is why one of the termination conditions is that it 
must run for 250 generations with no improvements without stopping, making it more 
likely that we found the most fit individual. 
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Figure 5.15 Evolutionary fitness plot and ROC curve of the preoperative ECG dataset's 
naive BN. 
Figure 5.15 also shows the ROC of this classifier with an AUC of 0.64, making it a fair 
risk stratifier. The sensitivity/specificity product plot, shown in Figure 5.16, shows the 
threshold value of the likelihood of AF occurrence output from the naïve BN found to 
best separate the classes, 0.030448. While it is difficult to discern the individuals in the 
plot, one can see that the AF patients tend to have values above this threshold while non-
AF patients tend to be under this value. Notice that many patients fall near the zero or on 
the 0.5 likelihood value, an interesting result given it is the result of the product of five 
probabilities. 
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Threshold=0.030448 
















Figure 5.16 Product of the sensitivity and specificity of the naïve BN output of the 
preoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
5.3.1.2.2 K2-built Traditional Bayesian Network 
The 3-parent restricted K2-built traditional BN of the preoperative ECG data has a 
classifier with a fitness of 0.52609, a sensitivity of 0.65, and a specificity of 0.44 using 
the three first-level and the four second-level variables in the structure seen in Figure 
5.17. Notice that the greedy K2 algorithm added P wave morphological features almost 
exclusively. The V1 lead’s P wave duration had a p value of 0.922 when investigated in 
chapter three, yet in this chapter, after binary discretization it is chosen as a first-level 
node. The other P wave morphological features chosen have similarly poor univariate 
predictive results. The only explanations of this could be that the binary discretization 
improved these features’ utility or that when paired with other features with full 
conditional probability tables, it matches more of the dataset’s samples. 
 

















Figure 5.17 K2-built 3-parent BN with the best fitness for the preoperative ECG dataset. 















Figure 5.18 ROC curve of the preoperative ECG dataset's K2-built 3-parent BN. 
Figure 5.18 shows the ROC of this classifier, making it a poor risk stratifier (AUC = 
0.56). The sensitivity/specificity product plot, Figure 5.19, shows the threshold value of 
the likelihood of AF occurrence output from the traditional K2-built BN found to best 
separate the classes, 0.42528. There does not appear to be a good separation of the two 
classes of data and the sensitivity/specificity product maximum is a fairly low value. This 
reinforces that fact that this is a poor classifier. 
 
- 164 - 























Figure 5.19 Product of the sensitivity and specificity of the K2-built 3-parent BN output 
of the preoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
The 5-parent restricted K2-built traditional BN of the preoperative ECG data has a fitness 
of 0.61047, a sensitivity of 0.46, and a specificity of 0.78 using the five first-level and the 
six second-level variables in the structure seen in Figure 5.20. Since this structure is built 
by adding nodes one-by-one in a greedy manner, it has the same nodes seen in the 
previous graph with several added. You can see that, again, two second-level nodes in the 
previous network, the P durations of the II lead and the combined I, II, and II lead, were 
shifted to first-level nodes. This reinforces that a strong correlation exists between the 
second-level nodes and the node of interest. Additionally, several additional 
morphological features were added as second-level nodes. 
 























Figure 5.20 K2-built 5-parent BN with the best fitness for the preoperative ECG dataset. 















Figure 5.21 ROC curve of the preoperative ECG dataset's K2-built 5-parent BN. 
Figure 5.21 shows the ROC of this classifier, making it a fair risk stratifier (AUC = 0.68). 
The sensitivity/specificity product plot, shown in Figure 5.22, shows the threshold value 
of the likelihood of AF occurrence output from the traditional K2-built BN found to best 
separate the classes, 0.40936. There does not appear to be a good separation of the two 
classes of data and the sensitivity/specificity product maximum is a fairly low value. 
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Additionally, many of the probability values fall immediately on the threshold line 
indicating possible over fitting, which could possibly cause difficulty during validation. 























Figure 5.22 Product of the sensitivity and specificity of the K2-built 5-parent BN output 
of the preoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
5.3.1.2.3 GA Built Traditional Bayesian Network 
AF
TQ I sym4 sc5 Shannon Entropy
TQ III bior2.2 sc30 Nonlinear Energy
TQ I rbio4.4 sc5 Spectral Entropy
TQ II coif4 sc30 Nonlinear Energy
 
Figure 5.23 Traditional BN with the best fitness for the preoperative ECG dataset. 
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The GA built traditional BN of the preoperative ECG data took 452 generations to find a 
classifier with a fitness of 0.73032, a sensitivity of 0.51, and a specificity of 0.86 using 
the three first-level and one second-level variables in the structure seen in Figure 5.23. 
This is an interesting combination of features as none of these have been identified in the 
previous univariate or multivariate analyses as being significant yet together they give the 
highest overall separation of all the preoperative risk stratification classifiers. This could 
just be a case of overfitting because of the sheer number of features that were tried to 
separate these 244 patients into their classes. Though, if this were the case, it would seem 
that the naïve BN training would have also found a better network than the 0.61 fitness 
that it achieved with this dataset. 







































Figure 5.24 Evolutionary fitness plot of the preoperative ECG dataset's traditional BN. 
Figure 5.24 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing showing 
that the evolving population was not too closely tied to the fittest individual. 
Additionally, we see a significant improvement in both the populations average fitness as 
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well as the best individual at around generation number 100. Changes in the average 
population fitness curve which coincide with the best individual’s fitness can indicate that 
the GA has found a new significantly better point in the feature space which not only 
improves that individual but imparts this improvement to its children and it improves 
their fitness as well. Typically, if the new global fitness maximum is an extremely narrow 
peak in the feature space, it only helps a single individual and not its children. If this were 
the case, the average population fitness would not improve significantly enough for a 
large noticeable change in its value. 
Figure 5.24 shows the ROC of this classifier, making it a good risk stratifier (AUC = 
0.76). The sensitivity/specificity product plot, shown in Figure 5.25, shows the threshold 
value of the likelihood of AF occurrence output from the GA built traditional BN found 
to best separate the classes, 0.49854. There appear to be relatively more AF patients with 
probability values above the threshold yet a great number of non-AF patients have these 
values as well. We also see a great number of patients that fall immediately before this 
boundary which, when validated with leave-one-out, could make this a poor risk 
stratifier. 
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Figure 5.25 Product of the sensitivity and specificity of the traditional BN output of the 
preoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
5.3.1.3 Clinical and ECG Combined Dataset 
5.3.1.3.1 Naïve Bayesian Network 
The naïve BN of the preoperative combined clinical and ECG data took 382 generations 
to find a classifier with a fitness of 0.69438, a sensitivity of 0.68, and a specificity of 0.68 
using the five variables in the structure seen in Figure 5.26. Notice the similarity of this 
network to that found by the naïve BN found in the clinical dataset. The only variable 
difference is an exchange of diabetes and left ventricle ejection fraction. Though this 
graph is slightly less fit than the BN with diabetes, these variables have been found to be 
correlated possibly explaining their interchangeability [100]. 
 







Figure 5.26 Naïve BN with the best fitness for the preoperative combined clinical and 
ECG dataset. 
Figure 5.27 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing showing 
that the evolving population was not too closely tied to the fittest individual. 
Additionally, we again see significant improvements in both the populations average 
fitness as well as the best individual after seemingly long periods of no improvement.  





























Figure 5.27 Evolutionary fitness plot and ROC curve of the preoperative combined 
clinical and ECG dataset's naive BN. 
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 Figure 5.27 shows the ROC of this classifier, making it a fair risk stratifier (AUC = 
0.73). The sensitivity/specificity product plot, shown in Figure 5.28, shows the threshold 
value of the likelihood of AF occurrence output from the naïve BN found to best separate 
the classes, 0.0034239. While it is difficult to discern the individuals in the plot, one can 
see that the AF patients tend to have values above this threshold while non-AF patients 
tend to be under this value. 























Figure 5.28 Product of the sensitivity and specificity of the naïve BN output of the 
preoperative combined clinical and ECG dataset including the maximum point indicating 
the optimum threshold. 
5.3.1.3.2 K2-built Traditional Bayesian Network 
The 3-parent restricted K2-built traditional BN of the preoperative combined clinical and 
ECG data had a fitness of 0.52558, a sensitivity of 0.38, and a specificity of 0.46 using 
the three first-level and the five second-level variables in the structure seen in Figure 
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5.29. This BN shows a definite mixing of both clinical and ECG features with several 



















Figure 5.29 K2-built 3-parent BN with the best fitness for the preoperative combined 
clinical and ECG dataset. 















Figure 5.30 ROC curve of the preoperative combined clinical and ECG dataset's K2-built 
3-parent BN. 
Figure 5.30 shows the ROC of this classifier, making it a poor risk stratifier (AUC = 
0.57). The sensitivity/specificity product plot, shown in Figure 5.31, shows the threshold 
value of the likelihood of AF occurrence output from the traditional K2-built BN found to 
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best separate the classes, 0.52219. There does not appear to be a good separation of the 
two classes of data and the sensitivity/specificity product maximum is a fairly low value. 
This reinforces that fact that this is a poor classifier. 






















Figure 5.31 Product of the sensitivity and specificity of the K2-built 3-parent BN output 
of the preoperative combined clinical and ECG dataset including the maximum point 
indicating the optimum threshold. 
The 5-parent restricted K2-built traditional BN of the preoperative combined clinical and 
ECG data had a fitness of 0.45477, a sensitivity of 0.36, and a specificity of 0.71 using 
the five first-level and the seven second-level variables in the structure seen in Figure 
5.32. Since this structure is built by adding nodes one-by-one in a greedy manner, it has 
the same nodes seen in the previous graph with several added. You can see that, again, 
two second-level nodes in the previous network were shifted to first-level nodes. 
Additionally, we continue to the see many of the same features that we have seen in the 
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clinical and ECG dataset’s K2-built networks which is expected since if they were 



























Figure 5.32 K2-built 5-parent BN with the best fitness for the preoperative combined 
clinical and ECG dataset. 















Figure 5.33 ROC curve of the preoperative combined clinical and ECG dataset's K2-built 
5-parent BN. 
Figure 5.33 shows the ROC of this classifier, making it a poor risk stratifier (AUC = 
0.51). The sensitivity/specificity product plot, shown in Figure 5.34, shows the threshold 
value of the likelihood of AF occurrence output from the traditional K2-built BN found to 
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best separate the classes, 0.59545. There does not appear to be a good separation of the 
two classes of data and the sensitivity/specificity product maximum is a fairly low value. 
This reinforces that fact that this is a poor classifier. 























Figure 5.34 Product of the sensitivity and specificity of the K2-built 5-parent BN output 
of the preoperative combined clinical and ECG dataset including the maximum point 
indicating the optimum threshold. 
5.3.1.3.3 GA Built Traditional Bayesian Network 
AF
Pre-op BB
Pre-op ACEI Post-op BB
Pre-op Statins
 
Figure 5.35 Traditional BN with the best fitness for the preoperative combined clinical 
and ECG dataset. 
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The GA built traditional BN of the preoperative combined clinical and ECG data took 52 
generations to find a classifier with a fitness of 0.6056, a sensitivity of 0.61, and a 
specificity of 0.58 using the three first-level and one second-level variables in the 
structure seen in Figure 5.35. This is an interesting combination of features as none of 
these have been identified in the previous univariate or multivariate analyses. It is also 
interesting that all of these nodes are based on the administration of medication. 
It may be surprising to see postoperative β-blocker (BB) as a predictor in a 
“preoperative” risk stratification system, but keep in mind that the label of pre- or 
postoperative classifiers identifies what the data collection was most focused on. In both 
of these datasets, important predictors were including without regard to pre- or 
postoperative status (i.e. pre- and post-op BB, etc.). 































Figure 5.36 Evolutionary fitness plot and ROC curve of the preoperative combined 
clinical and ECG dataset's traditional BN. 
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Figure 5.36 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing showing 
that the evolving population was not too closely tied to the fittest individual. 
Figure 5.36 shows the ROC of this classifier, making it a poor risk stratifier (AUC = 
0.63). The sensitivity/specificity product plot, shown in Figure 5.37, shows the threshold 
value of the likelihood of AF occurrence output from the GA built traditional BN found 
to best separate the classes, 0.25263. There does not appear to be a good separation of the 
two classes of data and the sensitivity/specificity product maximum is a fairly low value. 
This reinforces that fact that this is a poor classifier. 
























Figure 5.37 Product of the sensitivity and specificity of the traditional BN output of the 
preoperative combined clinical and ECG dataset including the maximum point indicating 
the optimum threshold. 
 
- 178 - 
5.3.2 Postoperative Risk Stratifiers 
5.3.2.1 Clinical Dataset 
5.3.2.1.1 Naïve BN 
The naïve BN of the postoperative clinical data took 24 generations to find a classifier 
with a fitness of 0.91976, a sensitivity of 0.89, and a specificity of 0.91 using the five 
variables in the structure seen in Figure 5.38. Notice that mitral regurgitation was also 
seen as a significant variable in chapter three preoperative univariate analysis. 
Additionally, preoperative P wave duration on lead II and β-blocker administration were 
found to be important variables as we have seen other researchers did in chapter two. 
AF










Figure 5.38 Naïve BN with the best fitness for the postoperative clinical dataset. 
Figure 5.39 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing showing 
that the evolving population was not too closely tied to the fittest individual. 
 
- 179 - 




























Figure 5.39 Evolutionary fitness plot and ROC curve of the postoperative clinical 
dataset's naive BN. 
Figure 5.39 shows the ROC of this classifier, making it an excellent risk stratifier (AUC 
= 0.97). The sensitivity/specificity product plot, shown in Figure 5.40, shows the 
threshold value of the likelihood of AF occurrence output from the naïve BN found to 
best separate the classes, 0.042453. One can see that the AF patients tend to have values 
above this threshold while non-AF patients tend to be under this value. The very tall and 
relatively narrow peak of the sensitivity/specificity product curve shows how well this 
classifier separates as well as orders the output predictions. 
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Threshold=0.042453       
















Figure 5.40 Product of the sensitivity and specificity of the naïve BN output of the 
postoperative clinical dataset including the maximum point indicating the optimum 
threshold. 
5.3.2.1.2 K2-built Traditional Bayesian Network 
The 3-parent restricted K2-built traditional BN of the postoperative clinical data had a 
fitness of 0.4803, a sensitivity of zero, and a specificity of one using the two first-level 











Figure 5.41 K2-built 3-parent BN with the best fitness for the postoperative clinical 
dataset. 
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Figure 5.42 shows the ROC of this classifier, making it an extremely poor risk stratifier 
(AUC = 0.50). The sensitivity/specificity product plot depicted in Figure 5.42 shows that 
all of the patients have a zero probability of AF. Obviously this is not a suitable classifier 
to stratify risk of these patients. 





































Figure 5.42 ROC curve and the product of the sensitivity and specificity of the K2-built 
3-parent BN output of the postoperative clinical dataset including the maximum point 
indicating the optimum threshold. 
 
The 5-parent restricted K2-built traditional BN has the same results as the previous 3-
parent K2-built network. Figure 5.43 shows the ROC of this classifier and the 
sensitivity/specificity product plot. 
 
- 182 - 




































Figure 5.43 ROC curve and product of the sensitivity and specificity of the K2-built 5-
parent BN output of the postoperative clinical dataset including the maximum point 
indicating the optimum threshold. 
5.3.2.1.3 GA Built Traditional Bayesian Network 
The GA built traditional BN of the postoperative clinical data took 23 generations to find 
a classifier with a fitness of 0.8955, a sensitivity of 0.85, and a specificity of 0.92 using 
the three first-level and one second-level variables in the structure seen in Figure 5.44. 
We see that the number of bypassed vessels was selected as a predictive variable which is 
directly related to the length and complexity of the surgery. Also, the patient’s heart rate 
as the come into the ICU as well as the heart rate on the third post-surgical day is 
important. This variable seems to be less desirable though since some patients would 
develop AF before day three. 
 











Figure 5.44 Traditional BN with the best fitness for the postoperative clinical dataset. 
Figure 5.45 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing after finding 
the best solution not long after initialization. 





























Figure 5.45 Evolutionary fitness plot ad ROC curve of the postoperative clinical dataset's 
traditional BN. 
Figure 5.45 shows the ROC of this classifier, making it a very good risk stratifier (AUC = 
0.93). The sensitivity/specificity product plot, shown in Figure 5.46, shows the threshold 
value of the likelihood of AF occurrence output from the GA built traditional BN found 
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to best separate the classes, 0.4444. One can see that the AF patients tend to have values 
above this threshold while non-AF patients tend to be under this value. The very tall peak 
of the sensitivity/specificity product curve shows how well this classifier separates as 
well as orders the output predictions. 






















Figure 5.46 Product of the sensitivity and specificity of the traditional BN output of the 
postoperative clinical dataset including the maximum point indicating the optimum 
threshold. 
5.3.2.2 ECG Feature Dataset 
5.3.2.2.1 Naïve Bayesian Network 
The naïve BN of the postoperative ECG data took 42 generations to find a classifier with 
a fitness of 0.94359, a sensitivity of 1, and a specificity of 0.90 using the four variables in 
the structure seen in Figure 5.47. These features are evenly distributed throughout the 36 
hours following surgery as well as using the PR and RP segments of the ECG equally. 
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AF
C4 PP Atrial gaus1 sc12 Energy min
C3 PP Atrial rbio5.5 sc5 Katz FD skewness C2 PR Chest gaus1 sc10 Shannon Entropy min
C1 RP Atrial sym6 sc20 Curve Length std
 
Figure 5.47 Naïve BN with the best fitness for the postoperative ECG dataset. 
Figure 5.48 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing and a steady 
increase in average and the best individual’s fitness 






























Figure 5.48 Evolutionary fitness plot and ROC curve of the postoperative ECG dataset's 
naive BN. 
Figure 5.48 shows the ROC of this classifier, making it an excellent risk stratifier (AUC 
= 0.98). The sensitivity/specificity product plot, shown in Figure 5.49, shows the 
threshold value of the likelihood of AF occurrence output from the naïve BN found to 
best separate the classes, 0.07098. While it is difficult to discern the individuals in the 
plot, one can see that the AF patients tend to have values above this threshold while non-
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AF patients tend to be under this value. Again, the peak is tall and narrow showing 
excellent classification and ordering. 
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Threshold=0.07098    
















Figure 5.49 Product of the sensitivity and specificity of the naïve BN output of the 
postoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
5.3.2.2.2 K2-built Traditional Bayesian Network 
The 3-parent restricted K2-built traditional BN of the postoperative ECG data had a 
fitness of 0.46532, a sensitivity of 0.19, and a specificity of 0.83 using the three first-level 
and the five second-level variables in the structure seen in Figure 5.50. None of these 
features appear as significant in chapter three or four. An interesting similarity between 
them all is that they are all derived from the PR segment of the electrogram signals. This 
is the segment that contains the P wave which corresponds to the atrial contraction. 
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AF
C1 PR Atrial gaus2 
sc19 Peak Freq kurtosis
C3 PR Chest bior4.4 
sc25 Peak Freq skewness
C2 PR Atrial gaus1 
sc8 Peak Freq kurtosis
C4 PR Chest gaus1 
sc12 Peak Freq kurtosis
C4 PR Chest gaus3 
sc19 Peak Freq skewness
C1 PR Atrial gaus2 
sc19 Peak Freq skewness
C2 PR Atrial gaus1 
sc8 Peak Freq skewness
C4 PR Chest gaus1 
sc12 Peak Freq skewness
 
Figure 5.50 K2-built 3-parent BN with the best fitness for the postoperative ECG dataset. 
Figure 5.51 shows the ROC of this classifier, making it an extremely poor risk stratifier 
(AUC = 0.51). The sensitivity/specificity product plot, shown in Figure 5.52, shows that 
almost all of the patients have a zero probability of AF. Obviously this is not a suitable 
classifier to stratify risk of these patients 















Figure 5.51 ROC curve of the postoperative ECG dataset's K2-built 3-parent BN. 
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Figure 5.52 Product of the sensitivity and specificity of the K2-built 3-parent BN output 
of the postoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
5.3.2.2.3 GA Built Traditional Bayesian Network 
The GA built traditional BN of the postoperative ECG data took 203 generations to find a 
classifier with a fitness of 0.9496, a sensitivity of 0.94, and a specificity of 0.93 using the 
three first-level and one second-level variables in the structure seen in Figure 5.53. 
Again, none of these variables are in the univariate or the multivariate classifiers found in 
chapters three and four. It is interesting that all of the features are calculated from the 
atrial electrogram lead. 
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AF
C3 PP Atrial coif4 
sc25 Peak Freq min
C3 PP Atrial rbio2.2 
sc13 Peak Power 
Amplitude skewness
C1 RP Atrial coif1 
sc30 Katz FD std
C1 PP Atrial mexh
sc9 Median Freq std
 
Figure 5.53 Traditional BN with the best fitness for the postoperative ECG dataset. 





























Figure 5.54 Evolutionary fitness plot and ROC curve of the postoperative ECG dataset's 
traditional BN. 
Figure 5.54 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing showing 
that the evolving population was not too closely tied to the fittest individual. 
Figure 5.54 shows the ROC of this classifier, making it an excellent risk stratifier (AUC 
= 0.99). The sensitivity/specificity product plot, shown in Figure 5.55, shows the 
threshold value of the likelihood of AF occurrence output from the GA built traditional 
BN found to best separate the classes, 0.5. One can see that the AF patients tend to have 
values above this threshold while non-AF patients tend to be under this value. The very 
 
- 190 - 
tall peak of the sensitivity/specificity product curve shows how well this classifier 
separates as well as orders the output predictions. 























Figure 5.55 Product of the sensitivity and specificity of the traditional BN output of the 
postoperative ECG dataset including the maximum point indicating the optimum 
threshold. 
5.3.2.3 Clinical and ECG Combined Dataset 
5.3.2.3.1 Naïve Bayesian Network 
The naïve BN of the postoperative combined clinical and ECG data took 297 generations 
to find a classifier with a fitness of 0.93063, a sensitivity of 0.96, and a specificity of 0.83 
using the three variables in the structure seen in Figure 5.56. Again, the heart rate on day 
four seems to be a good feature for risk stratification as it was used in the clinical dataset. 
This is a poor feature to use for early risk stratification though. The other features do not 
appear significant in earlier analyses. 
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AF
C2 RP Atrial rbio5.5 sc5 Nonlinear Energy skewness
Day 4
Heart Rate C2 PR Chest coif4 sc20 Energy skewness
 
Figure 5.56 Naïve BN with the best fitness for the postoperative combined clinical and 
ECG dataset. 
Figure 5.57 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing showing 
that the evolving population was not too closely tied to the fittest individual. Notice the 
large jump in the average population fitness that occurred around generation number 110. 
This indicates the possible addition of a feature with a surrounding feature space of 
greatly increased fitness. As the individual spun off new individuals, many of the new 
individuals were significantly more fit in this new feature space compared to those that 
were spun off the previous best individual. 






























Figure 5.57 Evolutionary fitness plot and ROC curve of the postoperative combined 
clinical and ECG dataset's naive BN. 
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Figure 5.57 shows the ROC of this classifier, making it an excellent risk stratifier (AUC 
= 0.96). The sensitivity/specificity product plot, Figure 5.58, shows the threshold value of 
the likelihood of AF occurrence output from the naïve BN found to best separate the 
classes, 0.018825. One can see that the AF patients tend to have values above this 
threshold while non-AF patients tend to be under this value. As you can see, the peak is 
not as narrow as other sensitivity/specificity product plots relating to the fact that the 
classification ordering is not as good as in more narrow classifiers’ plots. 




Post-op Combined Naive BN
Threshold=0.018825
















Figure 5.58 Product of the sensitivity and specificity of the naïve BN output of the 
postoperative combined clinical and ECG dataset including the maximum point 
indicating the optimum threshold. 
5.3.2.3.2 K2-built Traditional Bayesian Network 
The 3-parent restricted K2-built traditional BN of the postoperative combined clinical 
and ECG data had a fitness of 0.4803, a sensitivity of zero, and a specificity of one using 
the two first-level and the two second-level variables in the structure seen in Figure 5.59. 
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This network is almost exactly the same network built for clinical dataset with the 











Figure 5.59 K2-built 3-parent BN with the best fitness for the postoperative combined 
clinical and ECG dataset. 
Unfortunately, the result of this classifier is very similar to the clinical dataset’s result. 
Figure 5.60 shows the ROC of this classifier, making it an extremely poor risk stratifier 
(AUC = 0.50). The sensitivity/specificity product plot, shown in Figure 5.60, shows that 
all of the patients have a zero probability of AF. Obviously this is not a suitable classifier 
to stratify risk of these patients. Since the 3-parent network reached the maximum score 
before reaching the three allowed parents, there is no reason to test a 5-parent K2-built 
network because it will stop with the same network. 
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Figure 5.60 ROC curve and the product of the sensitivity and specificity of the K2-built 
3-parent BN output of the postoperative combined clinical and ECG dataset including the 
maximum point indicating the optimum threshold. 
5.3.2.3.3 GA Built Traditional Bayesian Network 
The GA built traditional BN of the postoperative combined clinical and ECG data took 
13 generations to find a classifier with a fitness of 0.7092, a sensitivity of 0.41, and a 
specificity of 0.89 using the three first-level and one second-level variables in the 
structure seen in Figure 5.61. We see that the time between the R peaks immediately as 
the patient is coming out of surgery seems to be of significant importance in this 
classifier. 
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AF
C1 RR dur max
C1 RR dur mean
C1 RR dur kurtosis C1 RR dur HF
 
Figure 5.61 Traditional BN with the best fitness for the postoperative combined clinical 
and ECG dataset. 
Figure 5.62 shows the evolution of the classifier with the fitness of the best individual as 
well as the average fitness of the population. There seems to be good mixing showing 
that the evolving population was not too closely tied to the fittest individual. 































Figure 5.62 Evolutionary fitness plot of the postoperative combined clinical and ECG 
dataset's traditional BN. 
Figure 5.62 shows the ROC of this classifier, making it a fair to good risk stratifier (AUC 
= 0.74). The sensitivity/specificity product plot, shown in Figure 5.63, shows the 
threshold value of the likelihood of AF occurrence output from the GA built traditional 
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BN found to best separate the classes, 0.49797. One can see that the AF patients tend to 
have values above this threshold while non-AF patients tend to be under this value. 
























Figure 5.63 Product of the sensitivity and specificity of the traditional BN output of the 
postoperative combined clinical and ECG dataset including the maximum point 
indicating the optimum threshold. 
5.4 Validation 
In order to see how well these systems continue to perform when not trained and tested 
on the same points, we again performed leave-one-out (LOO) validation as performed in 
chapter four. This was limited to the GA built naïve and tradition BNs due to the 
generally poor performance of the K2-built networks. A summary of these validation 
results is shown here in Table 5.2.  
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Table 5.2 Summary of validation performance of the GA built naive and traditional BNs 
   Sen/Spec Fitness 
Naïve BN 0.63/0.73 0.63609 Clinical Traditional BN 0.61/0.71 0.56503 
Naïve BN 0.76/0.54 0.50263 ECG Traditional BN 0.61/0.59 0.53099 






Combined Traditional BN 0.13/0.59 0.48694 
Naïve BN 0.81/0.85 0.80213 Clinical Traditional BN 0.37/0.89 0.55951 
Naïve BN 0.81/0.87 0.87654 ECG Traditional BN 1/0.93 0.94859 







Combined Traditional BN 0.75/0.80 0.6454 
5.4.1 Preoperative Risk Stratifiers 
5.4.1.1 Clinical Dataset 
5.4.1.1.1 Naïve Bayesian Network 
Referring back to Figure 5.3, we see that compared to Figure 5.64, the AUC has dropped 
from 0.74 to 0.67 but many of the significant points along the curve continue to remain in 
the same location while the overall curve has become more of a stair-step pattern. This 
tells us that the new training data actually spread the points out in the prediction-output 
probability space so that all the points are no longer landing at many of the same AF 
prediction probability. This is seen to be true in the sensitivity/specificity product plots by 
comparing Figure 5.65 to Figure 5.4. 
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Figure 5.64 ROC curve of the preoperative clinical dataset's validation of the naive BN. 
Figure 5.65 has quite a few new probability values which the patients posses, though 
many still fall in the zero probability region. 






















Figure 5.65 Product of the sensitivity and specificity of the validation of the naive BN 
output of the preoperative clinical dataset including the maximum point indicating the 
optimum threshold. 
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5.4.1.1.2 GA Built Traditional Bayesian Network 
Referring back to Figure 5.12, we see that compared to Figure 5.66, the AUC of the 
validation of this network has dropped from 0.71 to 0.59 but again, many of the 
significant points along the curve remain in the same location. When retraining the BN’s 
probability tables for every patient tested using different training points, the probability 
values in this table change slightly in every cell. These slight changes result in a slightly 
more diverse set of probability outcomes as we see in comparing Figure 5.67 to Figure 
5.13. You can see that there are now thirteen different outcome probabilities where there 
were previously eleven. 















Figure 5.66 ROC curve of the preoperative clinical dataset's validation of the traditional 
BN. 
We also observe another interesting trait of these new possible predictive probability 
outcomes: the AF and the non-AF patients actually separate into their own classes on 
either side of the probability value that they previously held together in Figure 5.13. This 
results from the removal of the single patient from the training of the probability tables. 
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Here we see that the removal of a single AF patient caused the other values to move 
slightly left while the removal of a non-AF patient caused the non-AF patient’s 
probability values to move slightly right. This is an example to an issue with leave-one-
out validation we discussed in chapter four [96]. This phenomenon will be a common 
trait in many of our LOO validation results but these results still show the classifier’s 
ability to separate the classes based on a single threshold by using sensitivity and 
specificity. 























Figure 5.67 Product of the sensitivity and specificity of the validation of the traditional 
BN output of the preoperative clinical dataset including the maximum point indicating 
the optimum threshold. 
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5.4.1.2 ECG Feature Dataset 
5.4.1.2.1 Naïve Bayesian Network 
Referring back to Figure 5.15, we see that compared to Figure 5.68, the AUC has 
dropped from 0.64 to 0.53 but, again, the significant points along the curve remain in the 
same location and the stair-step pattern appears. The separation of the classes from 
individual probability values are seen again in the sensitivity/specificity product plot, 
Figure 5.69. Much of the change in AUC can be attributed to all the patients of both 
classes that previously had a probability of 0.5 causing a diagonal line on the right side of 
AUC curve to the top right corner. When LOO validation was performed, it moved the 
probability values as we discussed previously causing the diagonal line of the 
sensitivity/specificity product plot to turn into a stair step that dropped the area under the 
curve significantly. 















Figure 5.68 ROC curve of the preoperative ECG dataset's validation of the naive BN. 
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Pre-op ECG Naive BN Validation
Threshold=0.020208
















Figure 5.69 Product of the sensitivity and specificity of the validation of the naive BN 
output of the preoperative ECG dataset including the maximum point indicating the 
optimum threshold. 
5.4.1.2.2 GA Built Traditional Bayesian Network 
Referring back to Figure 5.24, we see that compared to Figure 5.70, the AUC of the 
validation of this network has dropped from 0.76 to 0.55 but this time, we don’t see that 
most of the boundary point of the curve stay in the same place. In fact, all of them have 
dropped reducing the AUC significantly. Looking at the two sensitivity/specificity 
product plots in Figure 5.25 and Figure 5.71, we see that many of the patient probability 
values went from clustered on 0.5 to spread across the probability axis. This drastically 
changed the ordering and resulted in large swing in the AUC as well as an entirely new 
optimum threshold. This appears to be a case of over fitting. 
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Figure 5.70 ROC curve of the preoperative ECG dataset's validation of the traditional 
BN. 






















Figure 5.71 Product of the sensitivity and specificity of the validation of the traditional 
BN output of the preoperative ECG dataset including the maximum point indicating the 
optimum threshold. 
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5.4.1.3 Clinical and ECG Combined Dataset 
5.4.1.3.1 Naïve Bayesian Network 
Looking back to Figure 5.27, we see that compared to Figure 5.72, the AUC has dropped 
from 0.73 to 0.67 but, again, the significant points along the curve remain in the same 
location and the stair-step pattern appears. The separation of the classes from individual 
probability values are seen again in the sensitivity/specificity product plot as seen in 
Figure 5.73. Much of the change in AUC can be attributed to this stair step pattern, but 
overall this does not appear to be a case of over fitting. 















Figure 5.72 ROC curve of the preoperative combined clinical and ECG dataset's 
validation of the naive BN. 
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Pre-op Combined Naive BN Validation
Threshold=0.0033121















Figure 5.73 Product of the sensitivity and specificity of the validation of the naive BN 
output of the preoperative combined clinical and ECG dataset including the maximum 
point indicating the optimum threshold. 
5.4.1.3.2 GA Built Traditional Bayesian Network 
Observing Figure 5.36, we see that compared to Figure 5.74, the AUC of the validation 
of this network has dropped from 0.63 to 0.51. Again, we see similar changes in the 
ROC, Figure 5.74, and the sensitivity/specificity product plot, Figure 5.75, that we saw in 
the previously GA built traditional BN. An entirely new optimal threshold is selected and 
a large number of patient probabilities are now clustered around that new threshold. This, 
again, looks like a case of over fitting. 
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Figure 5.74 ROC curve of the preoperative combined clinical and ECG dataset's 
validation of the traditional BN. 

























Figure 5.75 Product of the sensitivity and specificity of the validation of the traditional 
BN output of the preoperative combined clinical and ECG dataset including the 
maximum point indicating the optimum threshold. 
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5.4.2 Postoperative Risk Stratifiers 
5.4.2.1 Clinical Dataset 
5.4.2.1.1 Naïve Bayesian Network 
Looking back to Figure 5.39, we see that compared to Figure 5.76, the AUC has dropped 
from 0.97 to 0.84 and the shape of the ROC has changed somewhat significantly. 
Although this may lead one to the thought of over fitting, the optimum threshold is not 
far from the original threshold and there continues to be good separation between the 
classes on the sensitivity/specificity product plot as seen in Figure 5.77. Our one worry 
for this entire family of postoperative classifiers is the small sample size that can be 
trained and tested with. This seems to give the classifiers a better chance, given a fairly 
large feature set, of finding better solutions. Though this can not be ignored, it should not 
invalidate the possibility of one of these classifiers being the solution cardiologists need. 















Figure 5.76 ROC curve of the postoperative clinical dataset's validation of the naive BN. 
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Post-op Clinical Naive BN Validation
Threshold=0.026161
















Figure 5.77 Product of the sensitivity and specificity of the validation of the naive BN 
output of the postoperative clinical dataset including the maximum point indicating the 
optimum threshold. 
5.4.2.1.2 GA Built Traditional Bayesian Network 
Referring back to Figure 5.45, we see that compared to Figure 5.78, the AUC of the 
validation of this network has dropped from 0.93 to 0.58. Again, we see similar changes 
in the ROC, Figure 5.78, and the sensitivity/specificity product plot, Figure 5.79, that we 
saw in some of the previously GA built traditional BN. Previously, there were no AF 
patients with probabilities of zero and now there are quite a few. This has completely 
changed the shape of the ROC and sensitivity/specificity product plot, all leading us to 
conclude that this is a case of over fitting. 
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Figure 5.78 ROC curve of the postoperative clinical dataset's validation of the traditional 
BN. 

























Figure 5.79 Product of the sensitivity and specificity of the validation of the traditional 
BN output of the postoperative clinical dataset including the maximum point indicating 
the optimum threshold. 
5.4.2.2 ECG Feature Dataset 
5.4.2.2.1 Naïve Bayesian Network 
Observing Figure 5.48, we see that compared to Figure 5.80, the AUC has dropped from 
0.98 to 0.91 following validation. The AUC value seems to still indicate a good classifier 
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and this holds true when looking at the sensitivity /specificity plot in Figure 5.81 which 
still shows excellent separation. 















Figure 5.80 ROC curve of the postoperative ECG dataset's validation of the naive BN. 







Post-op ECG Naive BN Validation 
Threshold=0.090657
















Figure 5.81 Product of the sensitivity and specificity of the validation of the naive BN 
output of the postoperative ECG dataset including the maximum point indicating the 
optimum threshold. 
5.4.2.2.2 GA Built Traditional Bayesian Network 
Referring back to Figure 5.54, we see that compared to Figure 5.82, the AUC of the 
validation of this network held constant at an almost perfect 0.99. We see small changes 
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in the ROC, Figure 5.82, and the sensitivity/specificity product plot, Figure 5.83, which 
are to be expected in any validation. There seems to be excellent separation among the 
classes following validation with good potential for a low/medium/high risk scale for 
stratification purposes. We must keep in mind though that this network was found using 
only 46 patients and over 111,000 features. Chances were very high that a combination of 
features could be found to stratify these few patients with excellent accuracy. 















Figure 5.82 ROC curve of the postoperative ECG dataset's validation of the traditional 
BN. 























Figure 5.83 Product of the sensitivity and specificity of the validation of the traditional 
BN output of the postoperative ECG dataset including the maximum point indicating the 
optimum threshold. 
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5.4.2.3 Clinical and ECG Combined Dataset 
5.4.2.3.1 Naïve Bayesian Network 
Comparing Figure 5.57 and Figure 5.84, we see that compared to Figure 5.84, the AUC 
has dropped from 0.96 to 0.91 following validation. The AUC value seems to still 
indicate a good classifier and this holds true when looking at the sensitivity /specificity 
plot in Figure 5.85 which still shows excellent separation. 















Figure 5.84 ROC curve of the postoperative combined clinical and ECG dataset's 
validation of the naive BN. 
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Post-op Combined Naive BN Validation
Threshold=0.023363
















Figure 5.85 Product of the sensitivity and specificity of the validation of the naive BN 
output of the postoperative combined clinical and ECG dataset including the maximum 
point indicating the optimum threshold. 
5.4.2.3.2 GA Built Traditional Bayesian Network 
When comparing Figure 5.62 to Figure 5.86, we see that the AUC has dropped from 0.74 
to 0.67 following validation. We see significant changes in the ROC and the 
sensitivity/specificity product plot, Figure 5.87. There seems to be fair separation among 
the classes following validation but the large changes in the curves and positions of the 
patients on the probability axis makes it possibly over fit causing generalization issues. 
Only a larger dataset could allow investigation of this. 
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Figure 5.86 ROC curve of the postoperative combined clinical and ECG dataset's 
validation of the traditional BN. 























Figure 5.87 Product of the sensitivity and specificity of the validation of the traditional 
BN output of the postoperative combined clinical and ECG dataset including the 
maximum point indicating the optimum threshold. 
5.5 Discussion 
We can see by the results summarized in Table 5.1 that the greedy K2-built traditional 
BNs do not perform well when compared to genetically evolved BNs. In all cases except 
one, the preoperative ECG dataset, the K2-built BNs were the worst tested. This is an 
interesting finding, since both the 3-parent K2 BNs and the traditional BN use the same 
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probability table computations and the same number of first-level nodes, yet they have 
drastically different fitness values. This shows the importance of finding the global 
maximum, versus greedily adding nodes in building a BN, given medical data with 
missing data points. Additionally, the 5-parent K2 BNs and the naïve BNs have the same 
number of first-level parents and it still performs worse. This shows the importance of 
using the independent conditional probability assumption associated with the naïve 
networks when using a relatively small dataset. 
In finding that the K2-built BNs performed so poorly, we investigated the cause, finding 
that when the K2 method looked greedily for the best nodes to add, it chose nodes with 
mostly missing data points. Previously, we described that the K2 method required a full 
dataset with no missing values to build the network. When we modified it to ignore 
missing data points and calculate the score on the data it had, it found that by adding 
nodes with very little data, it maximized, possibly by chance, the Bayesian scoring 
criterion. For this reason, structures were built with nodes having significant missing data 
and poorly populated joint probability tables. Though a compensation factor could be 
added to the K2 scoring criterion to account for the amount of data missing, possibly a 
probability of missingness term, optimization of greedy BN structure building is not the 
focus of this work and could be investigated in future works. 
Table 5.3 The winning classifiers for each of the different pre- and postoperative datasets 
for training and testing as well as their individual fitness. 
 Preoperative Postoperative 











ECG Traditional BN Traditional BN Traditional BN Traditional BN 
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We see again that the preoperative data were not as easily handled by our classifiers as 
the postoperative data. Besides the fact that the operation itself would affect the patient’s 
characteristics, this is most likely due to two characteristics of the postoperative dataset: 
• the small number of patients that were collected and 
• the large number of ECG features calculated. 
For instance, the best performing classifier of those investigated was the GA built 
traditional BN performed on the postoperative ECG dataset. Though this was the best 
classifier by fitness value alone, the three first-level features were selected out of over 
111,000 features, and it was performed on only 46 patients. This can be compared to the 
corresponding preoperative dataset which had 4,608 features with 244 patients. This is 
the most extreme case but it does illustrate that the likelihood of an excellent solution 
being found for the postoperative data is much higher. 
Analyzing the training results in Table 5.1 and the testing/validation results in Table 5.2, 
which were combined into Table 5.3, seems to show that the naïve BN performs better 
than the GA built traditional BN for the clinical dataset and the combined clinical and 
ECG dataset. Meanwhile, the GA built traditional network is superior on the ECG 
dataset. We believe these results are largely determined by two factors: 
• the BN building structure restrictions we imposed and 
• missing data in the datasets.  
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The naïve BN was allowed up to five first-level parents, since the naïve conditional 
independence assumption relaxed the amount of data needed to populate probability 
tables. Remember, the amount of data required to populate the probability tables rises 
exponentially as the number of parents in a traditional BN increases. Therefore, for the 
traditional BN, the maximum number of first-level parents allowed was three versus five, 
due to the dataset size. With an extra two possible variables, this gives the naïve BN two 
extra dimensions to separate the classes. Although the altered definition of the joint 
probability in the naïve BN somewhat degrades its exact representation of the data, the 
independence assumption uses more data to determine the value of each cell of these 
probability tables, making them generally more accurate in relation to the prediction. 
Though this seems to be the case for these naïve BNs, for an infinitely large and varied 
dataset, we believe the traditional BN would beat the naïve BN. For instance, the 
preoperative clinical dataset’s naïve and traditional BNs were similar, having several 
overlapping feature selections. If the traditional BN were allowed to pick more than three 
first-level nodes and it had enough data to fill the probability tables of these nodes, it 
probably would have equaled or beat the naïve network. 
Not only did the structural limitations contribute to the differences between these BN’s 
fitness, but the composition of the dataset did as well. Notice that for the ECG only 
dataset, the traditional BN held the highest fitness, while the naïve network is much less 
fit. Yet, for the combined clinical and ECG dataset, the naïve is far better than the 
traditional BN. This is a difference in the dataset composition of these two classifiers. 
The combined clinical and ECG dataset has 244 out of 545 patients that have no ECG 
features at all. That is a huge chunk of data with no values. Since clinical values were 
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available for all of the patients, and we saw before that the naïve network was better 
suited for this data, it was chosen over the traditional BN. 
Additionally, the naïve BN seemed slightly more robust than the traditional networks, 
seeing that they generally decreased less in fitness during validation than the traditional 
BN did. The one exception seems to be the postoperative ECG dataset analysis, but this 
dataset is very small, making its validation prone to bias. 
In order to determine the better classifier between chapters four and five, we compare the 
best of each chapter: the preoperative clinical logistic regression and naïve BN. Though 
their fitness values are not directly comparable since they were computed by different 
methods, we can compare their sensitivity, specificity, use of data, and robustness. The 
sensitivity and specificity of the logistic regression are slightly better than the naïve BN 
for training as well as testing. However, the regression classifier used significantly fewer 
patient samples to derive this classifier, roughly one third of the patients needing 
classification.  This was due to the missing data points in the dataset, which this classifier 
cannot tolerate. The naïve BN, on the other hand risk stratified all presented patients, 
handling any missing data points.  This coupled with the intuitive use of a probabilistic 
system that a cardiologist would more likely accept, caused the preoperative clinical 
naïve BN, shown with probability table values in Figure 5.88, to be the clear superior. 
When comparing the features that were used in our favorite classifiers of chapter four and 
five (preoperative clinical multivariate logistic regression and naïve BN, respectively), 
we see that the two have several common clinical features. Preoperative AF occurrence 
and cardiomegaly appear in both of these classifiers, as well as a number of others. 
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Ejection fraction, which replaces diabetes in the clinical dataset naïve classifier to arrive 
at the combined clinical and ECG dataset classifier, is also prominent through these 
analyses, much like smoking. Notice that many of these prominent features have 
appeared very little in the prior art, possibly due to our cohort or to the previous studies’ 
























Figure 5.88 The naive BN that was selected for the best postoperative AF risk 
stratification system. 
When observing the probabilities of the best risk stratifier, pictured in Figure 5.88, we 
notice that in this cohort, current smokers and African-Americans have a decreased 
occurrence of AF. It is very surprising that smoking, a variable long associated with 
pathological conditions, appears less frequently in smokers (p = 0.004). The other three 
variables in the classifier contribute to the occurrence of AF with preoperative AF being 
the most significant. 
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In summary, we believe that the best BN classifier is the naïve network found using the 
preoperative clinical dataset. It has an AUC of 0.67 and a sensitivity and specificity of 
0.63 and 0.73, respectively, for training and testing on the same data. This, is almost 
identical to the combined clinical and ECG dataset preoperative naïve BN except for the 
exchange of diabetes and ejection fraction. These classifiers seem to generalize well to 
new data, are simple, and their probability tables are easily populated with smaller 
datasets. 
5.6 Classifier Context 
Table 5.4 Point system for risk stratification system of postoperative AF. 
Borrowed from [17]. 
Predictor Points 
Age  
 <30 6 
 30-39 12 
 40-49 18 
 50-59 24 
 60-69 30 
 70-79 36 
 >80 42 
Medical History  
 Atrial Fibrillation 7 
 Chronic Obstructive  
     Pulmonary Disease 4 
 Concurrent Valve Surgery 6 
Withdrawal of  
 Postoperative Treatment  
 β-blocker 6 
 ACE Inhibitor 5 
β-Blocker Treatment  
 Preoperative and  
  Postoperative -7 
 Postoperative -11 
 Preoperative and Postoperative 
     ACE Inhibitor Treatment -5 
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Postoperative Treatment  
 Potassium Supplementation -5 
 NSAIDs -7 
In order to put our final classifier in the context of the current state of the art for risk 
stratification of postoperative AF, we present our results alongside a current risk 
stratification standard. For this we chose a recently published risk stratification method 
[17] that was also used by another author in a retrospective study of amiodarone 
prophalaxis in 2006 [7]. This risk stratification method uses a point scoring method 
related to multivariate regression. The point values for each of the characteristics seen in 
Table 5.4 are summed and placed on a scale that translates to the patient’s risk of 
postoperative AF (low risk: <14, medium risk: 14 to 31, high risk: >31).  
When performing this risk stratification method on our dataset, we did not have any 
information on postoperative potassium supplementation. This was only five possible 
points, so we do not believe that it invalidates the comparison. Additionally since our 
dataset has some missing points, we decided that any missing values would be counted as 
a negative for that characteristic, meaning no points are awarded. This again does not 
have a large bearing on the comparison, since in total there were only twelve missing data 
points for all ten variables and 545 patients. Instead of using the high, medium, and low 
risk classes they assigned in their paper, we found the optimum threshold for high and 
low risk stratification, sixteen (16) points, using the maximum of the 
sensitivity/specificity product plot, Figure 5.90, as we have on all of the classifiers in this 
work. This makes a more fair comparison of the outputs of the systems. 
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Figure 5.89 ROC of postoperative AF risk stratification method presented in [17]. 
One can see the ROC curve of the clinical state of the art postoperative AF risk 
stratification method performed on our data in Figure 5.89 as well as the 
sensitivity/specificity product plot in Figure 5.90. In comparing these to the 
corresponding validation plots from the naïve BN performed on the clinical dataset seen 
in Figure 5.64 and Figure 5.65, our classifier has an AUC of 0.67 versus the other 
method’s 0.60. This is the difference between a fair classifier and a borderline fair/poor 
classifier.  
We should keep in mind that our classifier was tailored using this data while the state of 
the art classifier was built using their own, and it is difficult to compare the two. We have 
tried to address this concern by using our LOO validation results in the above 
comparison. However, these results remain inconclusive as to which is the better 
classifier. Regardless of this, we can point out that the state of the art system uses eleven 
features while ours uses only five. If developed with more features, the difference would 
surely tip even more in the BN’s favor. Additionally, the BN tolerates missing data points 
which this method would have difficulties with. 
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Clinical State of the Art 
Threshold=16















Figure 5.90 Sensitivity/Specificity Product plot of the postoperative AF risk stratification 
method presented in [17]. 
5.7 Classifier Usage 
The first usage of the BN classifiers is that which we have presented throughout this 
chapter; the BN is trained using the frequentist probabilities calculated directly from the 
data and then future patients’ risk is computed by inputting their known predictive 
variables. This is a well respected way of performing and using Bayesian classifiers for 
inference.  
However, we could also approach this from the perspective that the probabilities that the 
BN encodes are merely one possible probability combination and the actual probability 
values are unknown. Therefore, by quantifying other degrees of belief such as a doctor’s 
prior experience or data provided in a clinical study, we might additionally include these 
types of data in our prediction. Bayesian statistics, as we discussed in chapter two, 
accounts for this by providing a means of combining prior information with the already 
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built BN. This gives the cardiologist the opportunity to perform an online sensitivity 
analysis by providing their own prior or posterior probability for any of the nodes in the 
network, as pointed out in Figure 5.91, and change these to observe the outcome’s 
corresponding reaction. Then, the likelihood ratio can be calculated for the AF and non-


















Figure 5.91 Naive BN AF prediction calculation given features F1 through Fp where p is 
the number of first-level parents. The possible locations for adjusting the prediction 
probabilities are also labeled.  Following this, the likelihood ratio would be calculated 
prior to prediction. 
In practice, these probabilities and their current values might be presented to the 
physician on a computer monitor with adjustable sliders allowing their alteration while 
showing the predictive outcome change. This allows the physician to test the hypotheses 
that the recommendation was made on and see under what conditions this 
recommendation would be reversed.  Though this trial-and-error balancing act could be a 
little more art than science, this tool is based on solid quantification of data mixed with 
educated clinician estimations in a structured statistical framework. 
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Chapter 6  
Conclusion 
In this concluding chapter, we discuss the predictive techniques we developed in the 
previous chapters and their benefits and drawbacks. Additionally, we reiterate our 
reasoning for the selection of the naïve BN classifier and offer suggestions for future 
work. 
6.1 Classifier Summary 
This work has presented univariate and multivariate risk stratification routines in the form 
of: 
• A single variable, 
• GA feature-selected multivariate logistic regression, 
• GA feature-selected k-Nearest Neighbor, 
• GA feature-selected naïve BN, 
• Greedily-built (K2 method) traditional BN, and 
• GA learned structure and feature-selected traditional BN. 
Of the univariate predictors, it seems that the patient’s age is the most reliable, as well as 
the best recognized. Unfortunately, this does not offer the sensitivity or specificity needed 
for making clinical decisions. The multivariate logistic regression seems to be prominent 
in the literature and has worked well in our experiments when the features are selected by 
GA. The k-NN actually performed slightly better than regression in terms of fitness, 
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though this method requires the loading of all training points into memory to perform 
tests, a significant problem when dealing with high dimensional, large dataset problems. 
Additionally, the cluster theory that the k-NN is based on has not gained acceptance with 
clinicians who seem to prefer regression or probability models. The traditional BNs were 
particularly useful in the ECG datasets when it was offered a large number of features. 
Overall, the GA feature-selected naïve BNs performed the best while offering other 
superior qualities that allow easy of use and robustness to clinical situations. Specifically, 
the naïve BN built using preoperative clinical data had the best combination of 
performance and usability. For instance, BNs are based on probabilities of previous AF 
patients’ data. This is similar to how a cardiologist might use their past experience to 
make decisions. Additionally, naïve BNs require less data to populate their probability 
tables due to their independent conditional probability assumptions. Since BNs perform 
inference probabilistically, physicians can use this classifier when some of the inputs 
have missing values. This is not possible with classifiers such as multivariate regression 
or k-NN. As we saw in chapter four, these classifiers discarded sometimes more than half 
of the patient population when finding the optimum feature subset. The BNs, on the other 
hand, always used all the patient data it was presented with and returned a comparable 
fitness. 
6.2 Suggested Work 
One of the main obstacles to the ECG analysis of the datasets is the lack of automated 
ECG annotation. Though there are certainly systems which do this in the hospital, these 
were not available for this work. A greater volume of quality ECG recordings and 
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annotations would allow much more advanced feature extraction routines to be 
performed, including various machine learning techniques. 
Though we have investigated many types of BNs in this study, there are a number of 
questions that need to be better understood to advance the use of these systems in a 
decision support role in medicine. We urge the use of these systems with larger sets of 
data, especially datasets that were collected in the hospital. In this way, missing data 
would appear as it naturally would instead of in a simulated manner. This would allow 
the BN to “learn” what missing values happen in what circumstances, allowing it to tailor 
itself to the best possible predictions in realistic cases. 
Larger datasets would also allow a number of other interesting investigations. In this 
work, we were limited by the number of levels we could discretize the data because if we 
allowed more than binary, this increases the size of the joint probability tables, thereby 
requiring more data points to create accurate probability estimates. We think a more 
varied discretization scheme for some interesting variables (i.e. age, left atrial volume, 
ejection fraction, etc.) could yield additional predictive information. 
Traditional BNs also perform best with large amounts of data and we think with a larger 
dataset, the traditional BNs might have been the best classifier, but this cannot be verified 
until a larger dataset is analyzed. 
An interesting topic would be the resolution of the probability shifting that occurs when 
using LOO validation as we saw in chapter five. This might be resolved through a 
probability correction term in the fitness function indicating the number of patients used 
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and discarded. This same type of approach might also be applied to the K2 greedy BN 
building method to cure its selection of variables with few patient samples. 
Lastly, we suggest the use of these methods of GA feature selection in naïve BNs and GA 
structure learning and feature selection for traditional BNs to be used in other medical 
fields. Their flexibility, robustness, and accuracy make them ideal for use in real world 
applications and we feel this methodology lends itself well to a wide range of risk 
stratification needs present in the medical community.  
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Appendix A  
Pre- and Postoperative Variable List 
Preoperative Variables 
Pre-operative AF  
Pre-operative use of ACEI  
Post-operative use of ACEI  
Pre-operative use of statins  
Post-op use of statins 
Pre-op use of BB  





Pre-operative use of IABP 
history of smoking (>3 months smoking vs. less than 3 months)  
current smoking  
hypertension  
active endocarditis  
age  
serum albumin  
ASA classification  
Aortic valve replacement 
Mitral valve replacement  
Body Mass Index 
Body surface area  
Number of total anastomoses 
Number of major coronaries with >50% stenosis  
Percent circ stenosis 
Cardiomegaly  
COPD  
Total CPB time in minutes  
Creatinine level  
Current diuretic  
Current digoxin use  
Cerebral vascular disease  
Diabetes (oral or insulin vs. none) 
Angina, CCS functional class  
NHYA class 
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Functional status  
Hemoglobin  
IV NTG within 48 hours before surgery  
Valve repair  
Mitral regurgitation 
Percent left main stenosis 
Physician’s pre-operative estimate of mortality  
Prior heart surgery ( 
Prior MI  
Resting ST depression  
Percent rca stenosis  
Percent lad stenosis  
Peripheral vascular disease  
Pulmonary rales  
Total cholesterol  
Low density lipoprotein  
LV contraction grade  
Priority level  
Great vessel repair  






Body Surface Area 
Weight (kg) 





History of Coronary Artery Disease (CAD) 
History of Supraventricular Tachycardia 
History of Nonsustained Ventricle Tachycardia (nsusVT) 
Family History of Coronary Artery Disease 
History of VT or Sudden Cardiac Death 
Left Ventricle end-diastolic pressure (LVEDP) 
Diabetes 
Chronic Obstructive Pulmonary Disease 
Hyperthyroidism 
Rheumatic Fever 
Chronic Renal Failure 
Prior Myocardial Infarction  
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Cardiomyopathy 
Valve Disease 
Prior Percutaneous transluminal coronary angioplasty 
Prior CABG 
History of AF 
Ejection Fraction Percentage 
Mitral Regurgitation 
CAD Left Main Artery Obstruction 
CAD Left Anterior Descending Artery Obstruction 
CAD Circumflex Artery Obstruction 
Right Coronary Artery Obstruction 
Patent Ductus Arteriosus 
Aortic Valve Surgery 
Left Atrium Thickness 
P-wave duration (II lead) 
Number of Vessels Bypassed 
Use of Mammary Artery 
Aortic Cross Clamp Time 
Cardiopulmonary Bypass Time 
Artificially Pumped Blood Volume 
Body Temperature Low 
Body Temperature High 




Intra-aortic Balloon Pump 
Time in Intensive Care Unit 
Time in SpDU  
Time in Hospital 
β Blocker Administration Post-op Days 1-5 
CK Enzyme Level 
Potassium Level 
Heart Rate for Hospital Stay 
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Appendix B  
Extended Univariate Results 
Preoperative Univariate Results 
Preoperative Binary Features  Non-AF  AF  Total  p value 
Pre_Bb_Key    58.0% (225/388) 68.8% (108/157) 61.1% (333/545) 0.019 
Post_BB_Key    89.7% (347/387) 82.2% (129/157) 87.5% (476/544) 0.017 
AF_fl_preop    1.6% (6/386) 19.7% (31/157) 6.8% (37/543) 0.000 
diabetes     35.6% (138/388) 47.1% (74/157) 38.9% (212/545) 0.012 
cm     13.7% (53/388) 29.3% (46/157) 18.2% (99/545) 0.000 
currsmok     37.9% (147/388) 24.8% (39/157) 34.1% (186/545) 0.004 
reststd     9.5% (37/388) 4.5% (7/157) 8.1% (44/545) 0.049 
priorhs     1.8% (7/388) 5.7% (9/157) 2.9% (16/545) 0.014 
curdig     3.4% (13/388) 9.6% (15/157) 5.1% (28/545) 0.003 
Htn     82.5% (320/388) 91.1% (143/157) 85.0% (463/545) 0.011 
mvr     1.8% (7/388) 6.4% (10/157) 3.1% (17/545) 0.005 
la     26.6% (42/158) 39.2% (38/97) 31.4% (80/255) 0.035 
black     16.2% (63/388) 5.7% (9/157) 13.2% (72/545) 0.001 
prevsmok     26.0% (101/388) 37.6% (59/157) 29.4% (160/545) 0.007 
 
 
Preoperative Categorical Feature Category Non-AF  AF  Total  p value 
LA_Key     384  157  541  0.000 
     0 58.9% (226/384) 38.2% (60/157) 52.9% (286/541) 
     1 6.8% (26/384) 7.6% (12/157) 7.0% (38/541) 
     2 23.4% (90/384) 29.9% (47/157) 25.3% (137/541) 
     3 3.9% (15/384) 12.7% (20/157) 6.5% (35/541) 
     4 1.6% (6/384) 2.5% (4/157) 1.8% (10/541) 
     5 3.9% (15/384) 7.6% (12/157) 5.0% (27/541) 
     6 1.0% (4/384) 0.6% (1/157) 0.9% (5/541) 
     7 0.5% (2/384) 0.6% (1/157) 0.6% (3/541) 
EF_Key     387  157  544  0.010 
     0 53.0% (205/387) 35.0% (55/157) 47.8% (260/544) 
     1 0.5% (2/387) 0.0% (0/157) 0.4% (2/544) 
     2 1.6% (6/387) 2.5% (4/157) 1.8% (10/544) 
     3 3.4% (13/387) 3.8% (6/157) 3.5% (19/544) 
     4 7.5% (29/387) 8.3% (13/157) 7.7% (42/544) 
     5 8.0% (31/387) 14.6% (23/157) 9.9% (54/544) 
     6 19.6% (76/387) 22.9% (36/157) 20.6% (112/544) 
     7 5.9% (23/387) 12.1% (19/157) 7.7% (42/544) 
     8 0.5% (2/387) 0.6% (1/157) 0.6% (3/544) 
Surgery_Key    387  157  544  0.005 
     1 4.7% (18/387) 1.9% (3/157) 3.9% (21/544) 
     2 15.8% (61/387) 8.9% (14/157) 13.8% (75/544) 
     3 30.5% (118/387) 27.4% (43/157) 29.6% (161/544) 
     4 30.0% (116/387) 32.5% (51/157) 30.7% (167/544) 
     5 3.4% (13/387) 6.4% (10/157) 4.2% (23/544) 
     6 0.8% (3/387) 0.0% (0/157) 0.6% (3/544) 
     7 2.3% (9/387) 3.8% (6/157) 2.8% (15/544) 
     8 4.9% (19/387) 8.9% (14/157) 6.1% (33/544) 
     9 0.5% (2/387) 1.3% (2/157) 0.7% (4/544) 
    10 0.3% (1/387) 3.8% (6/157) 1.3% (7/544) 
    11 5.2% (20/387) 3.8% (6/157) 4.8% (26/544) 
    12 1.8% (7/387) 1.3% (2/157) 1.7% (9/544) 
race     387  157  544  0.005 
     0 30.2% (117/387) 34.4% (54/157) 31.4% (171/544) 
     4 16.3% (63/387) 5.7% (9/157) 13.2% (72/544) 
     5 0.3% (1/387) 1.3% (2/157) 0.6% (3/544) 
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     6 53.2% (206/387) 58.6% (92/157) 54.8% (298/544) 
Csmok     317  135  452  0.026 
     1 22.4% (71/317) 25.2% (34/135) 23.2% (105/452) 
     2 39.7% (126/317) 25.9% (35/135) 35.6% (161/452) 
     3 6.0% (19/317) 5.2% (7/135) 5.8% (26/452) 
     4 31.9% (101/317) 43.7% (59/135) 35.4% (160/452) 
fcc     388  157  545  0.009 
     1 76.8% (298/388) 66.2% (104/157) 73.8% (402/545) 
     2 15.5% (60/388) 21.7% (34/157) 17.2% (94/545) 
     3 6.2% (24/388) 12.1% (19/157) 7.9% (43/545) 
     4 1.5% (6/388) 0.0% (0/157) 1.1% (6/545) 
cad     376  156  532  0.010 
     0 5.9% (22/376) 12.8% (20/156) 7.9% (42/532) 
     1 6.6% (25/376) 5.8% (9/156) 6.4% (34/532) 
     2 27.7% (104/376) 17.9% (28/156) 24.8% (132/532) 
     3 59.8% (225/376) 63.5% (99/156) 60.9% (324/532) 
mitreg     332  141  473  0.002 
     1 83.1% (276/332) 68.8% (97/141) 78.9% (373/473) 
     2 11.7% (39/332) 17.7% (25/141) 13.5% (64/473) 
     3 2.1% (7/332) 6.4% (9/141) 3.4% (16/473) 
     4 3.0% (10/332) 7.1% (10/141) 4.2% (20/473) 
cabgda_     388  157  545  0.028 
     0 8.5% (33/388) 13.4% (21/157) 9.9% (54/545) 
     1 5.2% (20/388) 7.0% (11/157) 5.7% (31/545) 
     2 19.1% (74/388) 8.9% (14/157) 16.1% (88/545) 
     3 30.4% (118/388) 30.6% (48/157) 30.5% (166/545) 
     4 33.5% (130/388) 33.1% (52/157) 33.4% (182/545) 
     5 2.8% (11/388) 6.4% (10/157) 3.9% (21/545) 
     6 0.5% (2/388) 0.6% (1/157) 0.6% (3/545) 
cabgdai     388  157  545  0.003 
     0 12.1% (47/388) 22.3% (35/157) 15.0% (82/545) 
     1 87.4% (339/388) 75.2% (118/157) 83.9% (457/545) 
     2 0.3% (1/388) 1.9% (3/157) 0.7% (4/545) 
     3 0.3% (1/388) 0.6% (1/157) 0.4% (2/545) 
 
Preoperative Continuous Feature  Non-AF  AF  Total  p value 
age     61.49+/-9.1(388) 64.98+/-8.9(157) 62.50+/-9.1(545) 0.000 
htin     69.70+/-2.7(388) 70.43+/-2.4(157) 69.91+/-2.6(545) 0.003 
bsa     2.04+/-0.2(388) 2.08+/-0.2(157) 2.05+/-0.2(545) 0.017 
lvedp     15.96+/-7.4(249) 18.11+/-10.5(113) 16.63+/-8.5(362) 0.025 
lad     72.01+/-29.8(381) 65.37+/-31.8(157) 70.07+/-30.5(538) 0.022 
isct     61.19+/-36.5(388) 71.45+/-38.4(157) 64.14+/-37.3(545) 0.004 
cpbt     98.90+/-49.7(388) 112.39+/-48.7(157) 102.78+/-49.7(545) 0.004 
totalchol     175.68+/-48.8(346) 165.67+/-46.6(137) 172.84+/-48.4(483) 0.040 
TQ_V1_db2_sc5_Mean_Freq   25.80+/-4.8(102) 28.34+/-8.0(55) 26.69+/-6.2(157) 0.014 
TQ_V1_db2_sc5_Median_Freq  23.94+/-5.6(102) 26.47+/-8.5(55) 24.83+/-6.8(157) 0.026 
TQ_II_db2_sc5_Mean_Freq   25.45+/-6.1(104) 28.06+/-7.3(54) 26.34+/-6.6(158) 0.019 
TQ_II_db2_sc5_Median_Freq   23.58+/-6.9(104) 26.34+/-7.6(54) 24.52+/-7.3(158) 0.022 
TQ_II_db2_sc15_Peak_Freq   8.05+/-2.6(104) 7.10+/-2.8(54) 7.72+/-2.7(158) 0.039 
TQ_II_db2_sc20_Curve_length  313.30+/-107.7(104)276.96+/-102.6(54) 300.88+/-107.0(158)0.043 
TQ_III_db2_sc25_Mean_Freq   13.52+/-5.8(86) 15.59+/-5.0(46) 14.24+/-5.6(132) 0.041 
TQ_II_db2_sc30_Peak_Freq   6.22+/-1.4(104) 5.63+/-1.7(54) 6.02+/-1.5(158) 0.022 
TQ_V1_db3_sc5_Mean_Freq   29.53+/-4.5(102) 31.53+/-7.0(55) 30.23+/-5.6(157) 0.031 
TQ_I_db3_sc5_Shannon_Entropy  0.21+/-0.1(86) 0.18+/-0.1(46) 0.20+/-0.1(132) 0.045 
TQ_II_db3_sc5_Mean_Freq   29.91+/-5.5(104) 32.26+/-6.6(54) 30.72+/-6.0(158) 0.018 
TQ_II_db3_sc20_Median_Freq  10.32+/-3.2(104) 11.61+/-3.6(54) 10.76+/-3.4(158) 0.023 
TQ_III_db3_sc20_Mean_Freq   15.10+/-5.5(86) 17.60+/-5.6(46) 15.97+/-5.7(132) 0.015 
TQ_II_db3_sc25_Mean_Freq   10.15+/-3.8(104) 11.82+/-4.8(54) 10.72+/-4.2(158) 0.018 
TQ_V1_db3_sc30_Shannon_Entropy  0.29+/-0.1(102) 0.26+/-0.1(55) 0.28+/-0.1(157) 0.011 
TQ_II_db3_sc30_Nonlinear_Energy  660.75+/-624.7(104)480.05+/-325.8(54) 598.99+/-547.0(158)0.049 
TQ_II_db3_sc30_Mean_Freq   8.49+/-3.0(104) 9.62+/-3.7(54) 8.87+/-3.3(158) 0.040 
TQ_II_sym4_sc5_Shannon_Entropy  0.21+/-0.1(104) 0.18+/-0.1(54) 0.20+/-0.1(158) 0.049 
TQ_V1_sym4_sc10_Peak_Freq  13.05+/-3.0(102) 11.85+/-3.5(55) 12.63+/-3.2(157) 0.028 
TQ_II_sym4_sc15_Median_Freq  9.65+/-2.8(104) 10.66+/-3.1(54) 9.99+/-3.0(158) 0.042 
TQ_II_sym4_sc20_Mean_Freq  9.79+/-4.0(104) 11.67+/-4.8(54) 10.43+/-4.3(158) 0.009 
TQ_II_sym4_sc20_Median_Freq  7.45+/-1.8(104) 8.26+/-2.6(54) 7.73+/-2.1(158) 0.021 
TQ_II_sym6_sc5_Mean_Freq   30.07+/-5.3(104) 32.01+/-6.2(54) 30.73+/-5.7(158) 0.042 
TQ_V1_sym6_sc15_Median_Freq  12.96+/-3.8(102) 11.68+/-3.2(55) 12.51+/-3.6(157) 0.036 
TQ_III_sym6_sc15_Mean_Freq  15.89+/-6.1(86) 18.28+/-5.9(46) 16.72+/-6.1(132) 0.032 
TQ_III_sym6_sc15_Median_Freq  11.57+/-3.7(86) 12.99+/-3.8(46) 12.07+/-3.8(132) 0.040 
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TQ_II_sym6_sc20_Mean_Freq  11.26+/-4.3(104) 13.20+/-5.2(54) 11.93+/-4.7(158) 0.013 
TQ_II_sym6_sc20_Median_Freq  8.47+/-2.2(104) 9.38+/-3.0(54) 8.78+/-2.6(158) 0.035 
TQ_II_sym6_sc25_Mean_Freq  8.55+/-3.3(104) 9.85+/-3.9(54) 9.00+/-3.6(158) 0.029 
TQ_II_coif1_sc15_Mean_Freq  13.77+/-3.6(104) 15.20+/-4.9(54) 14.26+/-4.1(158) 0.038 
TQ_II_coif1_sc15_Median_Freq  8.86+/-1.6(104) 10.06+/-3.3(54) 9.27+/-2.4(158) 0.003 
TQ_V1_coif1_sc20_Peak_Freq  7.35+/-2.4(102) 6.13+/-2.9(55) 6.92+/-2.7(157) 0.006 
TQ_II_coif4_sc20_Nonlinear_Energy  343.50+/-338.0(104)245.04+/-169.2(54) 309.85+/-294.6(158)0.046 
TQ_II_coif4_sc25_Mean_Freq  8.90+/-3.4(104) 10.37+/-4.1(54) 9.40+/-3.7(158) 0.017 
TQ_V1_bior2.2_sc5_Mean_Freq  34.10+/-4.8(102) 35.90+/-6.4(55) 34.73+/-5.5(157) 0.049 
TQ_II_bior2.2_sc5_Mean_Freq  33.73+/-5.9(104) 36.22+/-6.6(54) 34.58+/-6.2(158) 0.017 
TQ_II_bior2.2_sc5_Median_Freq  32.72+/-7.0(104) 35.56+/-7.3(54) 33.70+/-7.2(158) 0.019 
TQ_V1_bior2.2_sc10_Peak_Freq  15.16+/-3.9(102) 16.68+/-4.4(55) 15.69+/-4.1(157) 0.027 
TQ_II_bior2.2_sc20_Median_Freq  11.00+/-3.3(104) 12.45+/-4.2(54) 11.50+/-3.7(158) 0.018 
TQ_III_bior2.2_sc20_Mean_Freq  16.65+/-6.1(86) 19.42+/-6.0(46) 17.62+/-6.2(132) 0.013 
TQ_III_bior2.2_sc20_Median_Freq  12.74+/-3.7(86) 14.42+/-3.8(46) 13.33+/-3.8(132) 0.015 
TQ_II_bior2.2_sc25_Mean_Freq  11.63+/-4.7(104) 13.38+/-5.2(54) 12.23+/-4.9(158) 0.034 
TQ_II_bior2.2_sc25_Median_Freq  8.90+/-2.4(104) 9.97+/-3.0(54) 9.27+/-2.7(158) 0.017 
TQ_II_bior4.4_sc5_Mean_Freq  31.97+/-5.3(104) 34.49+/-6.1(54) 32.83+/-5.7(158) 0.008 
TQ_II_bior4.4_sc5_Median_Freq  30.17+/-6.0(104) 32.13+/-5.4(54) 30.84+/-5.8(158) 0.045 
TQ_II_bior4.4_sc20_Mean_Freq  12.48+/-4.8(104) 14.24+/-5.3(54) 13.08+/-5.1(158) 0.038 
TQ_II_bior4.4_sc20_Median_Freq  9.04+/-2.8(104) 10.13+/-3.0(54) 9.41+/-2.9(158) 0.028 
TQ_II_bior4.4_sc25_Mean_Freq  9.72+/-3.9(104) 11.33+/-4.5(54) 10.27+/-4.2(158) 0.021 
TQ_V1_bior5.5_sc9_Mean_Freq  18.96+/-5.2(102) 20.84+/-5.6(55) 19.62+/-5.4(157) 0.037 
TQ_III_bior5.5_sc9_Peak_Freq  16.08+/-4.0(86) 14.54+/-3.9(46) 15.55+/-4.0(132) 0.036 
TQ_III_bior5.5_sc17_Mean_Freq  13.57+/-4.6(86) 15.45+/-4.1(46) 14.23+/-4.5(132) 0.021 
TQ_II_bior5.5_sc21_Nonlinear_Energy  277.84+/-263.7(104)197.69+/-152.7(54) 250.45+/-234.4(158)0.041 
TQ_II_bior5.5_sc21_Mean_Freq  10.24+/-3.5(104) 11.91+/-4.3(54) 10.81+/-3.9(158) 0.010 
TQ_II_bior5.5_sc21_Median_Freq  7.88+/-1.3(104) 8.55+/-2.3(54) 8.11+/-1.8(158) 0.021 
TQ_II_bior5.5_sc25_Mean_Freq  8.72+/-3.5(104) 10.05+/-4.1(54) 9.17+/-3.8(158) 0.036 
TQ_II_bior6.8_sc20_Nonlinear_Energy  357.34+/-373.0(104)246.18+/-176.7(54) 319.35+/-323.5(158)0.040 
TQ_II_bior6.8_sc20_Mean_Freq  12.15+/-4.6(104) 13.80+/-5.1(54) 12.71+/-4.8(158) 0.042 
TQ_II_bior6.8_sc20_Median_Freq  9.15+/-2.7(104) 10.20+/-3.0(54) 9.51+/-2.8(158) 0.026 
TQ_II_bior6.8_sc25_Mean_Freq  9.36+/-3.6(104) 10.96+/-4.4(54) 9.91+/-3.9(158) 0.015 
TQ_II_bior6.8_sc25_Median_Freq  7.78+/-1.6(104) 8.46+/-2.4(54) 8.01+/-2.0(158) 0.037 
TQ_III_rbio2.2_sc13_Shannon_Entropy  0.22+/-0.1(86) 0.19+/-0.1(46) 0.21+/-0.1(132) 0.046 
TQ_II_rbio4.4_sc5_Mean_Freq  27.58+/-6.0(104) 29.86+/-5.6(54) 28.36+/-6.0(158) 0.023 
TQ_III_rbio4.4_sc15_Mean_Freq  14.51+/-5.6(86) 16.81+/-5.0(46) 15.31+/-5.5(132) 0.021 
TQ_II_rbio4.4_sc20_Mean_Freq  9.86+/-3.9(104) 11.58+/-4.7(54) 10.45+/-4.2(158) 0.015 
TQ_II_rbio5.5_sc5_Mean_Freq  29.29+/-6.0(104) 31.92+/-6.1(54) 30.19+/-6.1(158) 0.010 
TQ_II_rbio5.5_sc5_Median_Freq  26.93+/-6.3(104) 29.25+/-6.4(54) 27.72+/-6.4(158) 0.030 
TQ_II_rbio5.5_sc15_Median_Freq  11.88+/-3.2(104) 13.37+/-4.4(54) 12.39+/-3.7(158) 0.017 
TQ_II_rbio5.5_sc20_Mean_Freq  11.68+/-4.6(104) 13.66+/-5.6(54) 12.36+/-5.0(158) 0.018 
TQ_II_rbio5.5_sc20_Median_Freq  8.85+/-2.7(104) 10.04+/-3.5(54) 9.26+/-3.1(158) 0.020 
TQ_V1_rbio5.5_sc25_Peak_Freq  7.29+/-2.3(102) 6.41+/-2.6(55) 6.98+/-2.4(157) 0.030 
TQ_II_rbio5.5_sc25_Mean_Freq  9.14+/-3.6(104) 10.54+/-4.2(54) 9.62+/-3.8(158) 0.028 
TQ_II_rbio6.8_sc17_Nonlinear_Energy  279.02+/-286.2(104)190.19+/-141.4(54) 248.66+/-249.6(158)0.033 
TQ_III_rbio6.8_sc17_Mean_Freq  13.71+/-4.6(86) 15.70+/-4.5(46) 14.41+/-4.6(132) 0.018 
TQ_II_rbio6.8_sc21_Mean_Freq  9.97+/-3.6(104) 11.66+/-4.6(54) 10.55+/-4.1(158) 0.012 
TQ_II_rbio6.8_sc21_Median_Freq  7.79+/-1.5(104) 8.47+/-2.4(54) 8.02+/-1.9(158) 0.034 
TQ_II_rbio6.8_sc25_Mean_Freq  8.36+/-3.3(104) 9.60+/-3.8(54) 8.78+/-3.5(158) 0.037 
TQ_V1_gaus1_sc2_Mean_Freq  14.82+/-3.3(102) 16.66+/-7.2(55) 15.47+/-5.1(157) 0.030 
TQ_II_gaus1_sc6_Peak_Freq   5.97+/-1.6(104) 5.37+/-2.0(54) 5.77+/-1.8(158) 0.040 
TQ_II_gaus1_sc6_Curve_length  254.82+/-90.8(104) 219.70+/-76.5(54) 242.82+/-87.6(158) 0.016 
TQ_II_gaus1_sc8_Curve_length  331.11+/-119.8(104)288.94+/-104.2(54) 316.70+/-116.1(158)0.030 
TQ_III_gaus1_sc12_Peak_Freq  3.12+/-2.1(86) 4.15+/-2.6(46) 3.48+/-2.3(132) 0.014 
TQ_II_gaus2_sc7_Energy   673.71+/-852.6(104)429.42+/-420.0(54) 590.22+/-741.6(158)0.049 
TQ_III_gaus2_sc7_Mean_Freq  14.92+/-6.1(86) 17.20+/-5.5(46) 15.72+/-6.0(132) 0.037 
TQ_II_gaus3_sc7_Mean_Freq  14.23+/-5.7(104) 16.36+/-6.5(54) 14.96+/-6.0(158) 0.035 
TQ_II_gaus3_sc7_Median_Freq  11.10+/-3.8(104) 12.54+/-4.6(54) 11.59+/-4.2(158) 0.039 
TQ_II_gaus3_sc10_Katz_FD   1.24+/-0.1(104) 1.21+/-0.1(54) 1.23+/-0.1(158) 0.045 
TQ_II_gaus3_sc10_Peak_Freq  6.74+/-2.1(104) 5.91+/-2.4(54) 6.45+/-2.2(158) 0.028 
TQ_III_gaus3_sc10_Peak_Pow_Amp  2640.15+/-2803.0(86)4384.08+/-6049.1(46)3247.89+/-4285.3(132)0.025 
TQ_V1_gaus3_sc13_Peak_Freq  6.65+/-2.3(102) 5.78+/-2.6(55) 6.34+/-2.4(157) 0.032 
TQ_II_gaus3_sc13_Peak_Freq  6.64+/-1.4(104) 5.87+/-1.9(54) 6.38+/-1.6(158) 0.004 
TQ_II_gaus3_sc13_Curve_length  448.88+/-177.8(104)391.25+/-158.6(54) 429.18+/-173.1(158)0.047 
TQ_V1_gaus3_sc16_Median_Freq  9.09+/-2.1(102) 8.18+/-2.3(55) 8.77+/-2.2(157) 0.013 
TQ_V1_gaus3_sc16_Peak_Freq  6.55+/-2.4(102) 5.66+/-2.6(55) 6.24+/-2.5(157) 0.033 
TQ_II_gaus3_sc16_Peak_Freq  6.29+/-1.3(104) 5.81+/-1.6(54) 6.13+/-1.4(158) 0.046 
TQ_III_gaus3_sc16_Mean_Freq  10.07+/-4.2(86) 11.79+/-3.6(46) 10.67+/-4.0(132) 0.020 
TQ_III_gaus3_sc19_Shannon_Entropy  0.25+/-0.1(86) 0.21+/-0.1(46) 0.24+/-0.1(132) 0.021 
 
- 235 - 
TQ_II_gaus4_sc4_Mean_Freq  25.33+/-5.6(104) 27.58+/-6.1(54) 26.10+/-5.8(158) 0.021 
TQ_III_gaus4_sc7_Shannon_Entropy  0.15+/-0.1(86) 0.19+/-0.1(46) 0.17+/-0.1(132) 0.026 
TQ_III_gaus4_sc10_Mean_Freq  15.26+/-5.5(86) 17.80+/-5.4(46) 16.14+/-5.6(132) 0.012 
TQ_III_gaus4_sc10_Median_Freq  11.69+/-3.1(86) 13.14+/-3.1(46) 12.19+/-3.2(132) 0.011 
TQ_II_gaus4_sc13_Nonlinear_Energy  363.74+/-377.8(104)255.49+/-181.6(54) 326.74+/-327.8(158)0.049 
TQ_II_gaus4_sc13_Mean_Freq  10.85+/-4.0(104) 12.53+/-4.7(54) 11.42+/-4.3(158) 0.019 
TQ_II_gaus4_sc13_Median_Freq  8.56+/-1.9(104) 9.45+/-2.5(54) 8.86+/-2.2(158) 0.015 
TQ_II_gaus4_sc16_Mean_Freq  8.46+/-3.1(104) 9.69+/-3.8(54) 8.88+/-3.4(158) 0.030 
TQ_II_mexh_sc5_Energy   697.83+/-878.1(104)446.13+/-435.6(54) 611.80+/-764.4(158)0.049 
TQ_III_mexh_sc5_Mean_Freq  14.88+/-6.1(86) 17.15+/-5.5(46) 15.67+/-6.0(132) 0.037 
 
Postoperative Univariate Results 
Preoperative Continuous Feature  Non-AF  AF  Total  p value 
age     63.47+/-10.6(53) 72.59+/-6.9(27) 66.55+/-10.5(80) 0.000 
c4_ectopicRatio    0.06+/-0.2(26) 0.31+/-0.4(14) 0.15+/-0.3(40) 0.006 
c4_PVCRatio    0.05+/-0.2(26) 0.27+/-0.3(14) 0.13+/-0.3(40) 0.007 
c2_RR_Chest_Peak_Freq_mean   0.98+/-0.7(28) 0.35+/-0.2(13) 0.78+/-0.7(41) 0.005 
c3_PP_Atrial_Curve_length_kurtosis   2.99+/-0.9(29) 4.55+/-2.7(15) 3.52+/-1.8(44) 0.006 
c3_PP_Chest_Energy_skewness   1.93+/-1.3(26) 3.91+/-2.5(14) 2.62+/-2.0(40) 0.002 
c3_PP_Chest_Energy_kurtosis   10.09+/-7.4(26) 32.10+/-31.9(14) 17.80+/-22.1(40) 0.002 
c1_PR_Chest_db2_sc5_Shannon_Entropy_max  0.37+/-0.0(25) 0.32+/-0.1(14) 0.35+/-0.1(39) 0.005 
c2_PR_Chest_db2_sc5_Nonlinear_Energy_skewness 6.15+/-5.9(27) 1.48+/-2.1(14) 4.55+/-5.4(41) 0.006 
c2_PR_Chest_db2_sc5_Shannon_Entropy_max  0.36+/-0.0(27) 0.30+/-0.1(14) 0.34+/-0.1(41) 0.004 
c3_PP_Atrial_db2_sc5_Energy_skewness  0.43+/-0.4(29) 1.54+/-1.8(15) 0.81+/-1.2(44) 0.003 
c3_PP_Atrial_db2_sc5_Katz_FD_skewness  0.53+/-0.4(29) 1.60+/-2.1(15) 0.89+/-1.3(44) 0.009 
c3_PP_Atrial_db2_sc5_Nonlinear_Energy_skewness  0.49+/-0.4(29) 1.64+/-2.1(15) 0.88+/-1.4(44) 0.007 
c3_PP_Atrial_db2_sc5_Peak_Freq_mean  18.54+/-4.3(29) 22.50+/-3.8(15) 19.89+/-4.5(44) 0.004 
c3_PP_Atrial_db2_sc5_Curve_length_skewness  0.15+/-0.3(29) 0.61+/-0.8(15) 0.31+/-0.5(44) 0.007 
c3_RP_Atrial_db2_sc5_Peak_Freq_skewness  -0.09+/-0.9(26) -0.87+/-0.8(14) -0.36+/-0.9(40) 0.008 
c3_PR_Atrial_db2_sc5_Energy_skewness  0.61+/-0.6(26) 1.74+/-1.8(14) 1.01+/-1.3(40) 0.005 
c3_PP_Atrial_db2_sc10_Katz_FD_kurtosis  3.98+/-2.6(29) 10.13+/-11.0(15) 6.08+/-7.2(44) 0.006 
c4_RP_Atrial_db2_sc10_Peak_Freq_min  1.66+/-1.6(22) 0.35+/-0.7(13) 1.17+/-1.5(35) 0.009 
c1_PR_Atrial_db2_sc15_Nonlinear_Energy_skewness 0.53+/-0.9(25) -0.55+/-1.4(14) 0.14+/-1.2(39) 0.006 
c3_PP_Atrial_db2_sc15_Katz_FD_kurtosis  4.08+/-2.5(29) 14.99+/-21.2(15) 7.80+/-13.4(44) 0.009 
c1_PR_Atrial_db2_sc20_Nonlinear_Energy_skewness 0.47+/-0.8(25) -0.44+/-1.2(14) 0.14+/-1.1(39) 0.008 
c1_PR_Atrial_db2_sc20_Mean_Freq_kurtosis  8.02+/-9.1(25) 82.01+/-126.0(14) 34.58+/-82.3(39) 0.005 
c1_PR_Atrial_db2_sc20_Peak_Pow_Amp_skewness  1.51+/-1.4(25) 0.27+/-0.9(14) 1.06+/-1.4(39) 0.007 
c2_PR_Atrial_db2_sc20_Median_Freq_mean  7.10+/-3.0(27) 4.81+/-1.3(14) 6.32+/-2.7(41) 0.009 
c2_PR_Atrial_db2_sc25_Median_Freq_mean  6.99+/-3.1(27) 4.58+/-1.2(14) 6.17+/-2.8(41) 0.008 
c2_PR_Chest_db2_sc25_Peak_Freq_kurtosis  14.58+/-17.1(21) 127.87+/-188.7(10) 51.13+/-117.4(31) 0.009 
c4_RP_Atrial_db2_sc25_Shannon_Entropy_skewness -1.26+/-1.6(22) 0.18+/-1.3(13) -0.72+/-1.6(35) 0.009 
c2_PR_Atrial_db2_sc30_Peak_Freq_kurtosis  23.04+/-49.2(23) 153.31+/-186.5(12) 67.70+/-129.5(35) 0.003 
c4_RP_Atrial_db2_sc30_Shannon_Entropy_skewness -1.38+/-2.0(22) 0.48+/-1.3(13) -0.69+/-1.9(35) 0.004 
c4_PR_Atrial_db2_sc30_Shannon_Entropy_kurtosis  4.15+/-2.1(22) 12.34+/-13.3(13) 7.19+/-9.0(35) 0.007 
c1_PR_Atrial_db3_sc5_Mean_Freq_min  12.07+/-2.3(25) 9.96+/-2.0(14) 11.31+/-2.4(39) 0.006 
c1_PR_Atrial_db3_sc5_Peak_Freq_min   9.92+/-3.0(25) 7.21+/-2.7(14) 8.95+/-3.1(39) 0.008 
c2_PR_Chest_db3_sc5_Nonlinear_Energy_skewness 6.12+/-5.8(27) 1.45+/-2.0(14) 4.53+/-5.3(41) 0.006 
c3_PP_Atrial_db3_sc5_Energy_skewness  0.44+/-0.4(29) 1.51+/-1.8(15) 0.81+/-1.2(44) 0.003 
c3_PP_Atrial_db3_sc5_Katz_FD_skewness  0.50+/-0.4(29) 1.63+/-2.1(15) 0.89+/-1.3(44) 0.006 
c3_PP_Atrial_db3_sc5_Nonlinear_Energy_skewness  0.49+/-0.4(29) 1.66+/-2.1(15) 0.89+/-1.3(44) 0.005 
c3_PP_Atrial_db3_sc5_Peak_Freq_mean  18.94+/-3.7(29) 22.28+/-3.5(15) 20.08+/-3.9(44) 0.006 
c3_PR_Atrial_db3_sc5_Energy_skewness  0.63+/-0.6(26) 1.75+/-1.8(14) 1.02+/-1.2(40) 0.005 
c1_PR_Atrial_db3_sc15_Curve_length_skewness  0.48+/-0.9(25) -0.90+/-1.6(14) -0.01+/-1.3(39) 0.001 
c1_PR_Chest_db3_sc15_Peak_Freq_skewness  0.17+/-1.8(25) -1.98+/-2.6(14) -0.60+/-2.3(39) 0.004 
c3_PP_Atrial_db3_sc15_Katz_FD_kurtosis  4.12+/-2.6(29) 17.78+/-27.2(15) 8.78+/-17.0(44) 0.010 
c3_PP_Atrial_db3_sc15_Curve_length_kurtosis  4.18+/-2.2(29) 11.29+/-14.0(15) 6.60+/-8.9(44) 0.010 
c1_PR_Atrial_db3_sc20_Nonlinear_Energy_skewness 0.75+/-1.0(25) -0.42+/-1.2(14) 0.33+/-1.2(39) 0.003 
c1_PR_Atrial_db3_sc20_Peak_Freq_kurtosis  25.99+/-34.8(24) 110.60+/-134.4(13) 55.72+/-92.0(37) 0.006 
c1_PR_Atrial_db3_sc20_Curve_length_skewness  0.42+/-0.8(25) -0.78+/-1.5(14) -0.01+/-1.2(39) 0.002 
c1_PR_Atrial_db3_sc25_Nonlinear_Energy_skewness 0.79+/-1.0(25) -0.28+/-1.0(14) 0.40+/-1.1(39) 0.003 
c1_PR_Atrial_db3_sc25_Peak_Freq_max  5.02+/-3.0(25) 2.50+/-2.1(14) 4.12+/-3.0(39) 0.009 
c1_PR_Atrial_db3_sc25_Curve_length_skewness  0.30+/-0.8(25) -0.55+/-1.1(14) -0.00+/-1.0(39) 0.008 
c2_PR_Chest_db3_sc25_Median_Freq_min  4.43+/-1.3(27) 6.19+/-2.7(14) 5.03+/-2.1(41) 0.007 
c1_PR_Atrial_db3_sc30_Nonlinear_Energy_skewness 0.77+/-1.0(25) -0.20+/-1.0(14) 0.42+/-1.1(39) 0.007 
c4_PR_Chest_db3_sc30_Shannon_Entropy_skewness -1.04+/-1.2(22) -2.51+/-1.6(13) -1.59+/-1.5(35) 0.003 
c2_PR_Chest_sym4_sc5_Nonlinear_Energy_skewness 6.03+/-5.9(27) 1.47+/-2.1(14) 4.47+/-5.3(41) 0.008 
c3_PP_Atrial_sym4_sc5_Energy_skewness  0.44+/-0.4(29) 1.50+/-1.8(15) 0.80+/-1.2(44) 0.003 
c3_PP_Atrial_sym4_sc5_Katz_FD_skewness  0.48+/-0.3(29) 1.63+/-2.1(15) 0.87+/-1.3(44) 0.006 
c3_PP_Atrial_sym4_sc5_Nonlinear_Energy_skewness 0.48+/-0.4(29) 1.65+/-2.1(15) 0.88+/-1.3(44) 0.005 
c3_PP_Atrial_sym4_sc5_Curve_length_skewness  0.12+/-0.4(29) 0.62+/-0.8(15) 0.29+/-0.6(44) 0.009 
c3_PR_Atrial_sym4_sc5_Energy_skewness  0.61+/-0.5(26) 1.73+/-1.8(14) 1.01+/-1.2(40) 0.005 
c2_PR_Chest_sym4_sc10_Nonlinear_Energy_mean  0.00+/-0.0(26) 0.00+/-0.0(14) 0.00+/-0.0(40) 0.006 
c1_PR_Atrial_sym4_sc15_Curve_length_skewness  0.53+/-0.9(25) -0.90+/-1.8(14) 0.02+/-1.5(39) 0.002 
c2_PR_Chest_sym4_sc15_Mean_Freq_min  4.92+/-1.0(27) 6.59+/-2.8(14) 5.49+/-2.0(41) 0.008 
c2_PR_Chest_sym4_sc15_Median_Freq_min  5.83+/-1.7(27) 8.37+/-4.0(14) 6.70+/-2.9(41) 0.007 
c1_PR_Atrial_sym4_sc20_Nonlinear_Energy_skewness 0.75+/-1.1(25) -0.40+/-1.1(14) 0.34+/-1.2(39) 0.003 
c1_PR_Atrial_sym4_sc20_Curve_length_skewness  0.40+/-0.8(25) -0.77+/-1.5(14) -0.02+/-1.2(39) 0.003 
c2_PR_Atrial_sym4_sc20_Peak_Freq_skewness  0.76+/-3.7(27) -4.30+/-5.5(14) -0.97+/-5.0(41) 0.001 
c2_PR_Chest_sym4_sc20_Mean_Freq_min  4.59+/-1.3(27) 6.13+/-2.3(14) 5.12+/-1.8(41) 0.009 
c2_PR_Chest_sym4_sc20_Median_Freq_min  5.39+/-1.8(27) 7.98+/-3.5(14) 6.28+/-2.8(41) 0.004 
c4_RP_Atrial_sym4_sc20_Peak_Freq_mean  3.52+/-1.1(22) 2.50+/-0.8(13) 3.14+/-1.1(35) 0.006 
c1_RP_Atrial_sym4_sc25_Mean_Freq_max  5.97+/-1.6(25) 4.39+/-1.6(14) 5.41+/-1.8(39) 0.005 
c1_RP_Atrial_sym4_sc25_Peak_Freq_max  4.62+/-1.3(25) 3.32+/-1.5(14) 4.15+/-1.5(39) 0.007 
c1_PR_Atrial_sym4_sc25_Nonlinear_Energy_skewness 0.73+/-1.1(25) -0.30+/-1.0(14) 0.36+/-1.2(39) 0.008 
 
- 236 - 
c2_PR_Atrial_sym4_sc25_Peak_Freq_skewness  1.24+/-5.4(24) -3.50+/-4.4(14) -0.50+/-5.5(38) 0.008 
c3_RP_Atrial_sym4_sc30_Shannon_Entropy_std  0.04+/-0.0(26) 0.02+/-0.0(14) 0.03+/-0.0(40) 0.005 
c4_RP_Atrial_sym4_sc30_Peak_Freq_mean  2.41+/-0.8(22) 1.45+/-1.2(13) 2.05+/-1.1(35) 0.007 
c1_RP_Atrial_sym6_sc5_Shannon_Entropy_max  0.30+/-0.1(25) 0.21+/-0.1(14) 0.26+/-0.1(39) 0.009 
c2_PR_Chest_sym6_sc5_Nonlinear_Energy_skewness 6.02+/-5.9(27) 1.45+/-2.0(14) 4.46+/-5.4(41) 0.008 
c2_PR_Chest_sym6_sc5_Mean_Freq_std  2.59+/-1.2(27) 1.62+/-0.7(14) 2.26+/-1.1(41) 0.007 
c2_PR_Chest_sym6_sc5_Peak_Freq_max  23.94+/-6.2(27) 18.14+/-5.0(14) 21.96+/-6.4(41) 0.004 
c3_PP_Atrial_sym6_sc5_Energy_skewness  0.43+/-0.3(29) 1.49+/-1.8(15) 0.79+/-1.2(44) 0.003 
c3_PP_Atrial_sym6_sc5_Katz_FD_skewness  0.47+/-0.4(29) 1.62+/-2.0(15) 0.86+/-1.3(44) 0.005 
c3_PP_Atrial_sym6_sc5_Nonlinear_Energy_skewness 0.48+/-0.4(29) 1.65+/-2.0(15) 0.88+/-1.3(44) 0.004 
c3_PP_Atrial_sym6_sc5_Curve_length_skewness  0.14+/-0.4(29) 0.65+/-0.8(15) 0.31+/-0.6(44) 0.005 
c3_PR_Atrial_sym6_sc5_Energy_skewness  0.61+/-0.6(26) 1.76+/-1.8(14) 1.01+/-1.3(40) 0.004 
c2_RP_Atrial_sym6_sc10_Mean_Freq_kurtosis  4.18+/-2.2(27) 11.55+/-10.7(14) 6.70+/-7.3(41) 0.001 
c2_RP_Atrial_sym6_sc10_Median_Freq_kurtosis  4.07+/-3.1(27) 12.49+/-12.4(14) 6.95+/-8.5(41) 0.002 
c3_RP_Atrial_sym6_sc10_Mean_Freq_min  7.00+/-1.3(26) 5.81+/-1.2(14) 6.59+/-1.3(40) 0.006 
c1_PP_Atrial_sym6_sc15_Mean_Freq_min  4.41+/-0.9(28) 5.33+/-1.0(15) 4.73+/-1.0(43) 0.004 
c1_RP_Atrial_sym6_sc15_Mean_Freq_min  4.50+/-1.1(25) 5.71+/-1.2(14) 4.94+/-1.3(39) 0.004 
c1_RP_Atrial_sym6_sc15_Median_Freq_min  5.40+/-1.7(25) 7.18+/-2.3(14) 6.04+/-2.1(39) 0.010 
c1_PR_Atrial_sym6_sc15_Spectral_entropy_skewness 0.98+/-1.2(25) -0.13+/-1.0(14) 0.58+/-1.2(39) 0.005 
c1_PR_Atrial_sym6_sc15_Curve_length_skewness  0.71+/-1.3(25) -0.90+/-1.8(14) 0.13+/-1.7(39) 0.003 
c4_PR_Chest_sym6_sc15_Peak_Freq_min  1.82+/-1.9(22) 0.15+/-0.6(13) 1.20+/-1.7(35) 0.004 
c1_PR_Atrial_sym6_sc20_Nonlinear_Energy_skewness 0.79+/-1.1(25) -0.36+/-1.1(14) 0.38+/-1.2(39) 0.003 
c1_PR_Atrial_sym6_sc20_Curve_length_skewness  0.42+/-0.9(25) -0.75+/-1.4(14) -0.00+/-1.2(39) 0.003 
c2_PR_Atrial_sym6_sc20_Peak_Freq_skewness  1.42+/-4.8(27) -3.21+/-4.6(14) -0.16+/-5.2(41) 0.005 
c2_PR_Chest_sym6_sc20_Median_Freq_min  4.80+/-1.0(27) 6.69+/-2.7(14) 5.45+/-2.0(41) 0.002 
c1_RP_Atrial_sym6_sc25_Mean_Freq_max  5.85+/-1.3(25) 4.57+/-1.6(14) 5.39+/-1.5(39) 0.009 
c1_RP_Atrial_sym6_sc25_Median_Freq_max  8.30+/-2.2(25) 6.10+/-2.5(14) 7.51+/-2.5(39) 0.007 
c1_PR_Atrial_sym6_sc25_Nonlinear_Energy_skewness 0.74+/-1.1(25) -0.26+/-1.0(14) 0.38+/-1.1(39) 0.006 
c3_RP_Atrial_sym6_sc25_Peak_Freq_min  1.23+/-1.1(26) 2.21+/-0.9(14) 1.58+/-1.1(40) 0.008 
c1_RP_Atrial_sym6_sc30_Mean_Freq_max  5.22+/-1.1(25) 4.08+/-1.4(14) 4.81+/-1.3(39) 0.007 
c1_RP_Atrial_sym6_sc30_Median_Freq_max  7.38+/-1.9(25) 5.40+/-2.6(14) 6.67+/-2.3(39) 0.010 
c2_RP_Atrial_sym6_sc30_Shannon_Entropy_skewness 0.15+/-1.8(27) -1.88+/-2.3(14) -0.54+/-2.2(41) 0.003 
c2_PP_Atrial_coif1_sc5_Peak_Freq_std   5.01+/-1.7(29) 6.44+/-1.5(15) 5.50+/-1.7(44) 0.007 
c2_PR_Chest_coif1_sc5_Nonlinear_Energy_skewness 6.11+/-5.9(27) 1.48+/-2.1(14) 4.53+/-5.4(41) 0.007 
c3_PP_Atrial_coif1_sc5_Energy_skewness  0.45+/-0.4(29) 1.50+/-1.8(15) 0.81+/-1.2(44) 0.004 
c3_PP_Atrial_coif1_sc5_Katz_FD_skewness  0.53+/-0.4(29) 1.65+/-2.1(15) 0.91+/-1.4(44) 0.008 
c3_PP_Atrial_coif1_sc5_Nonlinear_Energy_skewness 0.49+/-0.4(29) 1.64+/-2.1(15) 0.88+/-1.4(44) 0.007 
c3_PP_Atrial_coif1_sc5_Peak_Freq_std   5.34+/-2.0(29) 7.13+/-1.4(15) 5.95+/-2.0(44) 0.003 
c3_PR_Atrial_coif1_sc5_Energy_skewness  0.62+/-0.6(26) 1.73+/-1.7(14) 1.01+/-1.2(40) 0.005 
c3_PR_Atrial_coif1_sc5_Spectral_entropy_skewness  1.30+/-1.8(26) 3.96+/-3.9(14) 2.23+/-2.9(40) 0.005 
c2_RP_Atrial_coif1_sc10_Shannon_Entropy_kurtosis  5.21+/-4.8(27) 20.10+/-23.6(14) 10.30+/-15.7(41) 0.003 
c2_PR_Chest_coif1_sc10_Nonlinear_Energy_mean  0.00+/-0.0(26) 0.00+/-0.0(14) 0.00+/-0.0(40) 0.007 
c4_PP_Atrial_coif1_sc10_Peak_Freq_min  1.94+/-1.9(24) 0.43+/-0.7(14) 1.38+/-1.7(38) 0.007 
c1_PR_Atrial_coif1_sc15_Nonlinear_Energy_skewness 0.48+/-0.8(25) -0.55+/-1.4(14) 0.11+/-1.2(39) 0.007 
c1_PR_Atrial_coif1_sc15_Curve_length_skewness  0.38+/-0.7(25) -0.97+/-1.8(14) -0.10+/-1.4(39) 0.002 
c3_PP_Atrial_coif1_sc15_Katz_FD_kurtosis  3.92+/-2.2(29) 15.51+/-20.7(15) 7.87+/-13.2(44) 0.004 
c3_PP_Atrial_coif1_sc15_Nonlinear_Energy_kurtosis  4.49+/-3.2(29) 17.75+/-26.0(15) 9.01+/-16.3(44) 0.009 
c3_PP_Atrial_coif1_sc15_Peak_Freq_min  1.10+/-1.2(29) 0.23+/-0.5(15) 0.81+/-1.1(44) 0.008 
c1_PR_Atrial_coif1_sc20_Nonlinear_Energy_skewness 0.48+/-0.8(25) -0.43+/-1.2(14) 0.16+/-1.1(39) 0.008 
c1_PR_Atrial_coif1_sc20_Curve_length_skewness  0.29+/-0.7(25) -0.82+/-1.5(14) -0.11+/-1.2(39) 0.004 
c2_PR_Chest_coif1_sc20_Median_Freq_min  4.85+/-1.0(27) 6.72+/-2.9(14) 5.49+/-2.0(41) 0.004 
c3_PP_Atrial_coif1_sc20_Katz_FD_kurtosis  4.49+/-3.0(29) 13.32+/-16.9(15) 7.50+/-10.8(44) 0.008 
c3_PP_Atrial_coif1_sc20_Peak_Freq_min  1.16+/-1.2(29) 0.27+/-0.5(15) 0.85+/-1.1(44) 0.010 
c4_PP_Atrial_coif1_sc20_Peak_Freq_mean  2.79+/-1.1(24) 1.64+/-1.1(14) 2.36+/-1.2(38) 0.004 
c4_RP_Atrial_coif1_sc20_Peak_Freq_mean  2.87+/-2.2(22) 1.02+/-1.3(13) 2.19+/-2.1(35) 0.009 
c1_RP_Atrial_coif1_sc25_Median_Freq_max  9.13+/-2.7(25) 6.55+/-2.8(14) 8.20+/-3.0(39) 0.007 
c1_PR_Chest_coif1_sc25_Mean_Freq_skewness  1.36+/-2.3(25) -0.72+/-2.1(14) 0.61+/-2.4(39) 0.009 
c2_PR_Chest_coif1_sc25_Median_Freq_min  4.58+/-1.7(27) 6.85+/-3.2(14) 5.36+/-2.5(41) 0.005 
c4_PP_Atrial_coif1_sc25_Peak_Freq_mean  2.33+/-1.1(24) 1.21+/-1.0(14) 1.92+/-1.1(38) 0.002 
c4_RP_Atrial_coif1_sc25_Peak_Freq_mean  2.35+/-1.7(22) 0.89+/-1.3(13) 1.81+/-1.7(35) 0.010 
c4_PR_Chest_coif1_sc25_Shannon_Entropy_skewness -0.60+/-0.5(22) -2.61+/-2.8(13) -1.35+/-2.0(35) 0.002 
c4_PP_Atrial_coif1_sc30_Peak_Freq_mean  2.06+/-1.0(24) 1.14+/-0.9(14) 1.72+/-1.1(38) 0.008 
c2_PR_Chest_coif4_sc5_Nonlinear_Energy_skewness 6.00+/-5.9(27) 1.45+/-1.9(14) 4.45+/-5.4(41) 0.008 
c3_PP_Atrial_coif4_sc5_Energy_skewness  0.42+/-0.4(29) 1.48+/-1.7(15) 0.78+/-1.2(44) 0.003 
c3_PP_Atrial_coif4_sc5_Katz_FD_skewness  0.47+/-0.4(29) 1.61+/-2.0(15) 0.86+/-1.3(44) 0.004 
c3_PP_Atrial_coif4_sc5_Nonlinear_Energy_skewness 0.48+/-0.4(29) 1.66+/-2.0(15) 0.88+/-1.3(44) 0.003 
c3_PP_Atrial_coif4_sc5_Median_Freq_max  26.56+/-4.8(29) 30.52+/-3.6(15) 27.91+/-4.8(44) 0.008 
c3_PP_Atrial_coif4_sc5_Curve_length_skewness  0.10+/-0.4(29) 0.59+/-0.7(15) 0.27+/-0.6(44) 0.006 
c3_PR_Atrial_coif4_sc5_Energy_skewness  0.61+/-0.6(26) 1.77+/-1.8(14) 1.01+/-1.3(40) 0.004 
c1_PP_Atrial_coif4_sc10_Mean_Freq_kurtosis  3.73+/-2.3(28) 6.83+/-4.4(15) 4.81+/-3.5(43) 0.004 
c2_RP_Atrial_coif4_sc10_Mean_Freq_kurtosis  3.99+/-2.4(27) 8.61+/-8.1(14) 5.57+/-5.5(41) 0.008 
c2_RP_Atrial_coif4_sc10_Median_Freq_kurtosis  3.67+/-2.8(27) 8.94+/-6.6(14) 5.47+/-5.0(41) 0.001 
c2_PR_Chest_coif4_sc10_Mean_Freq_std  1.32+/-0.8(27) 0.68+/-0.4(14) 1.10+/-0.7(41) 0.007 
c2_PR_Chest_coif4_sc10_Median_Freq_std  1.72+/-1.0(27) 0.97+/-0.3(14) 1.47+/-0.9(41) 0.010 
c3_PP_Atrial_coif4_sc10_Peak_Freq_skewness  1.31+/-1.6(29) -0.32+/-2.4(15) 0.76+/-2.0(44) 0.009 
c3_RP_Atrial_coif4_sc10_Mean_Freq_min  7.40+/-1.4(26) 6.20+/-1.2(14) 6.98+/-1.4(40) 0.009 
c1_PP_Atrial_coif4_sc15_Peak_Freq_min  3.39+/-0.6(28) 4.03+/-0.8(15) 3.62+/-0.7(43) 0.004 
c1_PR_Atrial_coif4_sc15_Curve_length_skewness  0.71+/-1.4(25) -0.82+/-1.7(14) 0.16+/-1.6(39) 0.004 
c2_PR_Chest_coif4_sc15_Peak_Freq_skewness  0.01+/-1.8(27) -1.68+/-1.9(14) -0.56+/-2.0(41) 0.008 
c1_PR_Atrial_coif4_sc20_Nonlinear_Energy_skewness 0.79+/-1.0(25) -0.33+/-1.1(14) 0.39+/-1.2(39) 0.003 
c1_PR_Atrial_coif4_sc20_Curve_length_skewness  0.41+/-0.9(25) -0.75+/-1.4(14) -0.01+/-1.2(39) 0.003 
c1_RP_Atrial_coif4_sc25_Peak_Freq_std  0.47+/-0.4(25) 0.19+/-0.1(14) 0.37+/-0.3(39) 0.009 
c1_PR_Atrial_coif4_sc25_Nonlinear_Energy_skewness 0.75+/-1.0(25) -0.23+/-0.9(14) 0.40+/-1.1(39) 0.006 
c1_PR_Atrial_coif4_sc25_Peak_Freq_kurtosis  24.22+/-35.5(23) 116.11+/-146.5(13) 57.41+/-100.8(36) 0.007 
c1_PP_Atrial_coif4_sc30_Mean_Freq_skewness  -0.22+/-2.2(28) 2.75+/-5.0(15) 0.82+/-3.7(43) 0.010 
c2_RP_Atrial_coif4_sc30_Shannon_Entropy_skewness 0.05+/-2.0(27) -2.07+/-2.7(14) -0.67+/-2.4(41) 0.007 
c2_PR_Chest_coif4_sc30_Peak_Freq_std  0.93+/-0.6(27) 0.44+/-0.4(14) 0.76+/-0.6(41) 0.005 
c3_PR_Chest_coif4_sc30_Spectral_entropy_kurtosis  4.49+/-2.6(26) 9.31+/-8.4(14) 6.18+/-5.8(40) 0.010 
c2_PR_Chest_bior2.2_sc5_Nonlinear_Energy_skewness 6.20+/-5.3(27) 1.64+/-2.2(14) 4.64+/-4.9(41) 0.004 
c2_PR_Chest_bior2.2_sc5_Median_Freq_std  3.47+/-0.8(27) 2.79+/-0.7(14) 3.24+/-0.8(41) 0.008 
c3_PP_Atrial_bior2.2_sc5_Energy_skewness  0.55+/-0.3(29) 1.71+/-2.2(15) 0.95+/-1.4(44) 0.008 
c3_PR_Atrial_bior2.2_sc5_Energy_skewness  0.68+/-0.4(26) 1.79+/-2.0(14) 1.07+/-1.3(40) 0.008 
c2_PR_Atrial_bior2.2_sc10_Peak_Freq_std  1.22+/-0.9(27) 2.41+/-1.8(14) 1.63+/-1.4(41) 0.007 
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c3_PP_Atrial_bior2.2_sc10_Mean_Freq_skewness  0.33+/-0.9(29) 1.66+/-1.7(15) 0.79+/-1.4(44) 0.001 
c3_PP_Atrial_bior2.2_sc10_Peak_Freq_min  3.97+/-2.4(29) 1.80+/-1.6(15) 3.23+/-2.4(44) 0.003 
c3_RP_Atrial_bior2.2_sc10_Mean_Freq_skewness  0.16+/-0.6(26) 1.69+/-1.8(14) 0.70+/-1.3(40) 0.000 
c3_RP_Atrial_bior2.2_sc10_Peak_Freq_skewness  0.19+/-1.1(26) 1.86+/-2.8(14) 0.77+/-2.0(40) 0.009 
c3_PR_Atrial_bior2.2_sc10_Katz_FD_skewness  0.71+/-0.8(26) 1.97+/-1.9(14) 1.15+/-1.4(40) 0.005 
c1_PR_Chest_bior2.2_sc15_Peak_Freq_skewness  0.08+/-1.9(25) -2.28+/-3.4(14) -0.77+/-2.8(39) 0.009 
c3_PP_Atrial_bior2.2_sc15_Katz_FD_skewness  0.60+/-0.4(29) 1.63+/-1.5(15) 0.95+/-1.1(44) 0.002 
c3_PP_Atrial_bior2.2_sc15_Nonlinear_Energy_skewness 0.48+/-0.5(29) 1.43+/-1.5(15) 0.80+/-1.0(44) 0.003 
c3_PP_Atrial_bior2.2_sc15_Nonlinear_Energy_kurtosis 3.63+/-1.4(29) 12.34+/-14.7(15) 6.60+/-9.4(44) 0.003 
c3_RP_Atrial_bior2.2_sc15_Katz_FD_skewness  0.68+/-0.5(26) 2.12+/-2.2(14) 1.18+/-1.5(40) 0.002 
c3_PR_Atrial_bior2.2_sc15_Katz_FD_skewness  0.68+/-0.4(26) 1.87+/-1.7(14) 1.10+/-1.2(40) 0.002 
c3_PR_Atrial_bior2.2_sc15_Katz_FD_kurtosis  3.64+/-1.0(26) 12.97+/-16.5(14) 6.91+/-10.6(40) 0.006 
c4_PP_Atrial_bior2.2_sc15_Peak_Freq_min  2.75+/-1.9(24) 1.14+/-1.4(14) 2.16+/-1.9(38) 0.010 
c3_PP_Atrial_bior2.2_sc20_Katz_FD_skewness  0.45+/-0.5(29) 1.65+/-2.1(15) 0.86+/-1.4(44) 0.005 
c3_PP_Atrial_bior2.2_sc20_Nonlinear_Energy_skewness 0.43+/-0.6(29) 1.74+/-2.4(15) 0.88+/-1.6(44) 0.007 
c3_PP_Atrial_bior2.2_sc20_Nonlinear_Energy_kurtosis 3.68+/-1.4(29) 17.86+/-28.1(15) 8.52+/-17.5(44) 0.009 
c3_RP_Atrial_bior2.2_sc20_Katz_FD_skewness  0.63+/-0.6(26) 1.75+/-1.8(14) 1.02+/-1.3(40) 0.005 
c3_PR_Atrial_bior2.2_sc20_Katz_FD_kurtosis  3.86+/-1.5(26) 12.32+/-15.9(14) 6.82+/-10.1(40) 0.010 
c4_PP_Atrial_bior2.2_sc20_Peak_Freq_min  1.83+/-1.3(24) 0.50+/-0.8(14) 1.34+/-1.3(38) 0.002 
c1_PR_Atrial_bior2.2_sc25_Peak_Freq_kurtosis  23.01+/-31.8(24) 129.61+/-173.3(12) 58.54+/-112.7(36) 0.006 
c3_PP_Atrial_bior2.2_sc25_Katz_FD_skewness  0.53+/-0.4(29) 1.32+/-1.3(15) 0.80+/-0.9(44) 0.004 
c3_PP_Atrial_bior2.2_sc25_Katz_FD_kurtosis  3.41+/-1.1(29) 10.52+/-14.2(15) 5.84+/-8.8(44) 0.010 
c3_PP_Atrial_bior2.2_sc25_Nonlinear_Energy_kurtosis 3.74+/-1.5(29) 11.39+/-13.4(15) 6.35+/-8.5(44) 0.004 
c3_PP_Atrial_bior2.2_sc25_Peak_Freq_min  1.53+/-1.2(29) 0.53+/-0.8(15) 1.19+/-1.2(44) 0.006 
c3_RP_Atrial_bior2.2_sc25_Katz_FD_skewness  0.66+/-0.6(26) 1.57+/-1.3(14) 0.98+/-1.0(40) 0.003 
c3_RP_Atrial_bior2.2_sc25_Katz_FD_kurtosis  4.02+/-1.7(26) 9.98+/-9.2(14) 6.11+/-6.2(40) 0.002 
c1_RP_Atrial_bior2.2_sc30_Peak_Freq_kurtosis  20.27+/-42.2(25) 113.56+/-161.5(14) 53.76+/-110.0(39) 0.009 
c2_PR_Chest_bior2.2_sc30_Mean_Freq_min  3.64+/-0.9(27) 4.61+/-1.4(14) 3.97+/-1.2(41) 0.010 
c4_RP_Atrial_bior2.2_sc30_Median_Freq_min  4.40+/-1.8(22) 2.96+/-0.6(13) 3.86+/-1.6(35) 0.008 
c4_RP_Atrial_bior2.2_sc30_Median_Freq_mean  6.61+/-2.5(22) 4.41+/-1.3(13) 5.79+/-2.4(35) 0.006 
c4_RP_Atrial_bior2.2_sc30_Peak_Freq_mean  2.84+/-1.5(22) 1.37+/-1.4(13) 2.29+/-1.6(35) 0.008 
c1_PP_Atrial_bior4.4_sc5_Peak_Freq_kurtosis  6.60+/-4.5(28) 12.82+/-7.3(15) 8.77+/-6.3(43) 0.001 
c2_PR_Atrial_bior4.4_sc5_Peak_Freq_skewness  0.32+/-1.3(27) 1.33+/-0.5(14) 0.66+/-1.2(41) 0.009 
c2_PR_Chest_bior4.4_sc5_Nonlinear_Energy_skewness 6.09+/-5.7(27) 1.48+/-2.1(14) 4.52+/-5.2(41) 0.006 
c3_PP_Atrial_bior4.4_sc5_Energy_skewness  0.46+/-0.3(29) 1.57+/-2.0(15) 0.84+/-1.3(44) 0.005 
c3_PP_Atrial_bior4.4_sc5_Katz_FD_skewness  0.53+/-0.4(29) 1.68+/-2.2(15) 0.92+/-1.4(44) 0.008 
c3_PP_Atrial_bior4.4_sc5_Nonlinear_Energy_skewness 0.51+/-0.4(29) 1.71+/-2.2(15) 0.92+/-1.4(44) 0.006 
c3_PP_Atrial_bior4.4_sc5_Mean_Freq_max  29.08+/-5.7(29) 33.70+/-3.8(15) 30.66+/-5.6(44) 0.008 
c3_PP_Atrial_bior4.4_sc5_Mean_Freq_mean  19.77+/-3.9(29) 23.11+/-3.1(15) 20.91+/-3.9(44) 0.006 
c3_PR_Atrial_bior4.4_sc5_Energy_skewness  0.62+/-0.5(26) 1.75+/-1.9(14) 1.02+/-1.3(40) 0.007 
c4_PP_Atrial_bior4.4_sc10_Peak_Freq_min  5.08+/-1.3(24) 3.71+/-1.3(14) 4.58+/-1.4(38) 0.004 
c1_PR_Atrial_bior4.4_sc15_Nonlinear_Energy_skewness 0.80+/-1.4(25) -0.57+/-1.5(14) 0.31+/-1.6(39) 0.007 
c1_PR_Atrial_bior4.4_sc15_Curve_length_skewness  0.46+/-0.8(25) -0.88+/-1.8(14) -0.02+/-1.4(39) 0.002 
c1_PR_Chest_bior4.4_sc15_Peak_Freq_std  0.57+/-0.3(25) 1.25+/-1.0(14) 0.81+/-0.7(39) 0.003 
c3_PP_Atrial_bior4.4_sc15_Katz_FD_kurtosis  4.10+/-2.7(29) 17.69+/-26.4(15) 8.74+/-16.6(44) 0.008 
c3_PP_Atrial_bior4.4_sc15_Curve_length_kurtosis  4.26+/-2.2(29) 13.18+/-17.7(15) 7.30+/-11.1(44) 0.010 
c4_PR_Chest_bior4.4_sc15_Shannon_Entropy_skewness -0.43+/-1.1(22) -1.89+/-1.9(13) -0.97+/-1.6(35) 0.008 
c1_PR_Atrial_bior4.4_sc20_Nonlinear_Energy_skewness 0.72+/-1.0(25) -0.40+/-1.1(14) 0.31+/-1.2(39) 0.003 
c1_PR_Atrial_bior4.4_sc20_Curve_length_skewness  0.41+/-0.8(25) -0.81+/-1.6(14) -0.03+/-1.3(39) 0.002 
c2_PR_Chest_bior4.4_sc20_Median_Freq_min  4.97+/-0.9(27) 6.68+/-2.7(14) 5.55+/-1.9(41) 0.004 
c1_PR_Atrial_bior4.4_sc25_Nonlinear_Energy_skewness 0.72+/-1.1(25) -0.29+/-1.0(14) 0.36+/-1.1(39) 0.006 
c1_PR_Atrial_bior4.4_sc25_Peak_Freq_kurtosis  20.94+/-34.0(23) 152.42+/-175.3(13) 68.42+/-124.0(36) 0.001 
c1_PR_Atrial_bior4.4_sc25_Curve_length_skewness  0.30+/-0.8(25) -0.68+/-1.2(14) -0.05+/-1.1(39) 0.006 
c2_RP_Atrial_bior4.4_sc25_Shannon_Entropy_kurtosis 4.79+/-4.4(27) 14.74+/-15.1(14) 8.19+/-10.5(41) 0.003 
c2_PR_Chest_bior4.4_sc25_Median_Freq_min  4.34+/-1.1(27) 6.04+/-2.4(14) 4.92+/-1.8(41) 0.004 
c1_RP_Atrial_bior4.4_sc30_Mean_Freq_std  0.45+/-0.3(25) 0.22+/-0.2(14) 0.37+/-0.3(39) 0.008 
c1_RP_Atrial_bior4.4_sc30_Median_Freq_max  7.99+/-2.4(25) 5.62+/-2.7(14) 7.14+/-2.7(39) 0.008 
c1_RP_Atrial_bior4.4_sc30_Peak_Freq_max  4.38+/-1.0(25) 3.39+/-1.2(14) 4.03+/-1.1(39) 0.008 
c2_PP_Atrial_bior4.4_sc30_Shannon_Entropy_kurtosis 4.29+/-3.0(29) 8.80+/-8.0(15) 5.83+/-5.6(44) 0.009 
c2_PR_Chest_bior4.4_sc30_Median_Freq_std  1.06+/-0.5(27) 0.62+/-0.5(14) 0.91+/-0.5(41) 0.008 
c3_PP_Atrial_bior5.5_sc5_Energy_skewness  0.43+/-0.4(29) 1.46+/-1.7(15) 0.78+/-1.1(44) 0.003 
c3_PP_Atrial_bior5.5_sc5_Katz_FD_skewness  0.49+/-0.3(29) 1.62+/-2.1(15) 0.87+/-1.3(44) 0.005 
c3_PP_Atrial_bior5.5_sc5_Nonlinear_Energy_skewness 0.48+/-0.4(29) 1.61+/-2.0(15) 0.86+/-1.3(44) 0.004 
c3_PP_Atrial_bior5.5_sc5_Mean_Freq_max  23.49+/-4.6(29) 27.78+/-5.5(15) 24.95+/-5.3(44) 0.009 
c3_PP_Atrial_bior5.5_sc5_Mean_Freq_mean  16.21+/-2.7(29) 18.69+/-2.6(15) 17.06+/-2.9(44) 0.005 
c3_PP_Atrial_bior5.5_sc5_Median_Freq_max  24.98+/-4.1(29) 28.83+/-4.2(15) 26.29+/-4.5(44) 0.005 
c3_PP_Atrial_bior5.5_sc5_Median_Freq_mean  18.37+/-3.3(29) 21.37+/-2.8(15) 19.39+/-3.4(44) 0.004 
c3_PR_Atrial_bior5.5_sc5_Energy_skewness  0.61+/-0.6(26) 1.73+/-1.8(14) 1.00+/-1.2(40) 0.005 
c4_PP_Atrial_bior5.5_sc5_Mean_Freq_max  22.30+/-3.7(24) 26.40+/-3.8(14) 23.81+/-4.2(38) 0.002 
c1_PP_Atrial_bior5.5_sc9_Mean_Freq_kurtosis  3.88+/-2.5(28) 7.42+/-6.0(15) 5.12+/-4.3(43) 0.009 
c1_PP_Atrial_bior5.5_sc9_Median_Freq_kurtosis  3.53+/-2.3(28) 7.18+/-5.9(15) 4.81+/-4.2(43) 0.006 
c1_RP_Atrial_bior5.5_sc9_Median_Freq_kurtosis  3.31+/-1.5(25) 7.36+/-7.2(14) 4.77+/-4.8(39) 0.010 
c1_PR_Atrial_bior5.5_sc9_Shannon_Entropy_kurtosis 3.16+/-1.7(25) 5.55+/-3.6(14) 4.02+/-2.8(39) 0.009 
c2_PR_Chest_bior5.5_sc9_Mean_Freq_std  1.32+/-1.0(27) 0.58+/-0.2(14) 1.07+/-0.9(41) 0.007 
c2_PR_Chest_bior5.5_sc9_Median_Freq_max  19.77+/-4.9(27) 15.18+/-4.6(14) 18.20+/-5.2(41) 0.006 
c3_PP_Atrial_bior5.5_sc9_Mean_Freq_min  7.58+/-1.0(29) 6.65+/-1.0(15) 7.26+/-1.1(44) 0.004 
c4_RP_Atrial_bior5.5_sc9_Curve_length_kurtosis  3.75+/-1.8(22) 7.36+/-5.8(13) 5.09+/-4.1(35) 0.010 
c1_PR_Atrial_bior5.5_sc13_Curve_length_skewness  0.62+/-1.2(25) -0.87+/-2.0(14) 0.08+/-1.7(39) 0.006 
c1_PP_Atrial_bior5.5_sc17_Mean_Freq_min  3.97+/-0.8(28) 4.63+/-0.7(15) 4.20+/-0.8(43) 0.010 
c1_PP_Atrial_bior5.5_sc17_Peak_Freq_mean  3.97+/-0.6(28) 4.55+/-0.6(15) 4.17+/-0.6(43) 0.004 
c1_RP_Atrial_bior5.5_sc17_Mean_Freq_min  4.03+/-0.9(25) 4.85+/-0.9(14) 4.33+/-0.9(39) 0.007 
c1_PR_Atrial_bior5.5_sc17_Nonlinear_Energy_skewness 0.78+/-1.3(25) -0.46+/-1.2(14) 0.33+/-1.4(39) 0.005 
c1_PR_Atrial_bior5.5_sc17_Curve_length_skewness  0.52+/-1.0(25) -0.88+/-1.7(14) 0.01+/-1.4(39) 0.002 
c2_PR_Atrial_bior5.5_sc17_Peak_Freq_kurtosis  15.75+/-20.0(26) 72.73+/-95.1(14) 35.69+/-63.5(40) 0.005 
c1_PR_Atrial_bior5.5_sc21_Nonlinear_Energy_skewness 0.68+/-1.0(25) -0.37+/-1.1(14) 0.30+/-1.1(39) 0.005 
c1_PR_Atrial_bior5.5_sc21_Curve_length_skewness  0.36+/-0.8(25) -0.77+/-1.4(14) -0.05+/-1.2(39) 0.004 
c2_PR_Chest_bior5.5_sc21_Median_Freq_min  4.51+/-0.8(27) 6.01+/-2.4(14) 5.02+/-1.7(41) 0.005 
c1_PR_Atrial_bior5.5_sc25_Nonlinear_Energy_skewness 0.71+/-1.1(25) -0.29+/-1.0(14) 0.35+/-1.2(39) 0.009 
c1_PR_Atrial_bior5.5_sc25_Peak_Freq_kurtosis  22.90+/-36.8(23) 149.74+/-158.7(12) 66.39+/-113.0(35) 0.001 
c2_PP_Atrial_bior6.8_sc5_Peak_Freq_max  27.55+/-5.6(29) 32.30+/-2.2(15) 29.17+/-5.2(44) 0.003 
c2_PR_Chest_bior6.8_sc5_Nonlinear_Energy_skewness 6.01+/-5.7(27) 1.48+/-2.1(14) 4.46+/-5.2(41) 0.007 
c3_PP_Atrial_bior6.8_sc5_Energy_skewness  0.45+/-0.3(29) 1.54+/-1.9(15) 0.82+/-1.2(44) 0.004 
c3_PP_Atrial_bior6.8_sc5_Katz_FD_skewness  0.49+/-0.4(29) 1.64+/-2.1(15) 0.89+/-1.4(44) 0.006 
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c3_PP_Atrial_bior6.8_sc5_Nonlinear_Energy_skewness 0.51+/-0.4(29) 1.70+/-2.1(15) 0.91+/-1.4(44) 0.004 
c3_PP_Atrial_bior6.8_sc5_Mean_Freq_max  26.93+/-5.2(29) 31.49+/-3.7(15) 28.48+/-5.2(44) 0.005 
c3_PP_Atrial_bior6.8_sc5_Median_Freq_max  27.70+/-4.6(29) 31.55+/-3.7(15) 29.01+/-4.7(44) 0.008 
c3_PP_Atrial_bior6.8_sc5_Peak_Freq_std  4.01+/-1.7(29) 5.30+/-1.0(15) 4.45+/-1.6(44) 0.009 
c3_PP_Atrial_bior6.8_sc5_Curve_length_skewness  0.13+/-0.4(29) 0.61+/-0.8(15) 0.29+/-0.6(44) 0.008 
c3_RP_Atrial_bior6.8_sc5_Peak_Freq_std  4.55+/-1.5(26) 5.86+/-1.3(14) 5.01+/-1.5(40) 0.008 
c3_PR_Atrial_bior6.8_sc5_Energy_skewness  0.62+/-0.5(26) 1.77+/-1.9(14) 1.02+/-1.3(40) 0.006 
c3_PR_Atrial_bior6.8_sc10_Mean_Freq_kurtosis  4.53+/-2.6(26) 8.26+/-5.6(14) 5.84+/-4.3(40) 0.007 
c1_PP_Atrial_bior6.8_sc15_Peak_Freq_min  3.29+/-0.7(28) 4.00+/-0.8(15) 3.53+/-0.8(43) 0.005 
c1_PR_Atrial_bior6.8_sc15_Curve_length_skewness  0.73+/-1.4(25) -0.81+/-1.7(14) 0.18+/-1.7(39) 0.004 
c1_PR_Atrial_bior6.8_sc20_Nonlinear_Energy_skewness 0.85+/-1.2(25) -0.34+/-1.1(14) 0.43+/-1.3(39) 0.004 
c1_PR_Atrial_bior6.8_sc20_Curve_length_skewness  0.45+/-0.9(25) -0.75+/-1.5(14) 0.02+/-1.3(39) 0.003 
c2_PR_Chest_bior6.8_sc20_Median_Freq_min  4.87+/-0.9(27) 6.60+/-2.6(14) 5.46+/-1.9(41) 0.003 
c1_PR_Atrial_bior6.8_sc25_Nonlinear_Energy_skewness 0.74+/-1.0(25) -0.25+/-1.0(14) 0.39+/-1.1(39) 0.005 
c2_PR_Chest_bior6.8_sc25_Median_Freq_min  4.29+/-1.3(27) 6.07+/-2.6(14) 4.90+/-2.0(41) 0.006 
c1_PP_Atrial_bior6.8_sc30_Mean_Freq_std  0.35+/-0.2(28) 0.18+/-0.1(15) 0.29+/-0.2(43) 0.007 
c1_RP_Atrial_bior6.8_sc30_Peak_Freq_max  4.26+/-0.9(25) 3.36+/-1.1(14) 3.94+/-1.1(39) 0.009 
c1_PR_Atrial_bior6.8_sc30_Peak_Freq_max  4.96+/-2.5(25) 2.82+/-2.0(14) 4.19+/-2.5(39) 0.009 
c2_RP_Atrial_bior6.8_sc30_Shannon_Entropy_skewness 0.01+/-1.5(27) -2.37+/-3.5(14) -0.80+/-2.6(41) 0.004 
c2_RP_Atrial_bior6.8_sc30_Shannon_Entropy_kurtosis 5.15+/-7.3(27) 26.44+/-38.0(14) 12.42+/-24.6(41) 0.007 
c2_PR_Chest_bior6.8_sc30_Median_Freq_std  1.14+/-0.5(27) 0.62+/-0.5(14) 0.96+/-0.6(41) 0.005 
c3_PP_Atrial_rbio2.2_sc5_Energy_skewness  0.38+/-0.6(29) 1.40+/-1.7(15) 0.73+/-1.2(44) 0.006 
c3_PP_Atrial_rbio2.2_sc5_Katz_FD_skewness  0.44+/-0.4(29) 1.44+/-1.7(15) 0.78+/-1.2(44) 0.005 
c3_PP_Atrial_rbio2.2_sc5_Nonlinear_Energy_skewness 0.42+/-0.5(29) 1.42+/-1.8(15) 0.76+/-1.2(44) 0.006 
c3_PP_Atrial_rbio2.2_sc5_Curve_length_skewness  0.07+/-0.4(29) 0.59+/-0.8(15) 0.25+/-0.6(44) 0.008 
c3_RP_Atrial_rbio2.2_sc5_Peak_Freq_kurtosis  4.66+/-2.7(26) 11.46+/-11.9(14) 7.04+/-7.9(40) 0.008 
c1_PR_Chest_rbio2.2_sc9_Peak_Freq_std  0.73+/-0.6(25) 1.51+/-1.0(14) 1.01+/-0.8(39) 0.003 
c2_PR_Chest_rbio2.2_sc9_Nonlinear_Energy_mean  0.00+/-0.0(26) 0.00+/-0.0(14) 0.00+/-0.0(40) 0.010 
c3_PP_Atrial_rbio2.2_sc9_Peak_Freq_min  1.24+/-1.3(29) 0.17+/-0.4(15) 0.88+/-1.2(44) 0.004 
c1_PR_Atrial_rbio2.2_sc13_Nonlinear_Energy_skewness 0.76+/-1.4(25) -0.50+/-1.3(14) 0.30+/-1.5(39) 0.009 
c1_PR_Atrial_rbio2.2_sc13_Curve_length_skewness  0.49+/-0.9(25) -0.87+/-1.5(14) 0.00+/-1.3(39) 0.001 
c3_PP_Atrial_rbio2.2_sc13_Katz_FD_kurtosis  4.34+/-2.9(29) 18.63+/-26.9(15) 9.21+/-17.0(44) 0.007 
c3_PP_Atrial_rbio2.2_sc13_Peak_Freq_mean  2.95+/-1.7(29) 1.70+/-0.9(15) 2.53+/-1.6(44) 0.010 
c4_PP_Atrial_rbio2.2_sc13_Peak_Freq_mean  2.97+/-1.2(24) 1.75+/-1.1(14) 2.52+/-1.3(38) 0.004 
c4_RP_Atrial_rbio2.2_sc13_Peak_Freq_mean  2.69+/-1.8(22) 1.11+/-1.3(13) 2.11+/-1.8(35) 0.010 
c4_PR_Atrial_rbio2.2_sc13_Peak_Freq_max  7.59+/-4.5(22) 3.42+/-3.6(13) 6.04+/-4.6(35) 0.008 
c1_PR_Atrial_rbio2.2_sc17_Nonlinear_Energy_skewness 0.64+/-1.1(25) -0.42+/-1.1(14) 0.26+/-1.2(39) 0.006 
c1_PR_Atrial_rbio2.2_sc17_Curve_length_skewness  0.36+/-0.8(25) -0.72+/-1.3(14) -0.03+/-1.2(39) 0.004 
c2_PR_Chest_rbio2.2_sc17_Median_Freq_min  4.69+/-1.3(27) 6.84+/-3.2(14) 5.42+/-2.3(41) 0.004 
c3_PR_Chest_rbio2.2_sc17_Shannon_Entropy_std  0.01+/-0.0(26) 0.03+/-0.0(14) 0.02+/-0.0(40) 0.003 
c4_PP_Atrial_rbio2.2_sc17_Peak_Freq_mean  2.40+/-1.1(24) 1.20+/-0.9(14) 1.96+/-1.1(38) 0.001 
c4_RP_Atrial_rbio2.2_sc17_Peak_Freq_mean  2.28+/-1.6(22) 0.84+/-1.1(13) 1.75+/-1.6(35) 0.007 
c2_PR_Chest_rbio2.2_sc21_Median_Freq_min  4.56+/-1.9(27) 6.90+/-3.4(14) 5.36+/-2.7(41) 0.007 
c2_PR_Chest_rbio2.2_sc21_Shannon_Entropy_mean 0.34+/-0.0(27) 0.30+/-0.1(14) 0.32+/-0.0(41) 0.008 
c3_PR_Atrial_rbio2.2_sc21_Median_Freq_kurtosis  5.72+/-8.3(26) 22.47+/-27.1(14) 11.58+/-18.8(40) 0.006 
c4_PP_Atrial_rbio2.2_sc21_Peak_Freq_mean  2.08+/-1.0(24) 1.06+/-0.8(14) 1.70+/-1.1(38) 0.003 
c4_RP_Atrial_rbio2.2_sc21_Peak_Freq_mean  1.98+/-1.4(22) 0.77+/-1.0(13) 1.53+/-1.4(35) 0.009 
c2_PR_Chest_rbio2.2_sc25_Shannon_Entropy_max  0.37+/-0.0(27) 0.34+/-0.0(14) 0.36+/-0.0(41) 0.007 
c3_PR_Atrial_rbio2.2_sc25_Mean_Freq_skewness  0.65+/-1.8(26) 3.77+/-5.1(14) 1.74+/-3.6(40) 0.007 
c1_PP_Atrial_rbio4.4_sc5_Peak_Freq_min  8.05+/-1.9(28) 6.00+/-3.1(15) 7.34+/-2.5(43) 0.010 
c3_PP_Atrial_rbio4.4_sc5_Energy_skewness  0.42+/-0.4(29) 1.42+/-1.6(15) 0.76+/-1.1(44) 0.004 
c3_PP_Atrial_rbio4.4_sc5_Katz_FD_skewness  0.45+/-0.4(29) 1.55+/-1.9(15) 0.82+/-1.3(44) 0.004 
c3_PP_Atrial_rbio4.4_sc5_Nonlinear_Energy_skewness 0.44+/-0.4(29) 1.57+/-1.9(15) 0.83+/-1.3(44) 0.003 
c3_PP_Atrial_rbio4.4_sc5_Curve_length_skewness  0.09+/-0.4(29) 0.63+/-0.9(15) 0.27+/-0.7(44) 0.008 
c3_PR_Atrial_rbio4.4_sc5_Energy_skewness  0.61+/-0.7(26) 1.73+/-1.7(14) 1.00+/-1.3(40) 0.005 
c1_PP_Atrial_rbio4.4_sc10_Peak_Freq_min  3.20+/-1.1(28) 4.10+/-0.9(15) 3.51+/-1.1(43) 0.009 
c2_PR_Chest_rbio4.4_sc10_Nonlinear_Energy_mean 0.00+/-0.0(26) 0.00+/-0.0(14) 0.00+/-0.0(40) 0.010 
c1_PR_Atrial_rbio4.4_sc15_Spectral_entropy_skewness 0.67+/-0.9(25) -0.15+/-0.8(14) 0.38+/-0.9(39) 0.008 
c1_PR_Atrial_rbio4.4_sc15_Curve_length_skewness  0.64+/-1.2(25) -0.84+/-1.7(14) 0.11+/-1.5(39) 0.003 
c1_PR_Atrial_rbio4.4_sc20_Nonlinear_Energy_skewness 0.75+/-1.1(25) -0.35+/-1.1(14) 0.35+/-1.2(39) 0.004 
c1_PR_Atrial_rbio4.4_sc20_Curve_length_skewness  0.35+/-0.8(25) -0.73+/-1.4(14) -0.04+/-1.2(39) 0.004 
c2_PR_Atrial_rbio4.4_sc20_Peak_Freq_skewness  1.23+/-3.8(26) -2.77+/-3.7(13) -0.10+/-4.1(39) 0.003 
c2_PR_Chest_rbio4.4_sc20_Median_Freq_min  4.88+/-1.4(27) 7.04+/-3.0(14) 5.62+/-2.3(41) 0.003 
c1_PR_Atrial_rbio4.4_sc25_Nonlinear_Energy_skewness 0.74+/-1.2(25) -0.27+/-1.0(14) 0.38+/-1.2(39) 0.010 
c1_PR_Atrial_rbio4.4_sc25_Peak_Freq_max  5.02+/-2.7(25) 2.61+/-2.5(14) 4.15+/-2.9(39) 0.010 
c1_RP_Atrial_rbio4.4_sc30_Peak_Freq_std  0.55+/-0.5(25) 0.19+/-0.1(14) 0.42+/-0.4(39) 0.010 
c1_RP_Atrial_rbio4.4_sc30_Peak_Freq_kurtosis  34.61+/-62.6(22) 146.55+/-149.2(11) 71.92+/-111.4(33) 0.005 
c4_PP_Atrial_rbio4.4_sc30_Peak_Freq_mean  2.28+/-0.7(24) 1.53+/-0.8(14) 2.00+/-0.8(38) 0.004 
c2_PR_Chest_rbio5.5_sc5_Nonlinear_Energy_skewness 6.11+/-5.7(27) 1.49+/-2.1(14) 4.53+/-5.2(41) 0.006 
c2_PR_Chest_rbio5.5_sc5_Mean_Freq_std  3.28+/-1.4(27) 2.06+/-0.8(14) 2.86+/-1.4(41) 0.005 
c2_PR_Chest_rbio5.5_sc5_Median_Freq_std  2.94+/-1.1(27) 2.02+/-0.4(14) 2.63+/-1.1(41) 0.006 
c2_PR_Chest_rbio5.5_sc5_Peak_Freq_max  26.35+/-6.7(27) 18.96+/-9.1(14) 23.83+/-8.3(41) 0.005 
c3_PP_Atrial_rbio5.5_sc5_Energy_skewness  0.44+/-0.4(29) 1.52+/-1.8(15) 0.81+/-1.2(44) 0.004 
c3_PP_Atrial_rbio5.5_sc5_Katz_FD_skewness  0.48+/-0.4(29) 1.60+/-2.1(15) 0.86+/-1.3(44) 0.006 
c3_PP_Atrial_rbio5.5_sc5_Nonlinear_Energy_skewness 0.49+/-0.4(29) 1.69+/-2.1(15) 0.90+/-1.4(44) 0.004 
c3_PP_Atrial_rbio5.5_sc5_Curve_length_skewness  0.14+/-0.4(29) 0.68+/-0.9(15) 0.33+/-0.6(44) 0.007 
c3_PR_Atrial_rbio5.5_sc5_Energy_skewness  0.62+/-0.5(26) 1.76+/-1.8(14) 1.02+/-1.3(40) 0.005 
c1_PP_Atrial_rbio5.5_sc10_Peak_Freq_skewness  -0.13+/-2.2(27) 1.83+/-2.1(15) 0.57+/-2.3(42) 0.007 
c2_PP_Atrial_rbio5.5_sc10_Peak_Freq_skewness  0.28+/-1.9(29) 2.55+/-3.7(15) 1.05+/-2.8(44) 0.010 
c2_RP_Atrial_rbio5.5_sc10_Peak_Freq_skewness  0.36+/-1.7(27) 3.12+/-3.7(14) 1.30+/-2.8(41) 0.002 
c3_RP_Atrial_rbio5.5_sc10_Shannon_Entropy_std  0.04+/-0.0(26) 0.07+/-0.0(14) 0.05+/-0.0(40) 0.002 
c4_RP_Atrial_rbio5.5_sc10_Curve_length_kurtosis  3.45+/-1.6(22) 6.32+/-4.2(13) 4.52+/-3.1(35) 0.007 
c1_PR_Atrial_rbio5.5_sc15_Spectral_entropy_skewness 0.80+/-1.0(25) -0.10+/-0.9(14) 0.48+/-1.0(39) 0.007 
c1_PR_Atrial_rbio5.5_sc15_Curve_length_skewness  0.73+/-1.4(25) -0.88+/-1.8(14) 0.15+/-1.7(39) 0.003 
c3_PR_Chest_rbio5.5_sc15_Peak_Freq_std  0.67+/-0.4(26) 1.64+/-1.7(14) 1.01+/-1.2(40) 0.009 
c1_PR_Atrial_rbio5.5_sc20_Nonlinear_Energy_skewness 0.83+/-1.1(25) -0.34+/-1.1(14) 0.41+/-1.2(39) 0.003 
c1_PR_Atrial_rbio5.5_sc20_Curve_length_skewness  0.42+/-0.9(25) -0.72+/-1.4(14) 0.01+/-1.2(39) 0.004 
c2_PR_Chest_rbio5.5_sc20_Median_Freq_min  4.92+/-1.1(27) 6.93+/-2.8(14) 5.61+/-2.0(41) 0.002 
c4_RP_Atrial_rbio5.5_sc20_Peak_Freq_mean  3.89+/-1.4(22) 2.68+/-0.8(13) 3.44+/-1.3(35) 0.008 
c1_PP_Atrial_rbio5.5_sc25_Peak_Freq_max  4.86+/-0.8(28) 3.83+/-1.1(15) 4.50+/-1.1(43) 0.002 
c1_RP_Atrial_rbio5.5_sc25_Peak_Freq_max  5.08+/-1.1(25) 3.50+/-1.3(14) 4.51+/-1.4(39) 0.000 
c1_PR_Atrial_rbio5.5_sc25_Nonlinear_Energy_skewness 0.76+/-1.1(25) -0.26+/-1.0(14) 0.40+/-1.1(39) 0.006 
c1_PR_Atrial_rbio5.5_sc25_Peak_Freq_kurtosis  36.54+/-58.7(24) 172.79+/-176.5(11) 79.36+/-124.9(35) 0.002 
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c1_PP_Atrial_rbio5.5_sc30_Mean_Freq_max  4.91+/-1.0(28) 3.97+/-1.1(15) 4.58+/-1.1(43) 0.007 
c1_PP_Atrial_rbio5.5_sc30_Median_Freq_max  6.66+/-2.0(28) 4.74+/-2.0(15) 5.99+/-2.2(43) 0.005 
c1_RP_Atrial_rbio5.5_sc30_Median_Freq_max  7.48+/-2.2(25) 5.34+/-2.6(14) 6.71+/-2.5(39) 0.008 
c2_PP_Atrial_rbio5.5_sc30_Shannon_Entropy_kurtosis 5.43+/-5.3(29) 12.75+/-12.0(15) 7.93+/-8.8(44) 0.007 
c2_PR_Chest_rbio5.5_sc30_Peak_Freq_std  0.89+/-0.6(27) 0.42+/-0.4(14) 0.73+/-0.6(41) 0.009 
c4_RP_Atrial_rbio5.5_sc30_Peak_Freq_mean  2.51+/-1.0(22) 1.33+/-1.2(13) 2.07+/-1.2(35) 0.003 
c1_RP_Atrial_rbio6.8_sc5_Shannon_Entropy_max  0.30+/-0.1(25) 0.21+/-0.1(14) 0.27+/-0.1(39) 0.003 
c2_PR_Chest_rbio6.8_sc5_Nonlinear_Energy_skewness 6.03+/-6.1(27) 1.44+/-1.9(14) 4.46+/-5.5(41) 0.010 
c3_PP_Atrial_rbio6.8_sc5_Energy_skewness  0.40+/-0.4(29) 1.42+/-1.6(15) 0.75+/-1.1(44) 0.002 
c3_PP_Atrial_rbio6.8_sc5_Katz_FD_skewness  0.44+/-0.4(29) 1.57+/-1.9(15) 0.83+/-1.3(44) 0.004 
c3_PP_Atrial_rbio6.8_sc5_Nonlinear_Energy_skewness 0.45+/-0.4(29) 1.60+/-1.9(15) 0.84+/-1.2(44) 0.002 
c3_PP_Atrial_rbio6.8_sc5_Curve_length_skewness  0.07+/-0.4(29) 0.58+/-0.8(15) 0.25+/-0.6(44) 0.007 
c3_PR_Atrial_rbio6.8_sc5_Energy_skewness  0.59+/-0.6(26) 1.75+/-1.8(14) 1.00+/-1.3(40) 0.004 
c2_RP_Atrial_rbio6.8_sc9_Mean_Freq_kurtosis  4.38+/-2.6(27) 9.74+/-7.9(14) 6.21+/-5.6(41) 0.002 
c2_RP_Atrial_rbio6.8_sc9_Median_Freq_kurtosis  3.96+/-3.1(27) 10.70+/-9.0(14) 6.26+/-6.5(41) 0.001 
c2_PR_Chest_rbio6.8_sc9_Mean_Freq_std  1.25+/-0.8(27) 0.61+/-0.4(14) 1.03+/-0.8(41) 0.009 
c3_PP_Atrial_rbio6.8_sc9_Mean_Freq_min  7.20+/-0.8(29) 6.32+/-0.9(15) 6.90+/-0.9(44) 0.002 
c3_RP_Atrial_rbio6.8_sc9_Mean_Freq_min  7.12+/-1.0(26) 6.13+/-1.1(14) 6.77+/-1.1(40) 0.005 
c3_RP_Atrial_rbio6.8_sc9_Mean_Freq_mean  10.64+/-2.0(26) 8.84+/-1.6(14) 10.01+/-2.1(40) 0.006 
c1_RP_Atrial_rbio6.8_sc13_Peak_Freq_min  3.24+/-1.0(25) 4.14+/-0.8(14) 3.56+/-1.0(39) 0.007 
c1_PR_Atrial_rbio6.8_sc13_Curve_length_skewness  0.70+/-1.2(25) -0.81+/-1.9(14) 0.16+/-1.6(39) 0.004 
c4_PR_Chest_rbio6.8_sc13_Shannon_Entropy_kurtosis 3.89+/-3.2(22) 11.47+/-11.8(13) 6.70+/-8.3(35) 0.007 
c1_RP_Atrial_rbio6.8_sc17_Mean_Freq_min  3.89+/-0.9(25) 4.71+/-0.9(14) 4.19+/-1.0(39) 0.010 
c1_PR_Atrial_rbio6.8_sc17_Nonlinear_Energy_skewness 0.83+/-1.3(25) -0.39+/-1.1(14) 0.39+/-1.4(39) 0.006 
c1_PR_Atrial_rbio6.8_sc17_Curve_length_skewness  0.53+/-1.0(25) -0.80+/-1.6(14) 0.05+/-1.4(39) 0.003 
c2_PR_Atrial_rbio6.8_sc17_Peak_Freq_kurtosis  10.91+/-14.4(25) 51.14+/-53.6(14) 25.35+/-38.7(39) 0.001 
c1_PR_Atrial_rbio6.8_sc21_Nonlinear_Energy_skewness 0.73+/-1.0(25) -0.31+/-1.0(14) 0.35+/-1.1(39) 0.004 
c1_PR_Atrial_rbio6.8_sc21_Curve_length_skewness  0.32+/-0.8(25) -0.73+/-1.3(14) -0.06+/-1.2(39) 0.005 
c2_PR_Chest_rbio6.8_sc21_Median_Freq_min  4.41+/-0.9(27) 6.06+/-2.4(14) 4.97+/-1.8(41) 0.003 
c1_PP_Atrial_rbio6.8_sc25_Mean_Freq_skewness  0.24+/-2.0(28) 3.89+/-6.0(15) 1.51+/-4.2(43) 0.005 
c1_PR_Atrial_rbio6.8_sc25_Nonlinear_Energy_skewness 0.74+/-1.1(25) -0.24+/-0.9(14) 0.39+/-1.1(39) 0.008 
c2_RP_Atrial_rbio6.8_sc25_Shannon_Entropy_std  0.04+/-0.0(27) 0.02+/-0.0(14) 0.04+/-0.0(41) 0.007 
c2_RP_Atrial_gaus1_sc2_Shannon_Entropy_skewness 0.41+/-1.1(27) -0.82+/-1.4(14) -0.01+/-1.3(41) 0.004 
c2_PR_Chest_gaus1_sc2_Mean_Freq_min  4.47+/-2.0(27) 8.72+/-4.7(14) 5.92+/-3.7(41) 0.000 
c2_PR_Chest_gaus1_sc2_Median_Freq_min  6.91+/-3.6(27) 11.56+/-6.3(14) 8.50+/-5.1(41) 0.004 
c2_PR_Chest_gaus1_sc2_Peak_Freq_mean  4.83+/-2.6(27) 7.44+/-3.0(14) 5.72+/-3.0(41) 0.007 
c3_PP_Atrial_gaus1_sc2_Energy_skewness  0.34+/-0.6(29) 1.58+/-1.7(15) 0.76+/-1.3(44) 0.001 
c3_PP_Atrial_gaus1_sc2_Energy_kurtosis  3.80+/-2.1(29) 15.92+/-19.8(15) 7.93+/-12.8(44) 0.002 
c3_PP_Atrial_gaus1_sc2_Katz_FD_skewness  0.43+/-0.4(29) 1.50+/-1.8(15) 0.79+/-1.2(44) 0.003 
c3_PP_Atrial_gaus1_sc2_Nonlinear_Energy_skewness 0.40+/-0.4(29) 1.46+/-1.9(15) 0.76+/-1.2(44) 0.005 
c3_PP_Atrial_gaus1_sc2_Curve_length_skewness  0.10+/-0.4(29) 0.67+/-0.9(15) 0.30+/-0.7(44) 0.006 
c3_PR_Atrial_gaus1_sc2_Median_Freq_skewness  0.15+/-0.8(26) 2.55+/-3.4(14) 0.99+/-2.3(40) 0.001 
c3_PR_Atrial_gaus1_sc2_Median_Freq_kurtosis  4.42+/-2.7(26) 31.25+/-50.7(14) 13.81+/-32.1(40) 0.010 
c1_PR_Atrial_gaus1_sc4_Curve_length_skewness  0.42+/-0.9(25) -0.81+/-1.9(14) -0.02+/-1.5(39) 0.009 
c3_PP_Atrial_gaus1_sc4_Curve_length_kurtosis  4.10+/-2.2(29) 12.88+/-16.0(15) 7.10+/-10.2(44) 0.005 
c4_PR_Atrial_gaus1_sc4_Peak_Freq_kurtosis  4.70+/-7.2(20) 21.63+/-24.5(13) 11.37+/-18.1(33) 0.007 
c1_PP_Atrial_gaus1_sc6_Median_Freq_kurtosis  4.16+/-2.9(28) 12.56+/-14.5(15) 7.09+/-9.6(43) 0.005 
c1_PR_Atrial_gaus1_sc6_Nonlinear_Energy_skewness 0.70+/-1.3(25) -0.49+/-1.2(14) 0.28+/-1.4(39) 0.010 
c3_PR_Chest_gaus1_sc6_Peak_Freq_mean  4.99+/-3.3(26) 1.99+/-2.4(14) 3.94+/-3.3(40) 0.005 
c3_PR_Chest_gaus1_sc6_Peak_Freq_skewness  -0.74+/-3.5(26) 4.30+/-7.6(14) 1.02+/-5.8(40) 0.007 
c4_PR_Chest_gaus1_sc6_Peak_Freq_mean  5.12+/-3.1(22) 1.71+/-2.4(13) 3.85+/-3.3(35) 0.002 
c2_PR_Chest_gaus1_sc8_Peak_Freq_mean  3.02+/-2.3(27) 0.95+/-1.3(14) 2.31+/-2.2(41) 0.003 
c2_PR_Chest_gaus1_sc8_Peak_Freq_skewness  -0.36+/-3.9(24) 4.56+/-6.3(11) 1.19+/-5.2(35) 0.007 
c3_PR_Chest_gaus1_sc8_Katz_FD_skewness  0.65+/-1.1(26) 2.17+/-1.8(14) 1.18+/-1.5(40) 0.002 
c3_PR_Chest_gaus1_sc8_Katz_FD_kurtosis  7.67+/-9.5(26) 20.20+/-15.8(14) 12.06+/-13.3(40) 0.003 
c4_PR_Chest_gaus1_sc8_Peak_Freq_kurtosis  31.81+/-45.9(18) 159.37+/-183.0(8) 71.06+/-120.0(26) 0.009 
c3_PR_Chest_gaus1_sc10_Energy_skewness  0.67+/-1.0(26) 2.36+/-2.2(14) 1.26+/-1.7(40) 0.002 
c3_PR_Chest_gaus1_sc10_Energy_kurtosis  5.64+/-4.5(26) 21.53+/-26.0(14) 11.20+/-17.3(40) 0.004 
c3_PR_Chest_gaus1_sc10_Spectral_entropy_kurtosis 4.82+/-2.7(26) 8.53+/-4.9(14) 6.12+/-4.0(40) 0.004 
c3_PR_Chest_gaus1_sc10_Shannon_Entropy_skewness 0.12+/-1.7(26) -2.42+/-3.5(14) -0.77+/-2.7(40) 0.003 
c4_PP_Atrial_gaus1_sc10_Spectral_entropy_max  3.71+/-2.8(24) 6.89+/-3.9(14) 4.88+/-3.5(38) 0.006 
c3_PR_Atrial_gaus1_sc12_Median_Freq_skewness  0.18+/-1.5(26) 1.89+/-2.3(14) 0.77+/-2.0(40) 0.007 
c3_PR_Atrial_gaus1_sc12_Median_Freq_kurtosis  5.64+/-5.2(26) 17.34+/-19.2(14) 9.73+/-13.1(40) 0.005 
c3_PR_Chest_gaus1_sc12_Energy_skewness  0.76+/-0.9(26) 2.58+/-2.4(14) 1.40+/-1.8(40) 0.001 
c3_PR_Chest_gaus1_sc12_Energy_kurtosis  5.39+/-3.3(26) 24.93+/-34.6(14) 12.23+/-22.2(40) 0.006 
c4_PP_Atrial_gaus1_sc12_Spectral_entropy_max  4.14+/-3.0(24) 7.42+/-3.8(14) 5.35+/-3.6(38) 0.006 
c4_RP_Atrial_gaus1_sc12_Spectral_entropy_max  2.85+/-2.9(22) 6.06+/-3.6(13) 4.04+/-3.5(35) 0.007 
c4_RP_Atrial_gaus1_sc12_Spectral_entropy_std  0.29+/-0.3(22) 0.66+/-0.5(13) 0.43+/-0.4(35) 0.005 
c4_PR_Chest_gaus1_sc12_Mean_Freq_kurtosis  5.42+/-6.2(22) 14.31+/-11.9(13) 8.72+/-9.6(35) 0.006 
c4_PR_Chest_gaus1_sc12_Shannon_Entropy_skewness -0.48+/-1.2(22) -2.47+/-2.8(13) -1.22+/-2.2(35) 0.007 
c2_RP_Atrial_gaus2_sc4_Median_Freq_kurtosis  3.38+/-1.7(27) 6.07+/-3.9(14) 4.30+/-2.9(41) 0.003 
c2_RP_Atrial_gaus2_sc4_Peak_Freq_skewness  0.72+/-1.4(27) 2.60+/-2.7(14) 1.36+/-2.1(41) 0.006 
c4_PP_Atrial_gaus2_sc4_Peak_Freq_min  1.85+/-1.6(24) 0.43+/-0.7(14) 1.33+/-1.5(38) 0.004 
c1_PR_Atrial_gaus2_sc7_Curve_length_skewness  0.63+/-1.3(25) -0.88+/-1.7(14) 0.09+/-1.6(39) 0.003 
c3_PP_Atrial_gaus2_sc7_Peak_Freq_mean  3.16+/-1.6(29) 1.91+/-1.0(15) 2.73+/-1.5(44) 0.009 
c3_RP_Atrial_gaus2_sc7_Peak_Freq_mean  2.59+/-1.8(26) 1.12+/-1.0(14) 2.08+/-1.7(40) 0.008 
c4_PP_Atrial_gaus2_sc7_Peak_Freq_mean  3.30+/-1.4(24) 2.09+/-1.1(14) 2.86+/-1.4(38) 0.010 
c4_RP_Atrial_gaus2_sc7_Peak_Freq_mean  2.94+/-1.8(22) 1.28+/-1.4(13) 2.33+/-1.8(35) 0.008 
c4_PR_Atrial_gaus2_sc7_Peak_Freq_max  7.61+/-4.2(22) 3.73+/-3.5(13) 6.17+/-4.4(35) 0.009 
c1_PR_Atrial_gaus2_sc10_Nonlinear_Energy_skewness 0.72+/-1.1(25) -0.28+/-1.0(14) 0.36+/-1.2(39) 0.008 
c2_PR_Chest_gaus2_sc10_Median_Freq_min  4.28+/-1.1(27) 6.30+/-2.8(14) 4.97+/-2.1(41) 0.002 
c4_PP_Atrial_gaus2_sc10_Peak_Freq_mean  2.44+/-1.1(24) 1.30+/-0.9(14) 2.02+/-1.2(38) 0.002 
c4_RP_Atrial_gaus2_sc10_Peak_Freq_max  5.45+/-2.8(22) 2.73+/-2.4(13) 4.44+/-3.0(35) 0.006 
c4_RP_Atrial_gaus2_sc10_Peak_Freq_mean  2.38+/-1.6(22) 0.89+/-1.1(13) 1.82+/-1.6(35) 0.007 
c4_PP_Atrial_gaus2_sc13_Peak_Freq_mean  2.05+/-1.0(24) 1.14+/-0.8(14) 1.72+/-1.0(38) 0.007 
c4_PR_Chest_gaus2_sc13_Peak_Freq_min  0.59+/-1.5(22) 2.65+/-2.7(13) 1.36+/-2.2(35) 0.006 
c1_PR_Atrial_gaus2_sc19_Peak_Freq_skewness  3.14+/-6.5(16) -5.41+/-4.8(6) 0.81+/-7.1(22) 0.008 
c2_PR_Chest_gaus2_sc19_Mean_Freq_min  3.14+/-1.5(27) 4.61+/-1.7(14) 3.64+/-1.7(41) 0.008 
c2_PR_Chest_gaus2_sc19_Median_Freq_min  4.12+/-2.8(27) 6.78+/-3.3(14) 5.03+/-3.2(41) 0.010 
c1_RP_Atrial_gaus3_sc4_Shannon_Entropy_max  0.32+/-0.0(25) 0.26+/-0.1(14) 0.30+/-0.1(39) 0.010 
c2_PP_Atrial_gaus3_sc4_Mean_Freq_kurtosis  2.79+/-0.8(29) 6.29+/-6.9(15) 3.98+/-4.3(44) 0.010 
c2_PP_Atrial_gaus3_sc4_Median_Freq_kurtosis  2.85+/-1.3(29) 6.19+/-6.2(15) 3.99+/-4.0(44) 0.008 
c2_RP_Atrial_gaus3_sc4_Mean_Freq_kurtosis  2.73+/-0.8(27) 7.56+/-8.2(14) 4.38+/-5.3(41) 0.004 
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c2_RP_Atrial_gaus3_sc4_Median_Freq_kurtosis  2.77+/-1.1(27) 6.52+/-6.2(14) 4.05+/-4.0(41) 0.003 
c3_PP_Atrial_gaus3_sc4_Peak_Freq_min  4.86+/-2.0(29) 2.90+/-2.1(15) 4.19+/-2.2(44) 0.005 
c1_RP_Atrial_gaus3_sc7_Mean_Freq_max  11.11+/-2.8(25) 8.58+/-2.2(14) 10.20+/-2.9(39) 0.006 
c1_RP_Atrial_gaus3_sc7_Median_Freq_max  15.00+/-4.1(25) 11.57+/-2.9(14) 13.77+/-4.0(39) 0.009 
c2_PR_Atrial_gaus3_sc7_Mean_Freq_mean  7.69+/-1.6(27) 6.18+/-1.0(14) 7.17+/-1.6(41) 0.003 
c2_PR_Atrial_gaus3_sc7_Peak_Freq_mean  6.90+/-1.3(27) 5.21+/-1.0(14) 6.32+/-1.5(41) 0.000 
c3_PR_Atrial_gaus3_sc7_Mean_Freq_kurtosis  5.91+/-5.4(26) 27.34+/-35.8(14) 13.41+/-23.5(40) 0.004 
c1_RP_Atrial_gaus3_sc10_Shannon_Entropy_skewness 0.13+/-2.0(25) -3.17+/-5.3(14) -1.06+/-3.8(39) 0.008 
c1_PR_Atrial_gaus3_sc10_Nonlinear_Energy_skewness 0.73+/-1.0(25) -0.39+/-1.1(14) 0.33+/-1.2(39) 0.003 
c1_PR_Atrial_gaus3_sc10_Curve_length_skewness  0.28+/-0.8(25) -0.63+/-1.2(14) -0.05+/-1.0(39) 0.008 
c1_RP_Atrial_gaus3_sc13_Mean_Freq_min  3.29+/-1.1(25) 4.61+/-1.3(14) 3.77+/-1.3(39) 0.002 
c1_RP_Atrial_gaus3_sc13_Median_Freq_min  4.25+/-1.8(25) 6.66+/-2.5(14) 5.11+/-2.3(39) 0.001 
c1_PR_Atrial_gaus3_sc13_Nonlinear_Energy_skewness 0.67+/-1.0(25) -0.26+/-1.0(14) 0.34+/-1.1(39) 0.010 
c3_PR_Chest_gaus3_sc13_Katz_FD_skewness  0.51+/-1.0(26) 2.35+/-2.4(14) 1.15+/-1.8(40) 0.001 
c3_PR_Chest_gaus3_sc13_Katz_FD_kurtosis  6.25+/-6.5(26) 22.30+/-24.7(14) 11.87+/-17.0(40) 0.003 
c3_PR_Chest_gaus3_sc13_Shannon_Entropy_skewness 0.18+/-2.0(26) -2.07+/-3.1(14) -0.61+/-2.6(40) 0.008 
c1_RP_Atrial_gaus3_sc16_Median_Freq_min  3.74+/-2.1(25) 5.74+/-2.0(14) 4.46+/-2.2(39) 0.006 
c1_RP_Atrial_gaus3_sc16_Peak_Freq_min  0.96+/-1.0(25) 2.07+/-1.4(14) 1.36+/-1.3(39) 0.008 
c4_PP_Atrial_gaus3_sc16_Median_Freq_mean  4.29+/-1.2(24) 5.65+/-1.4(14) 4.79+/-1.4(38) 0.004 
c1_PP_Atrial_gaus3_sc19_Peak_Freq_skewness  -0.30+/-2.6(26) -4.95+/-6.6(15) -2.00+/-4.9(41) 0.003 
c1_RP_Atrial_gaus3_sc19_Mean_Freq_min  2.46+/-0.8(25) 3.30+/-1.0(14) 2.76+/-1.0(39) 0.007 
c1_PR_Chest_gaus3_sc19_Median_Freq_kurtosis  5.44+/-4.1(25) 13.03+/-11.6(14) 8.16+/-8.4(39) 0.005 
c3_PR_Atrial_gaus3_sc19_Median_Freq_skewness  0.03+/-1.5(26) 1.72+/-2.2(14) 0.62+/-1.9(40) 0.006 
c3_PR_Atrial_gaus3_sc19_Median_Freq_kurtosis  5.52+/-5.3(26) 16.45+/-16.6(14) 9.34+/-11.7(40) 0.004 
c3_PR_Chest_gaus3_sc19_Spectral_entropy_kurtosis 4.39+/-2.0(26) 12.79+/-14.6(14) 7.33+/-9.5(40) 0.006 
c4_PP_Atrial_gaus3_sc19_Spectral_entropy_max  3.73+/-2.8(24) 6.64+/-3.5(14) 4.80+/-3.3(38) 0.008 
c4_PP_Atrial_gaus3_sc19_Median_Freq_mean  3.78+/-1.2(24) 4.91+/-1.3(14) 4.19+/-1.3(38) 0.009 
c4_RP_Atrial_gaus3_sc19_Spectral_entropy_max  2.58+/-2.6(22) 5.36+/-3.2(13) 3.61+/-3.1(35) 0.009 
c4_RP_Atrial_gaus3_sc19_Spectral_entropy_std  0.25+/-0.2(22) 0.58+/-0.4(13) 0.37+/-0.4(35) 0.007 
c3_PP_Atrial_gaus4_sc4_Katz_FD_skewness  0.36+/-0.6(29) 1.27+/-1.6(15) 0.67+/-1.1(44) 0.007 
c3_PP_Atrial_gaus4_sc4_Nonlinear_Energy_skewness 0.37+/-0.6(29) 1.34+/-1.7(15) 0.70+/-1.2(44) 0.008 
c1_PR_Atrial_gaus4_sc10_Spectral_entropy_skewness 0.77+/-0.9(25) -0.10+/-1.0(14) 0.46+/-1.0(39) 0.009 
c1_PR_Atrial_gaus4_sc10_Nonlinear_Energy_skewness 0.90+/-1.4(25) -0.38+/-1.2(14) 0.44+/-1.5(39) 0.007 
c1_PR_Atrial_gaus4_sc10_Curve_length_skewness  0.59+/-1.2(25) -0.82+/-1.7(14) 0.08+/-1.5(39) 0.003 
c2_PR_Chest_gaus4_sc10_Shannon_Entropy_skewness -1.40+/-2.2(27) 0.83+/-2.7(14) -0.64+/-2.5(41) 0.006 
c1_PR_Atrial_gaus4_sc13_Nonlinear_Energy_skewness 0.72+/-1.0(25) -0.26+/-0.9(14) 0.37+/-1.1(39) 0.004 
c1_PR_Atrial_gaus4_sc13_Curve_length_skewness  0.33+/-0.8(25) -0.72+/-1.3(14) -0.04+/-1.1(39) 0.004 
c2_PR_Chest_gaus4_sc13_Median_Freq_min  4.30+/-0.6(27) 5.83+/-2.3(14) 4.82+/-1.6(41) 0.002 
c1_PP_Atrial_gaus4_sc16_Mean_Freq_skewness  0.05+/-1.8(28) 2.82+/-4.8(15) 1.02+/-3.4(43) 0.010 
c2_RP_Atrial_gaus4_sc16_Shannon_Entropy_skewness -0.26+/-1.3(27) -2.44+/-3.6(14) -1.01+/-2.5(41) 0.008 
c2_RP_Atrial_gaus4_sc16_Shannon_Entropy_kurtosis 4.04+/-3.1(27) 26.32+/-41.9(14) 11.65+/-26.3(41) 0.008 
c2_RP_Atrial_gaus4_sc19_Shannon_Entropy_skewness 0.02+/-1.7(27) -2.55+/-3.5(14) -0.85+/-2.7(41) 0.003 
c2_PR_Chest_gaus4_sc19_Median_Freq_std  1.23+/-0.7(27) 0.66+/-0.5(14) 1.04+/-0.7(41) 0.009 
c2_RP_Atrial_mexh_sc3_Median_Freq_kurtosis  3.26+/-1.5(27) 6.24+/-3.9(14) 4.28+/-2.9(41) 0.001 
c2_RP_Atrial_mexh_sc3_Peak_Freq_skewness  0.81+/-1.4(27) 2.71+/-2.9(14) 1.46+/-2.2(41) 0.007 
c2_PR_Chest_mexh_sc3_Nonlinear_Energy_mean  0.00+/-0.0(26) 0.00+/-0.0(14) 0.00+/-0.0(40) 0.010 
c4_PP_Atrial_mexh_sc3_Peak_Freq_min  1.79+/-1.3(24) 0.43+/-0.7(14) 1.29+/-1.3(38) 0.001 
c1_PR_Atrial_mexh_sc5_Nonlinear_Energy_skewness 0.77+/-1.4(25) -0.52+/-1.3(14) 0.31+/-1.5(39) 0.007 
c1_PR_Atrial_mexh_sc5_Curve_length_skewness  0.63+/-1.3(25) -0.87+/-1.7(14) 0.09+/-1.6(39) 0.003 
c3_PP_Atrial_mexh_sc5_Peak_Freq_mean  3.14+/-1.6(29) 1.90+/-1.0(15) 2.72+/-1.5(44) 0.009 
c3_RP_Atrial_mexh_sc5_Peak_Freq_mean  2.58+/-1.8(26) 1.12+/-1.0(14) 2.07+/-1.7(40) 0.008 
c4_PP_Atrial_mexh_sc5_Peak_Freq_mean  3.26+/-1.4(24) 2.07+/-1.1(14) 2.82+/-1.4(38) 0.009 
c4_RP_Atrial_mexh_sc5_Peak_Freq_mean  2.92+/-1.8(22) 1.27+/-1.4(13) 2.31+/-1.8(35) 0.008 
c4_PR_Atrial_mexh_sc5_Peak_Freq_max  7.61+/-4.2(22) 3.65+/-3.6(13) 6.14+/-4.4(35) 0.008 
c1_PR_Atrial_mexh_sc7_Nonlinear_Energy_skewness 0.75+/-1.1(25) -0.27+/-1.1(14) 0.38+/-1.2(39) 0.008 
c2_PR_Chest_mexh_sc7_Median_Freq_min  4.31+/-1.1(27) 6.34+/-3.0(14) 5.00+/-2.1(41) 0.003 
c4_PP_Atrial_mexh_sc7_Peak_Freq_mean  2.46+/-1.1(24) 1.32+/-0.9(14) 2.04+/-1.2(38) 0.002 
c4_RP_Atrial_mexh_sc7_Peak_Freq_max  5.59+/-3.1(22) 2.73+/-2.4(13) 4.53+/-3.2(35) 0.007 
c4_RP_Atrial_mexh_sc7_Peak_Freq_mean  2.39+/-1.6(22) 0.90+/-1.2(13) 1.84+/-1.6(35) 0.007 
c2_PP_Atrial_mexh_sc9_Shannon_Entropy_kurtosis  5.03+/-3.1(29) 17.72+/-22.7(15) 9.36+/-14.5(44) 0.005 
c3_PR_Atrial_mexh_sc9_Median_Freq_kurtosis  5.87+/-8.3(26) 22.15+/-28.4(14) 11.57+/-19.3(40) 0.009 
c4_PP_Atrial_mexh_sc9_Peak_Freq_mean  2.08+/-1.0(24) 1.13+/-0.8(14) 1.73+/-1.0(38) 0.006 
c1_PR_Atrial_mexh_sc13_Peak_Freq_skewness  2.92+/-6.5(16) -5.67+/-4.9(6) 0.58+/-7.1(22) 0.008 
c2_PR_Chest_mexh_sc13_Mean_Freq_min  3.18+/-1.5(27) 4.64+/-1.6(14) 3.68+/-1.7(41) 0.007 
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